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ABSTRACT 
 
 
Over the past 25 years, federal government entities have become involved in 
defining and regulating misconduct in scientific research. Consistently, these definitions 
of research misconduct forbid three key actions—falsification, fabrication, and 
plagiarism—but do not take into account other professional communication issues, 
mainly authorship. This lack of acknowledgement and regulation of authorship—
particularly from the Office of Research Integrity, the nation’s highest research ethics 
body—seems to imply and communicate that the ethics of authorship are not important in 
science. However, this thesis demonstrates, through rhetorical, historical and interview 
research, that authorship ethics do matter to scientists; in fact, authorship is a leading 
concern, even if not defined or regulated by federal oversight bodies. The thesis then 
recommends how authorship ethics can be better acknowledged by federal oversight 
boards without slipping into positivistic rules and requirements, and includes a 
recommendation to integrate ethics instruction into science curricula.  
 
 iii 
DEDICATION 
 
 
The thesis is dedicated first to my steadfast husband: Your love and unending 
support carried me through every class, assignment, paper and revision. You never 
complained, even while I did, even as you made sacrifices so I could complete this 
degree. We began this journey when our daughter was three months old; she is now an 
active two-year-old who has become accustomed to spending many happy evenings with 
Daddy while Mama attends class or needs to write. Thank you for giving me (and her) 
that time, letting me bounce ideas off of you, share frustrations and triumphs with you, 
and take this journey with you. We did it! 
I am also sincerely grateful for my generous parents-in-law, Dale and Nancy 
Linvill. Even before I thought I was ready to return to school, they offered suggestions 
and support to allow me to follow this goal. I would not have been able to complete this 
thesis (or degree) without their constant encouragement, unwavering faith in me, and 
many, many hours of babysitting help.  
Finally, I offer many thanks to my parents, my friends, and my extended family 
for your patience during this time. I could not give you all the time and attention I would 
have preferred, but you all gave me the support and blessings that I needed. Thank you 
all. 
 iv 
ACKNOWLEDGMENTS 
 
This thesis quite literally would not exist if Dr. Steven B. Katz, R. Roy and 
Marnie Pearce Professor of Professional Communication, had not taken me on as a 
research assistant. Knowing me only from the recommendation of a few colleagues, he 
took a chance on me, and then guided me from interested novice to devout fan of the 
study of ancient and modern rhetoric, ethics and scientific communication. Questions that 
he encountered while writing Writing in the Sciences planted the seed for our research, 
but I don’t think either of us expected it to grow as it has. He never saw this thesis as just 
a paper, but instead as the beginning of a scholarly journey together. I am indebted to him 
for his time, expertise and unending enthusiasm. 
Additionally, I would like to thank my interview participants for being not only 
generous with their time, but also open, thoughtful, and encouraging. Professor Tharon 
Howard offered constructive ideas as I worked through the beginnings of the project, 
including encouraging me to add the interviews. My committee members, Dr. Teresa 
Fishman, Director of the International Center for Academic Integrity, and Associate 
Professor Scott Mogull, who has experience publishing his own scientific research, were 
kind and supportive readers who gave me astute advice related to their fields of expertise, 
and guided me to create a more thorough research project than I ever thought possible.  
 v 
TABLE OF CONTENTS 
 
 
Page 
 
TITLE PAGE .................................................................................................................... i 
 
ABSTRACT ..................................................................................................................... ii 
 
DEDICATION ................................................................................................................ iii 
 
ACKNOWLEDGMENTS .............................................................................................. iv 
 
LIST OF TABLES ......................................................................................................... vii 
 
LIST OF FIGURES ...................................................................................................... viii 
 
CHAPTER 
 
 I. INTRODUCTION ......................................................................................... 1 
   
 II. UNDERSTANDING AUTHORSHIP ETHICS ............................................ 7 
 
   Scientists as Authors ................................................................................ 7 
   Ethics of Authorship ................................................................................ 9 
   The Importance of Credit/Credibility .................................................... 11 
   Authorship Ethics vs. Research Ethics .................................................. 14 
 
 III. RESEARCH MISCONDUCT AND THE  
   INCLUSION/EXCLUSION OF AUTHORSHIP ETHICS ................... 18 
 
   The Power and Influence of the ORI ..................................................... 26 
   Why ORI Does Not Regulate Authorship ............................................. 31 
   Role of Journals and Journal Editors ..................................................... 34 
 
 IV. SHOULD AUTHORSHIP BE REGULATED? .......................................... 38 
 
   Interview Process ................................................................................... 38 
   Scientists as Authors and Ethical Researchers ....................................... 40 
   How Scientists Make Authorship Decisions.......................................... 43 
   Should ORI Regulate Authorship? ........................................................ 49 
 
 V. CONCLUSION AND DISCUSSION ......................................................... 54 
 vi 
 
Table of Contents (Continued) 
 
Page 
 
APPENDICES ............................................................................................................... 58 
 
 A: Timeline with Definitions of Misconduct .................................................... 59 
 B: Summary of the Process of Responding to Allegations 
   of Research Misconduct ......................................................................... 72 
 C: Information about Being in a Research Study ............................................. 74 
 D: Interview Questions ..................................................................................... 76 
 E: Interview Transcripts 
   1 ............................................................................................................. 78 
   2.............................................................................................................. 86 
   3.............................................................................................................. 94 
   4............................................................................................................ 108 
   5............................................................................................................ 118 
   6............................................................................................................ 125 
   7............................................................................................................ 137 
   8............................................................................................................ 149 
   9............................................................................................................ 163 
 
WORKS CITED .......................................................................................................... 171 
 vii 
LIST OF TABLES 
 
 
Table                                                                                                                               Page 
 
2.1  Percentage of Scientists Who Say that They Engaged in  
the Behavior Listed within the Previous Three  
Years (n=3,247)…………………………………………………………16  
  
 
 3.1 Definitions of Research Misconduct in Government 
   Agencies ................................................................................................. 18 
 
 
 
 viii 
LIST OF FIGURES 
 
 
Figure                                                                                                                             Page 
 
 3.1 Official Regulators of Research Ethics ........................................................ 30 
 
  
  
 
 CHAPTER ONE 
 
INTRODUCTION 
 
 
“In science the credit goes to the man who convinces the world, not the 
man to whom the idea first occurs” (Sir Francis Darwin, Eugenics Review, 
1914). 
 
In preparing the epitaph for this introduction, I came across a research problem. I 
had seen this quotation a few times and wanted to use it, so I ran a Google search to find 
its source. The resulting pages credited the quotation to three different men: Sir Francis 
Darwin, Sir William Osler and Francis Galton. Most pages cited the first two men, and 
though I tried to compare the reliability and veracity of the Web pages, I was not able to 
confirm which person had actually penned the phrase. The irony of not being able to 
properly give credit for a quotation about gaining credit was thick (and amusing). 
Thankfully, a research librarian offered the help and trustworthy research I needed. She 
confirmed that Sir Francis Darwin had written the sentence, and she was able to refer me 
to the original 1914 text in Eugenics Review.  Poor Francis Darwin: in trying to make a 
point about the importance of associating your name with your scientific discovery, his 
own name had become disassociated with the idea. It would seem that ensuring that 
scientists are able to effectively communicate their ideas to the world has been an issue 
for at least a century. 
Actually, the perceived split of communication from the “real work” of science 
dates back thousands of years.  From Plato’s assertion that rhetoric (and writing) had no 
 2 
role in seeking true knowledge to Sprat’s call for an end to rhetoric and any eloquence in 
writing, communication has come to be viewed as something to be dealt with only after 
knowledge is “discovered.” Yet rhetoric and communication scholars, and thankfully 
many scientists, now seem to understand that communication is vital to the spreading of 
scientific knowledge and the work of scientists. Most scientists learn about research not 
by visiting labs or recreating studies, but by reading others’ research reports. Scientists 
spread knowledge about their work in journals, magazines, and Web sites targeted to a 
wide variety of audiences. They must regularly write grant proposals to fund their 
research and conference proposals to meet with other scientists; as such, scientists must 
write regularly in order to be able to keep doing science. In fact, the writing of lab 
reports, studies and data collection actually creates scientific fact (Latour and Woolgar). 
Writing is not separate from scientists’ work, it is central to it (see Chapter 2 and 
Foucault; Gross; Halloran and Whitburn; Latour; Latour and Woolgar; Myers; Penrose 
and Katz). 
During the early stages of research for this project, an article appeared in 
American Scientist about an issue integrally related to the concept of a scientist as a 
writer: authorship ethics (Anderson et al.). The article discusses the effect of scientists’ 
cultural differences on their authorship and communication ethics, like determining the 
allocation of credit and citing others’ work. It opened with a seemingly simple assertion: 
“Among scientists, authorship is a very big deal—and for good reason” (Anderson et al. 
1). The authors stated – with no hedging or citations – that authorship matters. Yet in a 
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field in which such a statement can be made as if it were obvious, there is strikingly little 
agreement or consistency regarding authorship and its implications in science.  
Questions concerning authorship – and especially authorship ethics – are currently 
under heated discussion among the scientific community. The scientific associations and 
the peer-reviewed journals that the associations publish have tackled authorship issues in 
science with growing frequency. Over the past ten years, articles have been written in 
major journals in the fields of medicine, engineering, education and more attempting to 
define authorship guidelines regarding research, funding, partnerships, writing, 
publication and the peer-review process, as well as draw attention to growing problems 
regarding these authorship concerns (for some of many examples, see Anderson et al; 
Pearson; Jones; Wagner). General science and academic publications like Nature and The 
Chronicle of Higher Education have recently exposed and discussed cases of 
questionable research ethics related to authorship issues (Pearson; Zhang; Basken).  
These discussions, as well as concerns expressed by scientists in interviews, 
imply that authorship ethics are of paramount concern to scientists. But are authorship 
concerns the same as research misconduct? Are they as important? Research misconduct 
is currently defined and regulated by the Office of Research Integrity (ORI), a branch of 
the Department of Health and Human Services that serves as the official oversight 
organization for scientific research. “ORI monitors institutional investigations of research 
misconduct and facilitates the responsible conduct of research (RCR) through 
educational, preventive, and regulatory activities” (Office of Research Integrity, 
“Welcome”), making it the highest ethical office in the United States. ORI’s most recent 
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(2005) guidelines define “research misconduct” as “fabrication, falsification, or 
plagiarism, including misrepresentation of credentials, in proposing, performing, or 
reviewing research, or in reporting research results” (Office of Research Integrity, 
“Introduction”). Missing from ORI’s definition, last updated in 2007, is any reference to 
authorship (beyond plagiarism).  
In 2005, a seminal research study by Martinson, Anderson and de Vries, 
published in the widely circulated, interdisciplinary journal Nature, implied that research 
misconduct and authorship ethics were closely intertwined.  Their survey of professional 
scientists found that arguably seven of the top sixteen instances of misconduct most 
reported by scientists were related to authorship issues. Of these seven commonly 
reported authorship issues, only one – plagiarism – is included in the current research 
guidelines issued by the ORI. ORI’s guidelines do not include common (per the 
Martinson, Anderson and de Vries study) ethical issues concerning authorship like 
assigning credit, disclosing involvement of others, publishing data repeatedly, or taking 
cues from funding sources. Why not? If authorship issues are so related to research 
misconduct, why does the ORI not regulate authorship? Since the ORI – and other 
governing bodies in science – do not regulate authorship or issue authorship guidelines, 
what does that say about the importance of authorship ethics? In short, in science, do the 
ethics of authorship matter? 
 To attempt to understand whether authorship ethics matter in science, this study 
will take a three-tiered research approach, combining rhetorical and historical research 
with personal interviews. First, it will discuss the rhetorical and ethical implications of 
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the role of the scientist as author, which will provide a foundation to better understand the 
current responsibilities of scientists as communicators. Then, it will explore the history 
and the foundation that informed the Office of Research Integrity – as well as other key 
regulators of American scientists – and their definitions of research misconduct (and 
whether those definitions address authorship). This history includes a timeline that 
highlights the key decisions and definitions made regarding research misconduct and 
authorship issues in scientific research in the past twenty-five years. The research also 
identifies other key organizations that regulate science and includes their definitions and 
histories as well. The final result is a timeline and a snapshot of the evolution of key 
definitions of research misconduct, which both help illuminate the current state of 
government regulation of scientific ethics. 
Next, the thesis will explore how scientists make authorship decisions, and 
whether authorship should be regulated. This chapter includes interviews with nine 
actively researching scientists working in a variety of fields. They discuss their methods 
for making authorship decisions, how they learned about authorship ethics, and their 
understanding of the roles of government and other oversight boards. These interviews 
highlight the language, passions and concerns of several scientists regularly grappling 
with authorship issues. Their ideas, combined with further research, provide the 
groundwork for a discussion on whether or not the ORI should better define or regulate 
authorship issues. 
Finally, the thesis will make recommendations regarding authorship and ethics 
education for scientists. If authorship ethics do matter, then it becomes imperative to give 
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students of science a foundation in ethics and an understanding of their role as 
communicators in order to produce responsible scientists in the future. The implications 
for this research, revealing the importance of authorship ethics, should impact not only 
the scientific community, but researchers in all fields. For as go the science publications, 
so go the humanities. So if authorship matters in one field, it matters to us all, and 
impacts how we all communicate our work.  
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CHAPTER TWO 
UNDERSTANDING AUTHORSHIP ETHICS 
Scientists as Authors 
 
“A full supply of facts begets a full supply of words” (Cicero 99; III.21.125). 
 
For centuries, writing has been viewed as separate from discovering truth. In the 
Phaedrus, Plato (as Socrates) argues that writing prevents the discovery of Truth, which 
implies that Truth exists outside of writing, and words can only attempt to convey Truth 
(and, he would argue, they fail in effectively doing so). Plato believed that the author of a 
written text is removed from the Truth, is not contributing to the advancement of 
knowledge, but rather is using a crude method to attempt to portray Truth. Plato’s low 
opinion of writing influenced Enlightenment-era thought-leaders and the development of 
modern science. Francis Bacon, considered the father of modern science for his insistence 
on observation and replication in science, believed that language was misleading and 
diverted science from true knowledge. John Locke concurred, dubbing language only a 
conduit for ideas observed in the natural world. In establishing the Royal Society of 
London, Thomas Sprat called for an end to the use of rhetoric and a return to plain, more 
mathematical speech. He asserted that “eloquence ought to be banished out of all civil 
societies” (111), distinctly removing writing, speech and persuasion from a scientist’s 
encouraged skill set. 
Thus, in the centuries from Plato’s dialogues through the positivist movement, 
writing and rhetoric were viewed as separate from the “real work” of science, in that 
communication was perceived as something to be dealt with only after knowledge was 
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“discovered.” In recent history, Latour and Woolgar turned this concept on its head when 
their extensive study of practicing scientists strongly suggested that the facts scientists 
“discovered” were actually created by the scientists as they followed the processes 
(outlined originally by Bacon) that society has determined add legitimacy to their 
findings (processes which, according to Latour and Woolgar, often take place as writing). 
Scientific facts, according to Latour and Woolgar, are social constructions, and even the 
act of fact-creation is based on the creation of meaning from symbols, which in turn is 
rhetorical. Furthermore, the earlier positivist view of science implied that invention was 
unnecessary – since facts were there to be discovered, not invented – but the social 
constructionist idea and movements opened the gateway for invention to join form and 
style in scientific and technical writing (Miller, “A Humanistic Rationale”). Scientists 
argue for ways of seeing the world, and argument – in writing or science – is rhetoric.   
Other studies further supported the holistic role of scientists as rhetoricians. 
Scientists must use rhetorical appeals in order to persuade audiences that the studies they 
have conducted accurately reflect the “facts” they claim to have discovered, illustrated or 
supported. Gross illustrates the importance of these appeals when he dissects the style 
and order of scientific papers, which reflect the inductive nature of science and make 
scientific findings sound more conclusive and inevitable than perhaps they truly are. 
Myers’s studies illustrate that an author’s ethos greatly influences how findings are 
perceived and accepted by the scientific community, and that the words used by the 
scientist/author affect whether or not a study will even be published. Myers argued that 
there are several rhetorical devices at play in constructing, producing, convincing others 
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of and defending knowledge claims. His studies bring to the forefront scientists’ need to 
be rhetoricians – having to be persuasive and write well in order to contribute to the field 
of knowledge. It would seem, then, that it is not about the quality of the study but rather 
the way it is presented that adds to our understanding of the world. Thus, to be effective, 
the scientist must be a persuasive author.  
These studies are illustrative of the power of the author in scientific research as 
they reflect the role the scientist plays as a communicator and as a persuader – not just as 
a researcher. Modern research has shown that the scientific paper is not a rhetorically null 
report of a study, but rather a carefully constructed piece of persuasion that leads to 
socially constructed facts. As Dobrin argues, because “scientific writing makes a truth 
claim” (101), it influences and changes discourse, thus it must be persuasive, and thus it 
is rhetorical.  The scientist, who once tried to be transparent, is now the author, who has 
the power to create fact, to add to our understanding of the world, through his or her use 
of rhetoric.  
 
Ethics of Authorship 
If we acknowledge the scientist as an author, then it follows that the scientist is 
also shouldered with the power and responsibilities associated with authorship. As 
Carolyn Miller argues, we must understand “practical rhetoric as a matter of conduct 
rather than of production, as a matter of arguing in a prudent way toward the good of the 
community rather than of constructing texts” (“What’s Practical” 23). As part of the 
scientific community, scientists must write not only good science (Miller’s term techne, 
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or “knowing-how”) but also science writing for the good of a greater community 
(Miller’s term phronesis, or “knowing-that”). As authors, scientists must balance the 
power of creating fact with the responsibility of serving a greater community. As Slack, 
Miller and Doak contend about technical writers, but which also applies to science 
writers:  
“The consequences of extending authorship to technical communicators are 
significant. With the recognition that the communicator articulates and 
rearticulates meaning comes the responsibility for that rearticulation. No 
contribution is really transparent; it is only rendered transparent in relations of 
power. So, just as the power of technical communicators is recognized (as they 
are empowered), so too must they be held responsible.” (31)  
If science writers can articulate meaning and manage power, as argued by Slack, Miller 
and Doak, then it follows that they need to be knowledgeable about rhetoric and ethics in 
order to manage and be responsible for that power. 
Steven B. Katz articulated the importance of ethical communication in analyzing 
biotechnology, corporate, and risk management communications (“Biotechnology”; 
“Ethic of Expediency”; “Low-Level Radioactive” with Miller). In these genres, if the 
author does not properly take into account the audience, the situation, and the appropriate 
style, grave consequences could result, ranging from a panicked public to protests to 
government debacles to mass deaths. Poor communication, argues Katz, is not from bad 
writing (as in, poor grammar), but is rather “the result of rhetorical choices of 
organization, style, and/or diction that are ultimately based on unconscious and often 
 11 
flawed assumptions about the role of language, values, and emotion in communication 
and decision-making” (Katz, “Language and Persuasion” 93). Instead of taking into 
account crucial ethical considerations regarding the audience and the role of language 
interpretation, too often, risk management and biotechnology communicators rely on the 
dated information-theory model of communication, in which a sender (in this case, an 
expert believed to hold all the facts and power) encodes a message, sends it to a receiver, 
and hopes noise does not interfere (Katz, “Biotechnology”). The effectiveness of writing 
based on an ethic of expediency, which relies only on the information-theory model of 
relations between humans, leaves bare a host of issues concerning what is good for the 
community (phronesis), and the need for a communicator to understand both the means 
and ends of communication (Katz, “Ethic of Expediency”). Katz thus calls for 
biotechnology communicators to take into account human creativity in communication, 
the ambiguity of language, and the role of style in creating meaning; and thus, he 
effectively implies that communicators – even in scientific fields – have an ethical 
responsibility to understand rhetoric. To achieve a greater understanding of rhetoric and 
ethics, one must better understand specifically how issues of communication ethics 
directly affect scientists. Specifically, communication ethics are likely important to 
scientists because they affect credit and credibility, which are essential for the continued 
production of science. 
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The Importance of Credit/Credibility 
Because the credit one earns for research and publication is vital to a scientist’s 
ability to contribute to the discourse community, it would follow that authorship is a 
major issue in science. As Drummon Rennie, deputy editor of the Journal of the 
American Medical Association (JAMA) remarked, “Credit more than anything drives 
science” (qtd. in Pearson 591). Known as “the coin of the realm” (Wilcox 216; App. E, 3, 
101), credit affects scientists’ careers, ranging from earning tenure and promotions to 
receiving funding and resources to gaining influence and power (Wilcox; Latour and 
Woolgar). Latour and Woolgar discuss credit as not just the rewards a scientist can 
receive, like job promotions and tenure, but also the credibility it allows in the field. As a 
scientist is deemed credible by his or her peers (often via a history of publications, which 
must be continually made in order to keep credibility), that scientist is awarded his or her 
own lab to oversee, funded research assistants and – most importantly – can more easily 
make fact-claims that contribute to science. Latour and Woolgar, as well as Myers in his 
study following two biologists trying to publish research papers, have pointed out that 
who makes a factual claim in science is as important (if not more so) than what the claim 
is. Credibility – which determines the ability to even “be allowed to” (via gatekeepers 
like journal reviewers or grant readers) contribute to the social construction of fact – is 
awarded to scientists who have already proven themselves as trustworthy and capable to 
their peers via publications. (For further discussion the importance of authorship and 
links to credit, see Chapter 4). 
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The issue of ethics arises, though, in that the allocation of credit can be a difficult 
and usually unregulated process. With so much at stake regarding credit, scientists are 
faced with needing to receive authorship credit for the work they have accomplished, 
while also considering the contributions and careers of their fellow researchers. The key 
issue, though, is that there are few defined rules regarding the definition of an author 
(who should get credit) nor the order in which those authors should be credited (who 
contributed the most) (Jones; Louis et al.). When rules do exist, they tend to be 
discipline-specific, not overarching for scientists in general (Geelhoed et al.; Jones). This 
can create an ethical dilemma at the time of publication.  
 “The central problem is that there are no set rules for assigning credit…. [The] 
differences in expectation [among disciplines] create fertile ground for disputes. 
And many say that the number and ferocity of such clashes is rising with the 
number of collaborative projects, which often have multiple authors spanning 
disciplines and national borders. (Pearson 591-592). 
As this research will explore further, the complicating factors influencing authorship – 
including credit, status, reputation and more – seem to illustrate the need for the issue to 
be better defined and regulated. While the Pearson quotation above states that there are 
“no set rules for assigning credit,” various groups do have influence over scientists’ 
authorship decisions – including government agencies, journal editors, funding 
institutions and professional societies (see fig. 3.1). These rules, however, seem 
inconsistent or irrelevant to practicing scientists, who rarely research authorship rules and 
guidelines, even while admitting the issue is very important (see interviews in Chapter 4). 
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Authorship Ethics vs. Research Ethics 
In the textbook Writing in the Sciences, Penrose and Katz contend that the same 
values that science requires for ethical research – “honesty, skepticism, fairness, 
collegiality, and openness” – apply directly to authorship as well (62). As such, they 
seamlessly combine communication ethics with research ethics: one cannot research 
ethically without also communicating ethically. However, scientific agencies seem to 
hark back to the positivistic view that it is possible to separate communication from 
knowledge, or authorship ethics from research ethics. In this environment, how, then, do 
the ethics of authorship fit in with or relate to the ethics of proper scientific research? To 
today’s practicing scientists, are authorship concerns the same as research concerns? 
Though plenty of resources exist to educate scientists on basic, ethical research practices, 
and plenty of regulatory bodies exist to define research misconduct (see Chapter 3), few 
of these focus on the ethical questions raised when a scientist’s role becomes author, a 
creator of truth. But these questions are clearly becoming more pressing, especially as 
science requires larger research teams, more communication and converging cultures – 
what Louis et al. term “the increasing complexity of science” (89) – and those 
responsible for reviewing, editing and publishing scientific research are scrambling to 
answer them. 
Over the past ten years, articles have appeared in scientific journals from various 
fields and disciplines attempting to answer questions regarding authorship and 
publication ethics. Discussions of communication ethics in many of the articles has 
centered on publication ethics and authorship. Authorship and publication issues 
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mentioned in the literature include discussions of credit allocation, data fabrication, self-
plagiarism (also known as redundant publication), cultural differences in authorship 
decisions, roles of journal editors, and best practices for author order (Anderson et al.; 
Jones; Louis et al.; Pearson). Of all these discussions, one authorship issue in particular – 
the allocation of credit – appears in almost all discussions regarding publication ethics 
and concerns, which makes sense considering the importance that credit plays in 
furthering science.  These discussions help cement the idea that publication ethics are 
“forms of research misconduct that can undermine the scientific literature” (Wager et al. 
348).  One research piece in particular effectively argued the idea that authorship 
concerns are not only troublesome, but are in fact a form of research misconduct.  
In 2005, Martinson, Anderson and de Vries’s survey in the widely circulated 
journal Nature shed light not only on the various types of ethical dilemmas in research 
beyond simple research misconduct, but how many of them related to authorship. In 
Martinson, Anderson and de Vries’s survey, 33% of scientists self-reported that they had 
participated in one of the top ten instances of research misconduct. Arguable, six of those 
ten types of misconduct involve communication, including issues about assigning credit 
and not including research that contradicts one’s study (see table 2.1). Of the sixteen total 
instances of misconduct reported by scientists, seven were related to communication. 
Martinson, Anderson and de Vries’s survey helped galvanize the discussion that 
communication ethics in themselves were and are an important aspect of research and 
publication in science (for one example, see Penrose and Katz, Ch. 3). Yet two years after  
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Table 2.1 Percentage of Scientists Who Say that They Engaged in the Behavior Listed 
within the Previous Three Years (n=3,247) 
Top ten behaviors All 
    Mid-    
    Career 
  Early  
  Career 
1. Falsifying or ‘cooking’ research data 0.3 0.2 0.5 
2. Ignoring major aspects of human-subject 
requirements 0.3 0.3 0.4 
3. Not properly disclosing involvement in firms whose 
products are based on one's own research 0.3 0.4 0.3 
4. Relationships with students, research subjects or 
clients that may be interpreted as questionable 1.4 1.3 1.4 
5. Using another’s ideas without obtaining permission 
or giving due credit 1.4 1.7 1 
6. Unauthorized use of confidential information in 
connection with one’s own research 1.7 2.4 0.8 *** 
7. Failing to present data that contradict one’s own 
previous research 6 6.5 5.3 
8. Circumventing certain minor aspects of human-
subject requirements 7.6 9 6.0 ** 
9. Overlooking others' use of flawed data or 
questionable interpretation of data 12.5 12.2 12.8 
10. Changing the design, methodology or results of a 
study in response to pressure from a funding source 15.5 20.6 9.5 *** 
Other behaviors       
11. Publishing the same data or results in two or more 
publications 4.7 5.9 3.4 ** 
12. Inappropriately assigning authorship credit 10 12.3 7.4 *** 
13. Withholding details of methodology or results in 
papers or proposals 10.8 12.4 8.9 ** 
14. Using inadequate or inappropriate research designs 13.5 14.6 12.2 
15. Dropping observations or data points from analyses 
based on a gut feeling that they were inaccurate 15.3 14.3 16.5 
16. Inadequate record keeping related to research 
projects 27.5 27.7 27.3 
  
  
  
Note: significance of x2 tests of differences between mid- and early-career scientists as noted 
by **(P<.01) and ***(P<.001). 
Source: Brian C. Martinson, Melissa S. Anderson and Raymond de Vries, “Scientists 
Behaving Badly,” Nature 435.9 (2005): 737.  
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Martinson, Anderson and de Vries’s study was published, the Office of Research 
Integrity restated their definition of research misconduct as “fabrication, falsification, or 
plagiarism [FFP], including misrepresentation of credentials, in proposing, performing, or 
reviewing research, or in reporting research results” (Office of Research Integrity, 
“Introduction”), which does not take into account any authorship concerns beyond 
plagiarism. They seem to have ignored Martinson, Anderson and de Vries’s survey and 
much of the other published research about the link between authorship and research 
misconduct. It is therefore important to understand how the ORI arrived at such a 
definition and why they, and other regulating bodies, are refraining from defining and 
regulating authorship ethics. 
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CHAPTER 3 
RESEARCH MISCONDUCT AND THE INCLUSION/EXCLUSION  
OF AUTHORSHIP ETHICS 
“Promoting research integrity is important for preserving the trust within 
the research community and the public. Without integrity, progress can be 
thwarted easily and public health could be at risk.” (Scheetz 323) 
Authorship ethics, it would seem, are not only essential to the practice of science, 
they are inseparable from research ethics. But even the concept of research ethics is not 
always clear cut. To try to understand the role of authorship ethics within (or essential to, 
or peripheral to) research misconduct, we must first understand what constitutes research 
misconduct and which groups control and regulate research misconduct. A summary of 
the history and development of definitions of research misconduct can be found in the 
Timeline (Appendix A). A chart illustrating the evolution of definitions of research 
misconduct and listing each definition in full can be found in table 3.1. 
Table 3.1 Definitions of Research Misconduct in Government Agencies 
Date Organization Definition of Research Misconduct Of Note 
July 
1987 
National 
Science 
Foundation 
(NSF) 
"(1) fabrication, falsification, plagiarism, or other serious 
deviation from accepted practices in proposing, carrying out, 
or reporting results from activities funded by NSF; or  
(2) retaliation of any kind against a person who reported or 
provided information about suspected or alleged misconduct 
and who has not acted in bad faith" (Fischer). 
"Deviating from 
accepted practice" 
potentially 
prosecutes scientists 
using radical new 
approaches. 
1989 Public Health 
Services (PHS) 
"Fabrication, falsification, plagiarism, or other practices that 
seriously deviate from those that are commonly accepted 
within the scientific community for proposing, conducting, or 
reporting research" (Schechter and Schwartz). 
"Other practices" is 
vague wording. 
Potentially 
prosecutes scientists 
using radical new 
approaches. 
1992 National 
Academies of 
Sciences and 
Engineering 
In Responsible Science: Ensuring the Integrity of the 
Research Process: "Misconduct in science is defined as 
fabrication, falsification, or plagiarism, in proposing, 
performing, or reporting research. Misconduct in science 
FFP only 
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and the Institute 
of Medicine 
does not include errors of judgment; errors in the recording, 
selection, or analysis of data; differences in opinions 
involving the interpretation of data; or misconduct unrelated 
to the research process. Fabrication is making up data or 
results, falsification is changing data or results, and 
plagiarism is using the ideas or words of another person 
without giving appropriate credit." (27) 
1995 Commission on 
Research 
Integrity (aka 
The Ryan 
Commission) 
“Research misconduct is significant misbehavior that 
improperly appropriates the intellectual property or 
contributions of others, that intentionally impedes the 
progress of research, or that risks corrupting the scientific 
record or compromising the integrity of scientific practices. 
Such behaviors are unethical and unacceptable in proposing, 
conducting, or reporting research, or in reviewing the 
proposals or research reports of others. 
Examples of research misconduct include but are not 
limited to the following: 
Misappropriation: An investigator or reviewer shall not 
intentionally or recklessly 
a. plagiarize, which shall be understood to mean the 
presentation of the documented words or ideas of another 
as his or her own, without attribution appropriate for the 
medium of presentation; or 
b. make use of any information in breach of any duty of 
confidentiality associated with the review of any 
manuscript or grant application.  
Interference: An investigator or reviewer shall not 
intentionally and without authorization take or sequester or 
materially damage any research-related property of another, 
including without limitation the apparatus, reagents, 
biological materials, writings, data, hardware, software, or 
any other substance or device used or produced in the 
conduct of research. 
Misrepresentation: An investigator or reviewer shall not with 
intent to deceive, or in reckless disregard for the truth, 
a. state or present a material or significant falsehood; or 
b. omit a fact so that what is stated or presented as a 
whole states or presents a material or significant 
falsehood.” (15-17) 
Much of this 
recommendation was 
not taken by the 
Department of 
Health and Human 
Services. The DHHS 
referenced this 
recommendation 
when developing the 
definition below. 
Oct. 
1999 
(accept-
ed); 
Dec. 
2000 
(pub- 
lished) 
Department of 
Health and 
Human 
Services' Office 
of Research 
Integrity (ORI) 
and Office of 
Science and 
Technology 
Policy (OSTP) 
"Research misconduct is defined as fabrication, falsification, 
or plagiarism in proposing, performing, or reviewing 
research, or in reporting research results. … Fabrication is 
making up data or results and recording or reporting them. 
Falsification is manipulating research materials, equipment, 
or processes, or changing or omitting data or results such that 
the research is not accurately represented in the research 
record...Plagiarism is the appropriation of another person's 
ideas, processes, results, or words without giving appropriate 
credit. Research misconduct does not include honest error or 
differences of opinion." (Ferguson) 
Back to FFP (despite 
recommendations 
above) 
April 
2001 
National 
Science 
Foundation 
"Research misconduct means fabrication, falsification, or 
plagiarism in proposing or performing research funded by 
NSF, reviewing research proposals submitted to NSF, or in 
Revised from 1987, 
but still mainly FFP. 
Also includes phrase 
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(NSF) & Office 
of Inspector 
General 
reporting research results funded by NSF. 
(1) Fabrication means making up data or results and 
recording or reporting them. 
(2) Falsification means manipulating research materials, 
equipment, or processes, or changing or omitting data or 
results such that the research is not accurately represented in 
the research record. 
(3) Plagiarism means the appropriation of another person’s 
ideas, processes, results or words without giving appropriate 
credit.... 
Research misconduct does not include honest error or 
differences of opinion. (237) …. 
A finding of research misconduct requires that— 
(1) There be a significant departure from accepted practices 
of the relevant research community; and 
(2) The research misconduct be committed intentionally, or 
knowingly, or recklessly; and 
(3) The allegation be proven by a preponderance evidence." 
(238) 
potentially implying 
importance of 
community to self-
regulate: "significant 
departure from 
accepted practices of 
the relevant research 
community." 
May 
2005 
Office of 
Research 
Integrity (ORI) 
for PHS 
"Research misconduct means fabrication, falsification, or 
plagiarism in proposing, performing, or reviewing research, 
or in reporting research results. 
(a) Fabrication is making up data or results and recording or 
reporting them. 
(b) Falsification is manipulating research materials, 
equipment, or processes, or changing or omitting data or 
results such that the research is not accurately represented in 
the research record. 
(c) Plagiarism is the appropriation of another person's ideas, 
processes, results, or words without giving appropriate credit. 
(d) Research misconduct does not include honest error or 
differences of opinion." (U.S. Dept. of Health and Human 
Services) 
Definition of 
Research 
Misconduct, Sec. 
93.103 
    "Although most 
commentators 
supported the new 
definition of research 
misconduct, there 
were a number of 
comments 
recommending 
changes, including 
that: (1) The 
definition should be 
based on deception; 
(2) the definition of 
falsification is 
inadequate because it 
does not cover the 
nonexperimental 
manipulation of 
human or animal 
subjects with the goal 
of influencing 
research results, or 
bias in the coding of 
qualitative data; (3) 
the definition of 
plagiarism should 
expressly exclude 
authorship and credit 
disputes; and (4) the 
definition of 
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misconduct should 
be expanded to 
include negligent and 
intentional 
mistreatment of 
animals. 
    As explained in 
the preamble of the 
NPRM, the proposed 
definition of research 
misconduct, which is 
included in this final 
rule without change, 
includes OSTP's 
description of 
“fabrication, 
falsification, and 
plagiarism.” That 
description is clear 
and sufficiently 
concrete to provide 
the basis for 
reasonable 
determinations of 
whether research 
misconduct has 
occurred and whether 
the misconduct was 
intentional, knowing, 
or reckless. Given 
the careful 
consideration that 
has been given to this 
definition and the 
value of a uniform 
government-wide 
definition, we are 
adopting the 
definition as it was 
proposed." (U.S. 
Dept. of Heath and 
Human Services) 
 
 Research misconduct has only recently been formally defined and regulated in the 
United States on the federal level. Several government agencies and departmental 
committees have been developed in the past 30 years, and often later combined, to 
regulate the work of scientists. Major government funding agencies that oversee research 
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include the National Institutes of Health (NIH, part of the U.S. Department of Health and 
Human Services) and the National Science Foundation (NSF), which set research 
guidelines for scientists and institutions that apply for their grants. The top-most 
government services agency that regulates research is the Office of Research Integrity 
(ORI), which is housed within the U.S. Department of Health and Human Services. The 
ORI developed when two branches of the Public Health Service (PHS), the Office of 
Scientific Integrity (housed in the National Institute of Health) and the Office of 
Scientific Integrity Review (housed in Office of the Assistant Secretary for Health) 
consolidated in May 1992 (ORI, “About ORI – History”). Other organizations at the 
federal level also help educate scientists on research misconduct, including: the National 
Academies’ Committee on Science, Engineering and Public Policy (which publishes the 
booklet On Being a Scientist: Responsible Conduct in Research); the National Academies 
of Science and Engineering; the Institute of Medicine; the National Academies’ Panel on 
Scientific Responsibility and the Conduct of Research; and the Office of the Inspector 
General, which operates within the NSF (Committee on Science Engineering and Public 
Policy; Martinson, Anderson and de Vries). 
These organizations and the research-misconduct focused committees within them 
have been formed as research misconduct has become a bigger issue, one that needed 
defining and regulating. Research misconduct became a public issue in 1981 during 
Congressional hearings that were held in response to some high profile cases of unethical 
research (Office of Research Integrity “About ORI – History”; Jones; Schechter and 
Schwartz). The hearings led to the passage of the Health Research Extension Act in 1985. 
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This act required regulations regarding research fraud to be investigated and reported by 
federal government science agencies (ORI, “About ORI – History”), which in turn led to 
1) the NIH publishing research guidelines – mainly concerning funding, responsibilities 
and conflicts of interest – which were published in 1986 and codified in 1989 (ORI, 
“About ORI – History”), and 2) the NSF formally defining research misconduct in 1987 
(Fischer). The NSF’s original definition of research misconduct was:  
(1) fabrication, falsification, plagiarism, or other serious deviation from accepted 
practices in proposing, carrying out, or reporting results from activities funded by 
NSF; or  
(2) retaliation of any kind against a person who reported or provided information 
about suspected or alleged misconduct and who has not acted in bad faith. 
(Fischer) 
In 1989, the Public Health Service published a similar definition, which focused still on 
fabrication, falsification and plagiarism, but removed the retaliation segment and stressed 
the concept of deviating from the scientific community (Schechter and Schwartz). 
Definitions of research misconduct by the National Academies of Sciences and 
Engineering with the Institute of Medicine, and the Department of Health and Human 
Services’  two subgroups, the Office of Research Integrity and the Office of Science and 
Technology Policy (OSTP), have each published definitions of research misconduct that, 
like all the previously published ones, stress and define the three main tenants of 
fabrication, falsification and plagiarism (Panel on Scientific Responsibility; Ferguson).  
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 During the past 30 years, the definitions of research misconduct have gone 
through some subtle changes, but nothing drastic. Let’s briefly trace that history, which is 
summarized in table 3.1 and further expanded in the timeline in Appendix A. In 1991, the 
NSF revised their 1987 definition, and then revised it again in 2002 in conjunction with 
the Office of the Inspector General. This most recent iteration offers detailed definitions 
of fabrication, falsification and plagiarism and provides guidelines for determining if an 
action meets their standards of research misconduct (Office of Inspector General). The 
ORI published a definition in 2000 with the OSTP, then revised this definition in 2005 
for the PHS, though the revision is a near carbon-copy of the original. Throughout the 
past three decades and across all the federal agencies, all the definitions of research 
misconduct include at their core the three words “fabrication, falsification, plagiarism.” 
In fact, few of the definitions include anything beyond these three forbidden actions or 
brief descriptions of what the three terms mean. 
In 1995, the Commission on Research Integrity, also known as the Ryan 
Commission, was formed to make recommendations to the Secretary of Health and 
Human Services, the House Committee on Commerce, and the Senate Committee on 
Labor and Human Resources about the definition of research misconduct and to address 
incidences of retaliation against whistleblowers who had reported misconduct 
(Commission on Research Integrity). The Commission recommended a new definition of 
research misconduct that went well beyond the “fabrication, falsification, plagiarism” 
definition that was currently in place. The Ryan Commission defined research 
misconduct as: 
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 …significant misbehavior that improperly appropriates the intellectual property 
or contributions of others, that intentionally impedes the progress of research, or 
that risks corrupting the scientific record1
The definition goes on to include examples of misconduct in the categories of 
misappropriation (plagiarism or a breach of confidentiality), interference (disrupting the 
work of another scientist) and misrepresentation (lying or withholding information) 
(Commission on Research Integrity). The Ryan Commission’s recommended definition 
of research misconduct puts authorship issues – intellectual property and intellectual 
contribution – at the forefront of the definition, and includes further examples related to 
authorship ethics, including plagiarism, confidentiality, misrepresentation of the truth, 
and the altercation of facts in written reports. Clearly, the Ryan Commission felt that 
authorship ethics were central to research misconduct, yet their definition was not 
accepted in full by the then-Secretary of Health and Human Services, Donna Shalala, 
who instead implemented a definition of research misconduct proposed by the National 
Science and Technology Council (ORI, “About ORI – History”). The DHHS’s new 
Federal Research Misconduct Policy, published in December 2000, again defined 
research misconduct “as fabrication, falsification, or plagiarism in proposing, performing, 
or reviewing research, or in reporting research results” (Ferguson, n.p.). The Policy 
makes clear the DHHS’s choice to not include authorship issues, despite the Ryan 
Commission’s recommendations; in fact, the Policy included an acknowledgement of the 
 or compromising the integrity of 
scientific practices. (Commission on Research Integrity 15) 
                                                 
1 “The record encompasses any documentation or presentation of research, oral or written, published or 
unpublished” (Commission on Research Integrity 15, note 20). 
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omission in its FAQs: “Are authorship disputes covered by this policy? Authorship 
disputes are not covered by this policy unless they involve plagiarism” (Ferguson n.p.).  
 Clearly, then, the governmental regulation and funding agencies choose only to 
regulate and define the singular issue of plagiarism as an authorship concern related to 
research misconduct, leaving out other nuances of authorship ethics. Furthermore, 
Martinson, Anderson and de Vries’s survey, which exposed how many reports of 
research misconduct were related to authorship, was administered in 2002 and published 
in 2005, and concluded: “Our findings suggest that US scientists engage in a range of 
behaviours extending far beyond falsification, fabrication and plagiarism” (737).  Yet 
ORI’s definition was updated in 2005 (theoretically in time to have read the Martinson, 
Anderson and de Vries’ report) with no inclusion of authorship issues or any expansion 
beyond the three tenants. The actions seem obvious: the ORI, the nation’s highest 
oversight body on research ethics, chooses not to regulate or define issues concerning 
authorship as being part of research misconduct. But why? 
 
The Power and Influence of the ORI 
 Before further analyzing what the ORI does not regulate, we need to 
understand what they do regulate and their process of review and punishment. The ORI 
“oversees and directs Public Health Service (PHS) research integrity activities” (“About 
ORI”). The PHS is comprised of 10 agencies, including the National Institute for Health, 
the Food and Drug Administration and the Centers for Disease Control and Prevention 
(“About ORI”). PHS provides billions of dollars in funding to support research at federal 
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and non-government (e.g. universities, hospitals, research institutions) agencies (“About 
ORI”). The ORI oversees the integrity of research at the institutions they fund by: 
• developing policies, procedures and regulations related to the detection, 
investigation, and prevention of research misconduct and the responsible 
conduct of research;  
• reviewing and monitoring research misconduct investigations conducted 
by applicant and awardee institutions, intramural research programs, and 
the Office of Inspector General in the Department of Health and Human 
Services (HHS);  
• recommending research misconduct findings and administrative actions to 
the Assistant Secretary for Health for decision, subject to appeal;  
• assisting the Office of the General Counsel (OGC) to present cases before 
the HHS Departmental Appeals Board;  
• providing technical assistance to institutions that respond to allegations of 
research misconduct;  
• implementing activities and programs to teach the responsible conduct of 
research, promote research integrity, prevent research misconduct, and 
improve the handling of allegations of research misconduct;  
• conducting policy analyses, evaluations and research to build the 
knowledge base in research misconduct, research integrity, and prevention 
and to improve HHS research integrity policies and procedures;  
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• administering programs for: maintaining institutional assurances, 
responding to allegations of retaliation against whistleblowers, approving 
intramural and extramural policies and procedures, and responding to 
Freedom of Information Act and Privacy Act requests. (ORI, “About 
ORI”) 
As such, ORI serves as the nation’s highest regulation body for research misconduct in 
science. 
 When an allegation of misconduct takes place at an institution receiving PHS 
funds, the incident is reviewed on the institutional level but overseen by the ORI. See 
Appendix B for a summary of the process that is taken when an allegation of misconduct 
occurs. The ORI must be notified before an investigation begins and of the final outcome 
(ORI “Sample Policy”).  ORI becomes more immediately involved if the case exhibits: a 
possible health hazard to humans or animals; a need to protect federal funds or resources; 
a need to protect those involved in the allegation; an alleged incident that might be 
reported publicly prematurely or should be reported to the public promptly; research 
needs to be halted; or a crime might have been committed (ORI “Sample Policy”). 
 If, after an investigation, it is found by the institution (and agreed upon by ORI) 
that a respondent committed research misconduct, then the Public Health Services and 
the Department of Health and Human Services can administer significant actions, 
including:  
• debarment from eligibility to receive Federal funds for grants and 
contracts,  
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• prohibition from service on PHS advisory committees, peer review 
committees, or as consultants,  
• certification of information sources by respondent that is forwarded by 
institution,  
• certification of data by institution,  
• imposition of supervision on the respondent by the institution,  
• submission of a correction of a published article by respondent, and  
• submission of a retraction of a published articles by respondent. (ORI, 
“Handling Misconduct”) 
In other words, findings of research misconduct by the ORI can result in scientists losing 
funds, equality with their peers, seniority and respect of their universities. In short, 
scientists stand to lose that key important factor needed to practice science: credibility.  
 One could argue that due to its overarching range and its ability to essentially ban 
a scientist from research, the ORI thus serves as the most over-arching body influencing 
practicing scientists. Scientists’ actions are regulated by a variety of different agencies 
and influencers, as seen in figure 3.1, with the ORI serving as the largest, but perhaps 
most removed. The figure illustrates, using a solid line, how ORI actually oversees (by 
administrating investigations and prescribing punishment) the funding sources that 
oversee the institutions. The dotted line implies how, as the nation’s largest oversight 
body, their rules symbolically influence all aspects of a scientists’ career, even when their 
punishment is not a threat (in other words, ORI cannot specifically administer 
punishment on a journal or society, unless the case to turned over the institution where  
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Figure 3.1 Official Regulators of Research Ethics 
 
the scientist worked). The figure also makes clear how the regulators of scientists most 
related to publication and authorship – journals and professionally societies – are not 
within the realm of the ORI’s actual influence. Journals and societies have thus had to fill 
the void of the lack of authorship oversight by the ORI by creating their own guidelines 
for authorship ethics (for more information, see the section below about journals and 
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editors, as well as Appendix A, which lists regulations and definitions issued by the 
International Council of Medical Journal Editors and the Council of Science Editors.) It 
seems irresponsible, or at least incongruent, that ORI, the symbolic overseer of ethical 
research in the United States, has chosen not regulate an issue of great importance to 
some of the major influencers of scientists. 
 
Why ORI Does Not Regulate Authorship 
 In March 1999, Mary Scheetz of the Office of Research Integrity’s Division of 
Policy and Education wrote an article for the Croatian Medical Journal2
                                                 
2 Though Science Magazine claims the Croatian Medical Journal has “a respectable impact factor of 1.45” 
and “has garnered international respect for its quality standards” (Tatalovic, n.pag.), it seems odd (and 
perhaps telling?) that a foreign publication was the location of a paper regarding U.S. research misconduct 
standards. 
 explaining the 
role of ORI in regulating research misconduct and outlining why the ORI and the PHS do 
not get involved in authorship disputes. According to Scheetz, the ORI places the bulk of 
regulation for misconduct – including issues of authorship – on the institutions 
conducting research. The ORI first determines that institutions have regulations in place 
to monitor misconduct and conduct investigations. “Because institutions have the primary 
responsibility for responding to allegations of scientific misconduct, the ORI role in most 
investigations is usually that of reviewing the institution’s investigative report” (Scheetz 
322). “Because institutions are the recipients of the Public Health Service funds, ORI 
considers it the institutions’ responsibility to manage the funds they receive and mediate 
disputes that may arise over authorship controversies” (Scheetz 324). 
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Scheetz argues that the ORI cannot be directly involved in authorship disputes 
because so many of them are not related to scientific misconduct – in other words, per 
ORI’s definition, these disputes are not plagiarism:  
ORI receives many allegations that do not meet the Public Health Service 
definition of scientific misconduct. Misunderstandings about the Public Health 
Service definition have contributed to plagiarism allegations that are later 
determined to be authorship disputes. Authorship disputes comprised 
approximately 22% of the 166 allegations in 1997, and 27% of the 112 allegations 
that ORI received in 1998. Typically, a complainant submits an allegation of 
scientific misconduct believing it to be one of plagiarism; however, upon review 
ORI often determines that the alleged misconduct is better characterized as an 
authorship dispute, rather than plagiarism. One reason for this confusion may be 
that ORI’s interpretation of plagiarism under the Public Health Service definition 
of scientific misconduct has a more narrow scope than the term plagiarism as used 
more casually in the non-regulatory context. (Scheetz 323). 
Scheetz cites a previously published definition of plagiarism by the ORI3
…many of the ‘plagiarism’ allegations submitted to the ORI are found to be 
authorship or credit disputes between collaborators or former collaborators. 
, which clearly 
delineates plagiarism from other authorship or disputes. She then admits,  
                                                 
3 “As a general working definition, ‘ORI considers plagiarism to include both the theft or 
misappropriation of intellectual property and the substantial unattributed textual copying of another’s work. 
It does not include authorship or credit disputes. The theft or misappropriation of intellectual property 
includes the unauthorized use of ideas or unique methods obtained by a privileged communication, such as 
a grant or manuscript review.’” (Scheetz 324, citing “ORI Provides Working Definition of Plagiarism.” 
ORI Newsletter 1994;3(1):3) 
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Examples of such disputes include: misappropriation of collaborators’ ideas, 
disagreements over who should be an author, or the order of authorship. Other 
nuances of this issue include questions of whether consent must be obtained in 
order for a collaborator to publish independently from his or her research team 
and whether a member of a research team can publish conflicting analyses. 
(Scheetz 324) 
In this section of the article, she seems to acknowledge the myriad complicated issues 
involved in authorship ethics, yet holds fast that these problems are beyond the scope of 
the ORI. Scheetz is basically admitting that the issue of authorship is too cumbersome 
and difficult for the ORI to consider every case. Instead, the ORI hopes to educate and 
provide outreach support so that institutions and research organizations can better instruct 
their scientists (Scheetz). A metaphor that suits this power struggle is the U.S. federal 
government calling for the states to regulate an issue (like, gay marriage or the death 
penalty), believing it is both beyond the federal government’s scope and beneath them to 
be bothered with. ORI regulates the institutions; the institutions must regulate their 
member scientists; thus ORI is passing the buck to a more hands-on regulator.  
But between the federal government and the states, or in this case between the 
government agencies and the labs and universities they fund, lies a major player 
determining the research careers and rules scientists follow: the academic journals. Their 
role in defining and regulating research misconduct and authorship ethics on a case-by-
case basis provides guidelines beyond the scope of institutions but below the level of the 
government. 
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Role of Journals and Journal Editors 
During the early 1980s and through the decades that followed, while federal 
oversight boards continued to publish definitions of research misconduct that did not 
include authorship issues beyond plagiarism, the editors of scientific and medical journals 
began publishing their own rules concerning authorship ethics. In 1985, several journal 
editors began issuing statements and guidelines regarding authorship, including the 
International Committee of Medical Journal Editors (ICMJE). The ICMJE is a group of 
editors of various international medical journals and their related associations who meet 
solely for the purpose of establishing general publishing guidelines for all of their 
journals (ICMJE, “About the ICMJE”). Their published, formal authorship guideline is 
arguably the seminal one in science publication (Jones).  
“The ICMJE criteria have been adopted by hundreds of biomedical journals 
throughout the world and have also been the basis for authorship criteria 
developed by a number of U.S. medical schools, several scientific societies (e.g., 
the Association of University Radiologists and the Society for Neuroscience), and 
two countries.” (Jones 244) 
Under the Web site listing of their Uniform Requirements for Manuscripts Submitted to 
Biomedical Journals, Ethical Considerations category, the ICMJE includes statements 
and rules on a variety of authorship-related issues including allocation of credit, conflicts 
of interest, privacy and more (ICMJE, “Uniform Requirements”). The ICMJE guidelines 
also include a section on Publishing and Editorial Issues. Interestingly, this section is 
separate from the Ethical Considerations section, though many of the topics listed as 
 35 
Publishing and Editorial Issues are directly related to authorship ethics. Publishing and 
Editorial Issues discussed and regulated by the ICMJE include obligations to publish 
negative studies, overlapping publications by authors, working with the media, and other 
concerns (ICMJE, “Uniform Requirements”).  
Since no federal policy exists to tell scientists how to ethically allocate credit, the 
ICMJE’s guidelines serve as one of the only – if not the only – set of rules regarding 
authorship that apply equally to various disciplines and journals. Scientists can reference 
these Uniform Requirements to attempt to navigate the complicated waters of authorship 
and credit when they are working toward a publication in the biomedical field (how often 
scientists actually read or understand these requirements is unclear). Last updated in 
April 2010 (ICMJE, “Uniform Requirements…Ethical”), the Uniform Requirements have 
… been adopted in one iteration or another by several hundred biomedical 
journals throughout the world. The ICMJE authorship criteria insist that authors 
must assume responsibility, as well as accept credit, for publications that bear 
their name. The first criterion [in 1985] originally stressed the necessity for an 
author to make substantial intellectual contributions to the research being 
reported. The ICMJE revised this criterion in June 2000 to allow “acquisition of 
data” as an alternative to the previously required intellectual contributions. The 
second and third criteria require that authors must take part in drafting or critically 
revising the manuscript, and they must approve the final version.” (Jones 246)  
The outlined differences regarding which efforts should result in authorship credit is a 
hot-button issue in authorship ethics that will be discussed more in Chapter 4. 
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The Guidelines published by the ICMJE certainly have not settled the issue of 
authorship disputes or put to rest other authorship-related ethical issues in science. In 
fact, a study published in Academic Medicine showed that chairmen of departments of 
medicine did not change their authorship habits from 1979 – 1990, despite publications of 
guidelines by the ICMJE and many journals (Shulkin, Goin and Rennie, cited in Jones).  
It would seem, then, that the journals are not controlling the process of how authorship is 
determined, nor adequately educating their authors. This may be because the editors are 
not all fully invested in the idea of authorship ethics. In interviewing 231 editors of 
science and health care journals, Wager et al. found that editors are not very concerned 
about problems in publication ethics, as they believe that misconduct rarely occurs.  
Interestingly, Wager et al.’s survey was published four years after Martinson, Anderson 
and de Vries’s survey that exposed how often incidences of research misconduct actually 
occur, and how many of those instances are related to publication and authorship 
concerns. Thus, the editors seem to have their heads in the sand if they believe that 
misconduct is not occurring. This is a shame, since editors have one of the most hands-on 
roles in educating and informing scientists as they make authorship decisions.  
As Chapter 4 will explore further, scientists often look to journals when making 
authorship decisions. The journals may not have the power to regulate authorship via the 
type of sanctions that ORI can pass down, but they do have the advantage of working 
directly with scientists, as scientists are immediately concerned with how to get published 
in a journal and will therefore often read and follow that journal’s authorship rules (see 
Chapter 4 for interview discussions on this research process). It seems that the ability to 
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write rules, regulate and enforce rules, educate about the process and actually work in-
hand with scientists as they make authorship decisions lies in the hands of various groups 
and agencies, not in one particular organization (see Figure 3.1). Authorship decisions, 
though important, seem to be based on scattered resources and influencers. 
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CHAPTER 4 
SHOULD AUTHORSHIP BE REGULATED? 
Interview Process 
 
In an environment of limited and unclear regulation, inconsistent or nonexistent 
rules, and varied influences, how do scientists make authorship decisions? Beyond theory 
and rules, are the ethics of authorship actually important to practicing scientists? To 
expand my research and gain insight from scientists directly, I interviewed scientists 
about their understandings of research misconduct and authorship ethics.  I spoke with 
nine practicing scientists at a land-grant research institution in the Southeast. I selected 
scientists who have published in peer-reviewed journals or at conferences, who are 
tenured (or on track to be tenured) by a university, and who are now performing research 
with the intention of continuing to publish results. I used convenience sampling, selecting 
scientists who fit this description at the same university where I study. I began with a 
pilot study of three scientists who were personal acquaintances or with whom I had some 
connection. I emailed the three potential participants and they all agreed to meet with me. 
After my pilot study, I chose to expand my research. I used snowball sampling to 
find additional participants, asking members of my pilot study to recommend other 
scientists who may be interested in talking with me. Of the list of suggested scientists, 
many were from the same department, and I wanted to avoid speaking with scientists 
from the same disciplines in order to avoid skewing the data in line with the approach or 
methods one specific discipline may use in the research and publication process. I 
therefore randomly selected one participant from each suggested department and then, if 
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that person could not meet with me, I emailed another recommended name from that 
department (if more than one name was suggested). This process added four participants 
to my study. 
Finally, I used purposive sampling (Koerber and McMichael), selecting several 
scientists listed on the university’s various science departments’ Web sites, and focusing 
on departments that were not yet represented by my participants. I employed this 
sampling technique because I wanted to ensure that my interviewees were from a variety 
of research fields, which I felt was important to understand how different disciplines may 
view authorship ethics and misconduct. About eighty percent of these selected scientists 
accepted my email invitation to participate in the research. This added two additional 
participants to the study, bringing the total to nine. For more information about the 
academic titles, qualifications, and research and publication history of the nine 
participants, please see the first five-to-seven questions of each interview transcript in 
Appendix E. 
At the start of each interview meeting, each participant was asked to review and 
sign an IRB-approved consent form (see Appendix C), which informed them that I would 
be recording the interview, but that their identities will be protected and will not be 
associated with the interview answers in any way. I felt this confidentiality was important 
in order to allow the scientists to feel as comfortable as possible about sharing personal 
information about ethical situations they may have encountered. 
 Once I had selected my participants, I met with them for semi-structured 
interviews. I asked a series of prepared questions, asking them to share demographic 
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information, their knowledge of research misconduct, their understanding of the role of 
communication in science, their knowledge of formal definitions of misconduct, and the 
importance of authorship and their role as authors. I also prompted them to share personal 
stories related to authorship and allowed for open-ended story-sharing and information at 
the end of each interview (see Appendix D for the list of interview questions). I 
transcribed the interviews verbatim (see Appendix E) and analyzed them for similar 
responses, key phrases and overall themes. 
 While I believe I followed appropriate qualitative research techniques, I recognize 
the limitations of my interviews. First, I had a strong selection bias: one can assume that 
scientists willing to speak with me about authorship ethics likely have not participated in 
unethical authorship situations. Next, I was interviewing at a tier-one research institution; 
arguably, only well respected scientists in their field (those who have not been found 
guilty of authorship disputes or unethical actions) would receive tenure at such an 
organization, and they would not earn funding to continue their research if they had 
earned poor reputations. Finally, the use of snowball sampling ensured that participants 
recommended other scientists whom they knew would be interested in my research. In 
fact, during my interviews, I learned that some of my participants had done some of their 
own research on authorship issues and communication ethics in science.  
 All that said, my interviews were incredibly informative. While not generalizable 
to represent all scientists, these interviews provided me with the personal stories, 
vocabulary, and empathy to add color and support to my research. The struggles 
scientists experience in understanding their roles as authors and the rules, regulations and 
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complicated issues surrounding authorship truly came to life through the real words of 
scientists tackling these problems. The rest of this thesis will interweave responses from 
these interviews to illustrate my other research, and to help personalize the discussion of 
how much authorship ethics matter to some scientists. 
 
Scientists as Authors and Ethical Researchers 
 I interviewed scientists from the fields of biochemistry, bioengineering, 
chemistry, computer science, developmental biology, entomology, parasitology, and 
plant ecology. They were prolific researchers and writers: all had been publishing peer-
reviewed research (in journals and at conferences) for 8 to 30 years, with an average of 
14.4 years. Eight of the nine have co-authored all or almost all of their research 
publications with other scientists (and the other had worked with coauthors occasionally).  
 When asked if authorship is an important issue to them, all nine participants 
replied that it was. Many immediately made links between the role of authorship and the 
effect that publications have on a scientist’s career and future research. “Have you heard 
the term ‘publish or perish?’” asked one. “So yeah, [authorship is] important. It affects 
tenure, promotion considerations. It affects your reputation in the field. All that stuff” 
(App. E, 1, 81). Another scientist remarked, “Yeah it is [important], because authorship is 
credit, it’s the coin of the realm basically” (App. E, 3, 101). Though many of them had 
not experienced or been involved with unethical authorship practices, all of them had at 
least one story about problems that had arisen among other scientists regarding 
authorship issues. Many of them provided detailed stories about the struggles that they or 
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others had gone through to decide on authorship order, allocate credit fairly and 
appropriately, communicate with journal reviewers, and understand author requirements 
in other labs and countries. They were all open and animated when discussing the 
seemingly large and important role that authorship issues played in their daily lives. 
 The scientists also all made connections between authorship and research 
misconduct. I asked each to define research misconduct, and every one of them 
mentioned some form of authorship ethics in their definition – like plagiarism, giving 
credit, describing the research process honestly, and avoiding bias when interpreting data. 
Some of the responses to my question, “How would you personally define research 
misconduct” included (in the scientists’ own words): 
So there’s a couple of things I would define as research misconduct. Definitely, 
since we were talking about papers, if you don’t either give someone credit or 
credit is due – if they aren’t listed as an author even though they did work that 
deserved to be an author. Plagiarism is a big one. Like not citing something. And 
then fudging or lying about your data. (App. E., 2, 88) 
So there’s misconduct in kind of being dishonest about your research results.   
You know, misrepresenting results kind of claiming that certain things weren’t 
true, your results that aren’t true or kind of bending the truth a little bit more than 
you should be. There are some difficult issues of misconduct involving projects in 
which you have multiple investigators you know, not assigning appropriate credit 
or authorship issues, things like that. There’s probably misconduct in funding.  
You know spending funding on things that it's not supposed to be spent on. So 
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there’s all sorts of issues with, with kind of academic misconduct you could 
probably get into. (App. E., 6, 127) 
Taking work that is not yours that you have not primarily produced and selling it 
as your own. Not giving people acknowledgement for ideas…. Citing people for, 
from where you get the main, the major ideas that show up in your…publication. 
(App. E, 7, 138) 
Boil it down: lying, cheating, stealing. (App. E, 8, 151) 
Though one scientist admitted that misconduct is “a really hard topic” (App. E., 9, 165), 
and many of them struggled a bit to give me a clear definition, another quickly summed 
up research misconduct as, “Anything that knowingly deviates from honesty: from not 
presenting results that might contradict their study, to falsifying results of the study in 
anything and everything in between” (App. E, 4, 110). Several of them defined 
misconduct using the term “dishonesty” or other synonyms; applying it not just to the 
performance of research but also how it is presented. To these scientists, authorship 
ethics are research ethics – they are not separable.  
 
How Scientists Make Authorship Decisions 
“Authorship sits at the intersection between collective effort and individual 
ambition” (Anderson et al. 7). 
The interview participants regularly mentioned two key issues within authorship 
ethics: the process of determining who should be given authorship credit, and in what 
order to list authors on a paper. These two challenges were cited to cause conflict, stress, 
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career problems, and reputation and credibility issues. For example, in Interview 2, the 
scientist knew of a professor who had been fired from a revered university for not giving 
proper credit to his students. Another scientist discussed the process of determining 
author order: 
…There is some sort of negotiation and problems arise when that negotiation 
doesn’t take place or if science, you know, goes funny ways and sometimes the 
person that is third author ends up generating most of the data for the paper then 
there must be a re-assessment of author order and that can cause a lot of 
tensions…. So that [choice of author order] is probably the twitchiest area. (App. 
E, 3, 102) 
I asked all the participants to describe any processes they use – or think should be 
used – to determine who should get credit as an author, and in what order those authors 
should be listed on the research publication. First, it should be noted that the different 
academic disciplines within science approach authorship order differently. In most 
scientific fields, according to my interviews, some disciplines give the most prestige to 
the first author, while others perceive the last listed name as the most prestigious. In 
computer science, authors are listed alphabetically – regardless of their amount of 
contribution – so issues regarding order are rare, but they do appear when researchers 
work with other disciplines that list authors differently (App E, 1; App. E, 6). 
Considerations that the scientists I interviewed make when determining authorship credit 
include: intellectual contribution (as one scientist noted, “whatever that means” (App. E, 
8, 156), the actual performance of the work/data collection, seniority in the lab, 
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production of data, and contribution to the writing of the final paper. I was told by most 
of the scientists that not all authors on a paper need to actually write the paper, but they 
should all have read and had the opportunity to review and edit the final paper. Most 
implied to me that it was unethical to give authorship credit to a senior scientist who has 
not at all been involved in the research, though they admitted that these “gift authorships” 
occur often, especially when given to lab owners.  
The participants did not all have the same methods for determining authorship, so 
it seemed to me that the process of selecting and ordering authors was not clearly defined. 
Thus, I asked the participants if they had read or consulted authorship guidelines of any 
kind. Six of the nine had done some kind of research on authorship guidelines; three had 
not. Of the six that had read guidelines, all of them looked to the individual journals 
where they planned to submit their papers to read that journal’s particular rules. One 
scientist admitted that guidelines are vague, and he did not fully understand how they 
work, even within his rather small field of study. Interestingly, it seems that the awarding 
of authorship, an issue that causes problems and is incredibly important to these 
scientists, is not clearly understood or universally defined. 
Several published studies have attempted to pinpoint the process of how scientists 
make authorship decisions, both practically and ethically (Louis et al. and Geelhoed et al. 
provide extensive literature reviews on the subject of authorship guidelines). Geelhoed et 
al. found that scientists who had formal authorship guidelines to follow – in this case, 
from the American Psychological Association – expressed satisfaction with the process 
they followed and decisions they made. However, Louis et al. interviewed twenty-eight 
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tenured scientists who had funding from the National Institutes of Health about how they 
make authorship decisions during the research process, and they found that scientists 
usually do not follow formal guidelines. Instead, scientists rely on personal “rules of 
thumb” in each particular case. In general, the scientists followed three core guidelines in 
making authorship decisions: fairness (rewards should be proportional to contributions), 
reciprocity (contributions should match benefits), and sponsorship (senior scientists 
should assist the careers of junior colleagues) (Louis et al.).  Louis et al.’s results match 
my interview findings: scientists seem to rely to their own personal ethic when making 
authorship decision, without seeking out formal rules or guidelines.  
Furthermore, scientists do not seem to be learning how to make ethical authorship 
decisions during their education. Verdan et al.’s study implies that even when students 
are taught research ethics in the classroom, they learn specifics like how to handle data 
appropriately, but seem to not be taught “scientific norms and the nature of science” 
(Verdan et al. 118). When asked where they learned the definitions of research 
misconduct and ethical communication in science, only one of the nine scientists I 
interviewed mentioned their undergraduate or graduate classes. Three spoke of personal 
ethics gained from their backgrounds or childhoods, and five spoke of mentors and 
advisers who led by example. Examples of responses to my questions regarding where 
they learned ethical research practices or how to communicate ethically in science 
included: 
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It was experience, and I guess it’s one of those things you pick up at school or 
grad school or whatever from good professors that teach you the right thing. 
(App. E, 1, 81) 
…They didn't teach me much about kind of ethics and academic you know, how 
to properly conduct academic work.  They didn't teach me much about that as a 
graduate student. So it's kind of you learn by kind of keeping your eyes open and 
listening to what you know, other people have told you about their experiences 
and you kind of learn by example. (App. E, 6, 128) 
I think as a 2-year-old I was taught what was right and wrong.  And I had good 
parents.  I just don’t see how it’s any different than the way someone in a normal 
civilization, you know, civilized society behaves. You tell the truth you know. 
It’s, to me it’s, there really is not a distinction between everyday life and research 
in a way…. I think [my education about communicating ethically] includes, and 
this sounds really ridiculous, but includes my upbringing, right?  But I do think 
having mentors who are clearly straight shooters, you know, that don’t participate 
or even tolerate any sort of misleading behavior. (App. E., 8, 152) 
There is nothing formally written down about the rules. So most of this comes 
from my mentor, starting…as an undergraduate student and moving all the way 
through personal training…. I had different mentors, but every single one of them 
has … stated very much the same thing. (App. E, 9, 165) 
 Using personal ethics to regulate authorship decisions, which seems to be the 
most common source of scientists’ decisions, presents several problems, especially as the 
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scope of science and scientific collaboration has expanded. American, professional 
scientists are struggling with authorship ethics, so adding additional components, like 
power-struggles of subordinates and mentors, cultural differences, and expanding 
technological capabilities, only further complicates the issue. Multi-national research 
teams have reported problems in authorship omission, undeserved authorship credit, 
different understandings of order, and different interpretations of plagiarism (Anderson et 
al.), which can lead to problems ranging from personal affronts to losses of credibility 
and funding. Also, one of my interviewees mentioned that, in her experience, students 
from some countries (particularly Asian cultures) will never speak out against professors 
who run labs, even if the professors make unethical decisions, because those cultures 
value respect for seniority so highly (App. E, 9). The Anderson et al. article discusses 
how other cultures interpret plagiarism differently, and often do not understand American 
standards against directly copying text. Furthermore, conflicts presented by mentorship – 
in which the mentor may be responsible for teaching ethics, but may also have the power 
to take advantage of students working under him or her by taking credit for their work, 
came up several times in my interviews. Scheetz, in discussing the ORI’s role and 
recommendations regarding authorship issues, acknowledged the complicated 
mentor/mentee relationship and how it can affect authorship ethics: 
“[Authorship] disputes often involve persons in some form of training who 
challenge the mentor over the ownership of research ideas which results in 
arguments over authorship priority and status. Although these situations are not 
considered by ORI to fall under the Public Health Service definition of scientific 
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misconduct, their existence highlights the lack of generally accepted standards 
regarding the mentor/trainee relationship in the research training environment. 
(Scheetz 324) 
Finally, as technology makes online publication more accessible and the sharing of ideas 
more instantaneous, concepts of plagiarism, intellectual property, the drive to publish 
quickly, shared resources and more affect how research is produced and published. These 
issues – of culture, power and technology – open a host of discussions that are beyond the 
scope of this thesis, but which deserve future analysis. In short, authorship ethics will 
only become more complicated as the practice of science becomes more complex. 
 
Should ORI Regulate Authorship? 
 In light of the important role that authorship ethics play in the practice of science, 
it almost seems obvious that organizations on the local and federal level should be 
publishing rules and regulating authorship issues. But the solution – and its implications – 
may be more complicated than simply writing more rules. Who should write them? Who 
should regulate them? How would they be regulated? And will scientists even heed these 
new rules? 
Just who should be responsible for regulating authorship ethics has been 
discussed and advised in various publications. Several of my interviewees rest the 
responsibility of authorship ethics on the researchers themselves to sort out. Many of my 
interviewees advised that authorship should be discussed and decided within the research 
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team – both early in the decision to work together as well as throughout the process – as 
the best way to avoid authorship problems. The ORI makes a similar recommendation: 
…It is highly advisable to address authorship issues prior to writing the initial 
draft of a manuscript, or even prior to initiating a collaborative research effort. 
This should promote a clearer understanding among co-authors about their 
authorship responsibilities and thereby reduce the possibility of future conflicts. 
(Scheetz 324) 
(It is worth nothing that the ORI itself called on scientists to make decisions among 
themselves, not to look to printed rules or regulations). However, Anderson et al. admit 
that discussion, even among those with a vested interest in quality research, may not be 
enough, and they instead look to the journal editors and other publications to offer 
regulation: 
It is clear, though, that discussions alone will not clear away all authorship 
problems. Several resources provide additional guidance. Collaborators should 
consult the policies of the journals to which they plan to submit their work. 
International guidance is available through the Council of Science Editors, the 
Committee on Publication Ethics and the International Committee on Medical 
Journal Editors’ Uniform Requirements for Manuscripts Submitted to Biomedical 
Journals. The Singapore Statement, released in conjunction with the Second 
World Conference on Research Integrity in 2010, provides a succinct statement 
that responsible authorship is a duty of researchers worldwide. Scientists can join 
AuthorAID, a free, international research community that supports researchers 
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from developing countries with services such as networking and mentorship. 
(Anderson et al. 7) 
Anne Hudson Jones also explored the idea of using journal editors as the key source for 
regulating misconduct, but concluded, “Editors’ establishing guidelines for authorship 
and disseminating them widely may be necessary but are not sufficient to change practice 
and solve some of the most persistent problems of scientific authorship” (248). She then 
calls for the professional scientific societies to better regulate scientific misconduct 
among their members. Finally, Linda J. Wilcox, writing to the medical establishment, 
echoed ORI’s current stance, calling for academic departments and institutions, including 
Ombuds offices, to regulate authorship. 
 Clearly, the scientific community does not have a single answer to avoid 
problems or better regulate authorship ethics. Even the ORI admits, “Some researchers 
are not aware of the expectations and standards of the journals, professional societies, or 
even their own institutions” (Scheetz 324). In light of this ignorance, shouldn’t the ORI, 
the nation’s highest ethical body, step in to provide regulation? If, by their own 
admission, journals, societies and universities cannot be trusted to teach and regulate 
authorship ethics, then shouldn’t the ORI take control? 
The first concern of relying on the ORI to define and regulate authorship ethics is 
that the ORI may not have the perceived authority to make a difference. Of my interview 
participants, only five of the nine knew that a federal body like the ORI existed to 
regulate research misconduct. Not one of them knew the ORI’s definition of research 
misconduct. One participant said that the idea of research misconduct “just goes unsaid” 
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(App. E, 1, 81), and another frankly commented: “I wouldn’t say I was consciously aware 
[that ORI publishes a definition of research misconduct], I’m aware that they must have, 
but they have no impact on my research or how I communicate my research whatsoever” 
(App. E, 5, 166). Her implication, which was shared by other participants, was that 
scientists look to themselves for their own rules and regulations, not to governing bodies. 
As one interviewee said, “There is a lab culture, so every lab I was in there was a culture 
that valued truth and doing it the right way” (App. E, 3, 100). Two other interviewees 
remarked that scientists have to operate under the assumption that everyone else is 
following ethical guidelines. “If we’re not all being objective,” which was one 
interviewee’s definition of ethical conduct, “then it sort of all crumbles” (App. E, 5, 121). 
This supports Penrose and Katz’s statement, “Ultimately the whole enterprise of science 
depends on collegiality and trust” (62).  
As mentioned earlier, when these scientists do need to read authorship guidelines 
(for the few that chose to do so), they visit the Web sites of the journals and funding 
agencies where they want to publish; most do not look to federal guidelines. Louis et al.’s 
research also implies that scientists do not look to federal rules when making authorship 
decisions. Comparing official regulatory bodies to actual reported influencers of ethics 
(per my nine interview participants and those participating in research like Louis et al.’s)  
points to a disparity between ORI’s perceived influence over scientists and the factors 
that actually do influence their decisions. This discrepancy indicates that, at least to these 
scientists, if ORI listed new authorship guidelines, it likely would not affect scientists’ 
actions. 
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 Next, ORI has admitted, through the article written by Scheetz, how difficult it 
would be to regulate authorship issues. They have determined that institutions need to 
settle authorship disputes, as it is beyond ORI’s scope to handle each case (Scheetz). 
Expanding the definition of research misconduct would only increase the number of cases 
ORI would be asked to handle, as evidenced now by the number of authorship disputes 
they have to send back to the institutions to investigate, as they do not meet the definition 
of research misconduct that ORI regulates – i.e. they are not part of ORI’s definition of 
plagiarism (Scheetz). Scheetz leads us to believe that ORI as it currently stands would not 
be able to investigate more cases, so should a broader definition be written that would 
only increase their caseload? Likely, the rules would not be regulated fully, and arguably, 
rules should not be put in place that cannot be regulated. That said, I will discuss in 
Chapter 5 how the community of science may be able to work around this conundrum. 
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CHAPTER 5 
CONCLUSION & DISCUSSION 
 
 The purpose of this research paper was to answer the question, do authorship 
ethics matter? Giving that authorship issues beyond plagiarism are not defined or 
regulated by government oversight bodies, one could assume they are not important. But 
the rhetorical, historical and interview evidence described above has indicated that not 
only do authorship ethics matter, they are fundamental to the very practice of science. 
The ethical practice of research is integrally tied to collaboration, writing, peer-review 
and the shared publication process. Ethical communication, particularly ethical 
authorship practices, is inseparable from ethical research. 
 Given that authorship ethics are so important, the question then becomes: what 
should be done about the lack of regulation (if anything)? The Office of Research 
Integrity, the federal government entity that oversees the ethical practice of scientific 
research, has continually published a definition of research misconduct that does not 
include authorship ethics beyond avoiding plagiarism. The ORI has admitted that 
authorship issues are pervasive and complicated, and studies like the Martinson, 
Anderson and de Vries survey have linked authorship issues to research misconduct, yet 
the ORI has avoided defining or regulating authorship. The ORI asserts that the 
regulation of authorship lies at the institutional level, while other researchers have 
suggested that journal editors or scientific societies should lead the way. As these 
discussions continue, there is still no overarching definition of authorship ethics, nor a 
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unifying method for awarding and ordering authors, two issues that particularly affect 
practicing scientists. 
 Symbolically, though, the ORI should strongly consider making a statement about 
authorship ethics in order to draw attention to their importance. The ORI’s choice for the 
past two decades to omit authorship ethics from their definition of research misconduct 
seems to indicate that the issue is not important. As this thesis has shown, though, 
authorship issues are not only important, but they are fundamental to the production of 
science and the communication of knowledge. Thus, to grant authorship ethics the import 
they deserve, the ORI should consider adopting a new definition of research misconduct 
that goes beyond fabrication, falsification, and plagiarism.  
To develop a new, more expansive definition of research misconduct, it may 
behoove the ORI to return to the Ryan Commission’s recommendations for defining 
research misconduct. The Commission’s definition, which focuses on misappropriation, 
interference, and misrepresentation, seems to encompass a more well rounded concept of 
research misconduct, one that includes data manipulation as well as communication and 
publication issues. In fact, this definition better matches what the scientists I interviewed 
already believe research misconduct entails: that ethics apply not just to the research 
process, but also to the communication of it; that the credit a scientist earns and grants in 
publications can promote or destroy careers and reputations; and that stealing from others 
goes beyond plagiarism to also include how one acknowledges ideas, contributions and 
effort. A new, more expansive definition from ORI that echoes the Ryan Commission’s 
recommendation would potentially establish, at the highest federal level, the importance 
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of communication ethics in the practice of scientific research. It would also align the ORI 
with the beliefs and practices that many scientists currently follow, which could possibly 
even make the ORI more relevant to practicing scientists. 
 That said, a new definition would not necessarily require new regulation. ORI’s 
concern about the complications of regulating authorship along with the scientific 
community’s splintered opinions regarding who should oversee scientists implies that 
further regulation may not solve the issue or even make a difference. While I believe that 
a new definition of research misconduct needs to be written that includes authorship 
issues, I acknowledge that a conundrum exists: though a new definition will be in place, 
it will be understood that the regulation to support that definition cannot really be 
enforced on the federal level, or perhaps enforced at all. To set a rule insisting that 
scientists be objective, be fair, and present only the truth harkens back to the positivistic 
view of science. It takes science back to Plato’s false separation of Truth from rhetoric, 
and to Bacon’s insistence on objectivity separate from the senses. But our current 
understanding of science as a social construction acknowledges the subjective and social 
nature of fact creation; scientists cannot escape personal interpretation and the effects of 
collaboration, credibility and the written processes of fact-creation (per Latour and 
Woolgar). So a new definition of research misconduct, while symbolically important in 
elevating the role of authorship beyond just plagiarism, in fact goes against our 
understanding of the practice of science.  
In summary, I believe that the ORI should acknowledge that research misconduct 
encompasses so much more than fabrication, falsification and plagiarism, but I also 
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realize that this definition likely would not change behavior or result in more regulation. 
Until ORI has more effect on scientists’ actions, listing new rules will likely not change 
behaviors. That said, it’s a step toward the entire scientific community formally 
acknowledging the role of writing, ethical communication – in short, rhetoric – in the 
production of science. Thus, I argue for what Foucault would call the “myth of the 
institution:” as the nation’s highest ethical body, ORI can take the symbolic step of 
acknowledging the vital importance of authorship ethics, but they need not regulate it.  
Further echoing Foucault, the discourse of science, which may now better understand the 
importance of authorship ethics, will likely become the institution that regulates itself. 
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Appendix A 
Timeline of the Evolution of Research Misconduct Regulation and Definitions 
 
KEY 
Red = Key definitions of research misconduct 
Green = Notes specific to authorship 
Yellow highlight = Years that major decisions were made 
 
1981 – Research misconduct became a public issue due to the first Congressional 
Hearings of the Investigations and Oversight Subcommittee of the House Science and 
Technology Committee (ORI, “About ORI – History”). 
 
1981, 1985 – According to Anne Hudson Jones, the Darsee and Slutsky cases exposed 
ramifications of fraudulent data but also about gift authorship. Coauthors took credit for 
years but then didn’t take ownership when data was found to be faked. This led to many 
journal editors issuing statements on authorship and/or guidelines, as well as the ICMJE 
publishing formal authorship guidelines (see second1985 entry below). 
 
1985 – Congress passes Health Research Extension Act, which required regulations 
regarding fraud to be researched and reported by government science agencies (ORI, 
“About ORI – History”) 
 
1985 - “The best known and most influential authorship criteria in the sciences are those 
established by the International Committee of Medical Journal Editors (ICMJE) in 1985. 
The ICMJE criteria have been adopted by hundreds of biomedical journals throughout the 
world and have also been the basis for authorship criteria developed by a number of U.S. 
medical schools, several scientific societies (e.g., the Association of University 
Radiologists and the Society for Neuroscience), and two countries.” (Jones 244) 
(See the ICMJE’s “Uniform Requirements for Manuscripts Submitted to Biomedical 
Journals.”) 
“The [ICMJE’s] ‘Uniform Requirements for Manuscripts Submitted to Biomedical 
Journals,’ now [in 2003] in an updated fifth edition, has been adopted in one iteration or 
another by several hundred biomedical journals throughout the world. The ICMJE 
authorship criteria insist that authors must assume responsibility, as well as accept credit, 
for publications that bear their name. The first criterion originally stressed the necessity 
for an author to make substantial intellectual contributions to the research being reported. 
The ICMJE revised this criterion in June 2000 to allow “acquisition of data” as an 
alternative to the previously required intellectual contributions. The second and third 
criteria require that authors must take part in drafting or critically revising the manuscript, 
and they must approve the final version.” (Jones 246) 
 
1986 – NIH publishes research guidelines.  
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July 1987 – National Science Foundation defines “misconduct” in science or engineering 
as: 
“(1) fabrication, falsification, plagiarism, or other serious deviation from accepted 
practices in proposing, carrying out, or reporting results from activities funded by 
NSF; or  
(2) retaliation of any kind against a person who reported or provided information 
about suspected or alleged misconduct and who has not acted in bad faith” 
(Fischer). 
  
This definition was revised in May 1991, but was replaced by the April 2002 definition 
(see below) (Fischer). 
 
1989 – NIH’s guidelines (which mainly concern funding, responsibilities and conflicts of 
interests) were codified as 42 CFR Part 50, Subpart A (ORI, “About ORI – History”). 
 
1989 – Public Health Services founds “Office of Scientific Integrity (OSI) within the 
Office of the Director, NIH, and the Office of Scientific Integrity Review (OSIR) in the 
Office of the Assistant Secretary for Health (OASH), to handle research misconduct” 
(“About ORI – History”). 
 
1989 - National Academies’ Committee on Science, Engineering and Public Policy 
releases first edition of On Being a Scientist: Responsible Conduct in Research 
(Committee on Science, Engineering, and Public Policy). 
 
1989 - A definition of research misconduct “was developed in response to a directive 
from Congress after several well-publicized cases of scientific misconduct. This 
definition-‘fabrication, falsification, plagiarism, or other practices that seriously deviate 
from those that are commonly accepted within the scientific community for proposing, 
conducting, or reporting research’-applies to all research funded by the Public Health 
Service, but not to that supported by the National Science Foundation or other federal 
agencies. Since its adoption, much concern has been raised about the vagueness of the 
‘other practices’ phrase” (Schechter and Schwartz). 
 
May 1992 – OSI and OSIR consolidate into ORI (ORI, “About ORI – History”). 
 
1992 – A National Academies of Sciences report links questionable research practices to 
scientific integrity (Martinson, Anderson, and de Vries 737). The report changed 
discussion from being about a few ‘bad’ individuals to being about overall “responsible 
conduct of research” (Martinson, Anderson, and de Vries 738). 
 
1992 - National Academies of Sciences and Engineering and the Institute of Medicine 
publish Responsible Science: Ensuring the Integrity of the Research Process. The 
opening chapter argues that a lack of definition for what research misconduct is has led 
to confusion. Thus, the panel offers this definition of scientific misconduct: 
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Misconduct in science is defined as fabrication, falsification, or 
plagiarism, in proposing, performing, or reporting research. 
Misconduct in science does not include errors of judgment; errors in 
the recording, selection, or analysis of data; differences in opinions 
involving the interpretation of data; or misconduct unrelated to the 
research process. 
Fabrication is making up data or results, falsification is changing data or 
results, and plagiarism is using the ideas or words of another person 
without giving appropriate credit. (Panel on Scientific Responsibility and 
the Conduct of Research 27) 
In Responsible Science, the chapter on misconduct first covers incidences (much 
lower than what Martinson, Anderson, and de Vries’ study later revealed), then 
discusses definition(s): 
Government Definitions of Misconduct in Science—Ambiguity in 
Categories 
The PHS's misconduct-in-science regulations apply to research sponsored 
by all PHS agencies, including the National Institutes of Health, the 
Alcohol, Drug Abuse, and Mental Health Administration, the Centers for 
Disease Control, the Food and Drug Administration, and the Agency for 
Health Care Policy and Research. The PHS defines misconduct in science 
as “fabrication, falsification, plagiarism, or other practices that seriously 
deviate from those that are commonly accepted within the scientific 
community for proposing, conducting, or reporting research. It does not 
include honest error or honest differences in interpretations or judgments 
of data” (DHHS, 1989a, p. 32447).  
The PHS's definition does not further define fabrication, falsification, 
plagiarism, or other serious deviations from commonly accepted research 
practices. The ambiguous scope of this last category is a topic of major 
concern to the research community because of the perception that it could 
be applied inappropriately in cases of disputed scientific judgment. 
The first annual report of the DHHS's OSIR suggests the types of alleged 
misconduct in science that might fall within the scope of this category 
(DHHS, 1991b): 
• Misuse by a journal referee of privileged information contained in 
a manuscript, 
• Fabrication of entries or misrepresentation of the publication status 
of manuscripts referenced in a research bibliography, 
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• Failure to perform research supported by a PHS grant while stating 
in progress reports that active progress has been made, 
• Improper reporting of the status of subjects in clinical research 
(e.g., reporting the same subjects as controls in one study and as 
experimental subjects in another), 
• Preparation and publication of a book chapter listing co-authors 
who were unaware of being named as co-authors, 
• Selective reporting of primary data, 
• Unauthorized use of data from another investigator's laboratory, 
• Engaging in inappropriate authorship practices on a publication 
and failure to acknowledge that data used in a grant application 
were developed by another scientist, and 
• Inappropriate data analysis and use of faulty statistical 
methodology. 
The panel points out that most of the behaviors described above, such as 
the fabrication of bibliographic material or falsely reporting research 
progress, are behaviors that fall within the panel's definition of misconduct 
in science proposed in Chapter 1. 
The NSF's definition (NSF, 1991b) is broader than that used by the PHS 
and extends to nonresearch activities supported by the agency, such as 
science education. NSF also includes in its definition of misconduct in 
science acts of retaliation against any person who provides information 
about suspected misconduct and who has not acted in bad faith. (85-86) 
1993 – National Academies form the Panel on Scientific Responsibility and the Conduct 
of Research (Martinson, Anderson, and de Vries). 
 
1993 – Study published in Academic Medicine showed that chairmen of departments of 
medicine did not change their authorship habits from 1979 – 1990, despite publications of 
guidelines by the ICMJE and many journals (Shulkin, Goin and Rennie, cited in Jones). 
 
June 1993 – “The process of removing responsibility for handling allegations of research 
misconduct from the funding agencies was completed when President Clinton signed the 
NIH Revitalization Act of 1993. This Act established the ORI as an independent entity 
within HHS and replaced the term ‘scientific misconduct’ with ‘research misconduct’” 
(ORI, “About ORI - History”). 
 
1995 – National Academies’ Committee on Science Engineering and Public Policy 
release updated second edition of On Being a Scientist: Responsible Conduct in 
Research. “This version incorporates new material from Responsible Science and other 
recent reports” as well as comments from instructors and critiques, and new hypothetical 
scenarios. (Committee on Science, Engineering, and Public Policy v).  This book 
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addresses (among other issues, but these are the key authorship-related chapters): 
Conflicts of Interest, Publications and Openness, Allocation of Credit, and Authorship 
Practices. The book discusses misconduct as follows: 
Beyond honest errors and errors caused through negligence are a third 
category of errors: those that involve deception. Making up data or results 
(fabrication), changing or misreporting data or results (falsification), and 
using the ideas or words of another person without giving appropriate 
credit (plagiarism)—all strike at the heart of the values on which science is 
based. These acts of scientific misconduct not only undermine progress 
but the entire set of values on which the scientific enterprise rests. Anyone 
who engages in any of these practices is putting his or her scientific career 
at risk. Even infractions that may seem minor at the time can end up being 
severely punished. 
The ethical transgressions discussed in earlier sections—such as 
misallocation of credit or errors arising from negligence—are matters that 
generally remain internal to the scientific community. Usually they are 
dealt with locally through the mechanisms of peer review, administrative 
action, and the system of appointments and evaluations in the research 
environment. But misconduct in science is unlikely to remain internal to 
the scientific community. Its consequences are too extreme: it can harm 
individuals outside of science (as when falsified results become the basis 
of a medical treatment), it squanders public funds, and it attracts the 
attention of those who would seek to criticize science. As a result, federal 
agencies, Congress, the media, and the courts can all get involved. 
… In addition to falsification, fabrication, and plagiarism, other ethical 
transgressions directly associated with research can cause serious harm to 
individuals and institutions. Examples include cover-ups of misconduct in 
science, reprisals against whistleblowers, malicious allegations of 
misconduct in science, and violations of due process in handling 
complaints of misconduct in science. Policymakers and scientists have not 
decided whether such actions should be considered misconduct in 
science—and therefore subject to the same procedures and sanctions as 
falsification, fabrication, and plagiarism—or whether they should be 
investigated and adjudicated through different channels. Regulations 
adopted by the National Science Foundation and the Public Health Service 
define misconduct to include "other serious deviations from accepted 
research practices," in addition to falsification, fabrication, and plagiarism, 
leaving open the possibility that other actions could be considered 
misconduct in science. The problem with such language is that it could 
allow a scientist to be accused of misconduct for using novel or 
unorthodox research methods, even though such methods are sometimes 
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needed to proceed in science. Federal officials respond by saying that this 
language is needed to prosecute ethical breaches that do not strictly fall 
into the categories of falsification, fabrication, or plagiarism and that no 
scientist has been accused of misconduct on the basis of using unorthodox 
research methods. This area of science policy is still evolving. (Committee 
on Science, Engineering, and Public Policy 16-18).   
Nov. 1995 – Commission on Research Integrity (also known as the Ryan 
Commission) recommends to Donna Shalala, then-Secretary of Health and 
Human Services, a new definition of research misconduct (ORI, “About ORI – 
History”). The report made 33 recommendations, including this proposed new 
definition:  
The Commission recommends that the Secretary replace the existing definition of 
misconduct in science with the definition of research misconduct and definitions 
of other forms of professional misconduct related to research, to follow. The 
definition of research misconduct is based on the premise that research 
misconduct is serious violation of the fundamental principle that scientists be 
truthful and fair in the conduct of research and the dissemination of its results. 
 
The Federal Government has an interest in professional misconduct involving the 
use of federal funds in research, as covered by the following definitions: 
 
1. Research Misconduct 
Research misconduct is significant misbehavior that improperly appropriates the 
intellectual property or contributions of others, that intentionally impedes the 
progress of research, or that risks corrupting the scientific record20 or 
compromising the integrity of scientific practices. Such behaviors are unethical 
and unacceptable in proposing, conducting, or reporting research, or in reviewing 
the proposals or research reports of others. 
 
Examples of research misconduct include but are not limited to the following: 
Misappropriation: An investigator or reviewer shall not intentionally or 
recklessly 
a. plagiarize, which shall be understood to mean the presentation of the 
documented words or ideas of another as his or her own, without attribution 
appropriate for the medium of presentation; or 
b. make use of any information in breach of any duty of confidentiality 
associated with the review of any manuscript or grant application.  
Interference: An investigator or reviewer shall not intentionally and without 
authorization take or sequester or materially damage any research-related property 
of another, including without limitation the apparatus, reagents, biological 
materials, writings, data, hardware, software, or any other substance or device 
used or produced in the conduct of research. 
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Misrepresentation: An investigator or reviewer shall not with intent to deceive, or 
in reckless disregard for the truth, 
a. state or present a material or significant falsehood; or 
b. omit a fact so that what is stated or presented as a whole states or presents a 
material or significant falsehood. (Commission on Research Integrity 15-17) 
 
Oct. 1999 – The Secretary of Health and Human Services implemented some of the Ryan 
Commission’s recommendations. “The HHS adopted the proposed government-wide 
definition of research misconduct developed by the National Science and Technology 
Council that was published in the Federal Register on October 13, 1999. The ‘Federal 
Research Misconduct Policy’ containing the final definition was published in the Federal 
Register on December 6, 2000” (ORI, “About ORI – History”).  
 
Dec. 2000 – The “Federal Research Misconduct Policy” (see Oct. 1999 entry) of ORI is 
published. It includes a new definition of research misconduct, as well as comments and 
discussions that led to that definition. Point of note: it reads “Are authorship disputes 
covered by this policy? Authorship disputes are not covered by this policy unless they 
involve plagiarism” (Ferguson). The new definition was: 
 
I. Research Misconduct Defined 
 
Research misconduct is defined as fabrication, falsification, or plagiarism in 
proposing, performing, or reviewing research, or in reporting research results.  
 
\1\ No rights, privileges, benefits or obligations are created or abridged by 
issuance of this policy alone. The creation or abridgment of rights, privileges, 
benefits or obligations, if any, shall occur only upon implementation of this policy 
by the Federal agencies.  
 
\2\ Research, as used herein, includes all basic, applied, and demonstration 
research in all fields of science, engineering, and mathematics. This includes, but 
is not limited to, research in economics, education, linguistics, medicine, 
psychology, social sciences, statistics, and research involving human subjects or 
animals. 
 
Fabrication is making up data or results and recording or reporting them. 
 
Falsification is manipulating research materials, equipment, or processes, or 
changing or omitting data or results such that the research is not accurately 
represented in the research record. 
 
\3\ The research record is the record of data or results that embody the facts 
resulting from scientific inquiry, and includes, but is not limited to, research 
proposals, laboratory records, both physical and electronic, progress reports, 
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abstracts, theses, oral presentations, internal reports, and journal articles. 
 
Plagiarism is the appropriation of another person's ideas, processes, results, or 
words without giving appropriate credit. Research misconduct does not include 
honest error or differences of opinion. (Ferguson) 
 
2002 – ORI proposes conducting a survey to “collect empirical evidence of behaviours 
that can undermine research integrity, but which fall outside the OSTP’s narrow 
definition of misconduct,” but it was rejected by the Federation of American Societies for 
Experimental Biology and the Association of American Medical Colleges (Martinson, 
Anderson and de Vries 737). 
 
March/April 2002 – Office of the Inspector General (within National Science 
Foundation) defines research misconduct in the NSF regulations (part 689, “Research 
Misconduct”): 
 
         The following definitions apply to this part: 
(a) Research misconduct means fabrication, falsification, or plagiarism in 
proposing or performing research funded by NSF, reviewing research proposals 
submitted to NSF, or in reporting research results funded by NSF. 
(1) Fabrication means making up data or results and recording or reporting 
them. 
(2) Falsification means manipulating research materials, equipment, or 
processes, or changing or omitting data or results such that the research is not 
accurately represented in the research record. 
(3) Plagiarism means the appropriation of another person’s ideas, processes, 
results or words without giving appropriate credit. 
(4) Research, for purposes of paragraph 
(a) of this section, includes proposals submitted to NSF in all fields of 
science, engineering, mathematics, and education and results from such 
proposals. 
(b) Research misconduct does not include honest error or differences of 
opinion. (National Science Foundation 237) …. 
…(c) A finding of research misconduct requires that— 
(1) There be a significant departure from accepted practices of the relevant 
research community; and 
(2) The research misconduct be committed intentionally, or knowingly, or 
recklessly; and 
(3) The allegation be proven by a preponderance evidence. (National Science 
Foundation 238) 
 
2002 – The Institute of Medicine issues a report, Integrity in Scientific Research: 
Creating an Environment that Promotes Responsible Conduct, about the environments in 
which scientists work. They recommend “an institutional (primarily university-level) 
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approach to promoting responsible research.” Report suggested (but did not empirically 
state) the importance of the broader scientific environment (funding, agencies, peer-
review) in influencing integrity (Martinson, Anderson and de Vries 738) 
 
2002 – Martinson, Anderson and de Vries issue first-ever survey for scientists to self-
report misconduct. The study displays the first empirical evidence from scientists of their 
behaviors. (Martinson, Anderson and de Vries).  
2005 – Martinson, Anderson and de Vries’s survey and commentary is published in 
Nature. 
May 2005 – ORI publicizes new “Public Health Services Policies on Research 
Misconduct,” which “removes 42 CFR part 50, subpart A, ‘Responsibilities of Awardee 
and Applicant Institutions for Dealing With and Reporting Possible Misconduct in 
Science,’ and replaces it with a new, more comprehensive part 93, ‘Public Health Service 
Policies on Research Misconduct’” (U.S. Department of Health and Human Services).  
 
A. Definition of Research Misconduct, Sec. 93.103 
 
    Although most commentators supported the new definition of research 
misconduct, there were a number of comments recommending changes, 
including that: (1) The definition should be based on deception; (2) the 
definition of falsification is inadequate because it does not cover the 
nonexperimental manipulation of human or animal subjects with the goal 
of influencing research results, or bias in the coding of qualitative data; (3) 
the definition of plagiarism should expressly exclude authorship and credit 
disputes; and (4) the definition of misconduct should be expanded to 
include negligent and intentional mistreatment of animals. 
    As explained in the preamble of the NPRM, the proposed definition of 
research misconduct, which is included in this final rule without change, 
includes OSTP's description of “fabrication, falsification, and plagiarism.” 
That description is clear and sufficiently concrete to provide the basis for 
reasonable determinations of whether research misconduct has occurred 
and whether the misconduct was intentional, knowing, or reckless. Given 
the careful consideration that has been given to this definition and the 
value of a uniform government-wide definition, we are adopting the 
definition as it was proposed. We note that the nonexperimental 
manipulation of human or animal subjects to influence the research results 
would appear to be a manipulation of research materials or processes 
within the intendment of the definition of falsification. (U.S. Department 
of Health and Human Services) 
 
    Sec.  93.103  Research misconduct. 
 
Research misconduct means fabrication, falsification, or plagiarism in proposing, 
performing, or reviewing research, or in reporting research results. 
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(a) Fabrication is making up data or results and recording or reporting them. 
(b) Falsification is manipulating research materials, equipment, or processes, 
or changing or omitting data or results such that the research is not 
accurately represented in the research record. 
(c) Plagiarism is the appropriation of another person's ideas, processes, 
results, or words without giving appropriate credit. 
(d) Research misconduct does not include honest error or differences of 
opinion. (U.S. Department of Health and Human Services) 
 
Dec. 2006 (revised April 2008) – The Gallup Organization, working for the ORI, 
publishes results of a three-year study, “Observing and reporting suspected misconduct in 
biomedical research,” which uncovered the types and frequency of misconduct in projects 
funded by the NIH. Found that “scientists…endorse open communication as a way to 
detect research misconduct” (Wells, qtd. in Penrose and Katz 59).  
Aug 2007 – ORI publishes revised “Introduction to the Responsible Conduct of 
Research:”  
After a decade of sometimes spirited debate, in December 2000 the Office of 
Science and Technology Policy (OSTP) in the Executive Office of the President 
adopted a Federal Policy on Research Misconduct. The OSTP Policy is in most 
respects similar to earlier ones adopted by the Public Health Service (PHS) and 
the National Science Foundation (NSF), but it did recommend some significant 
changes to the definition of research misconduct. When it is finally implemented 
by all government research agencies (the target date of December 2001 was not 
met), all federally funded researchers will be subject to a uniform definition of 
research misconduct. 
Definition. The OSTP Policy defines “research misconduct” as “fabrication, 
falsification, or plagiarism in proposing, performing, or reviewing research, or in 
reporting research 
results” (see accompanying box for details*). It also sets the legal threshold for 
proving charges of misconduct. 
To be considered research misconduct, actions must: 
• represent a “significant departure from accepted practices”; 
• have been “committed intentionally, or knowingly, or recklessly”; and 
• be “proven by a preponderance of evidence.” 
These further stipulations limit the Federal Government’s role in research 
misconduct (fabrication, falsification, or plagiarism) to well-documented, serious 
departures from accepted research practices. When using the common Federal 
definition to discuss research misconduct, it is important to understand that it 
establishes a minimum standard for measuring acceptable behavior, not a standard 
for judging all research behavior. In particular, it does not imply that all other 
behaviors are acceptable. It also does not encompass criminal behavior, personal 
disputes, violations of grant management policies or other unacceptable behaviors 
not unique to research, such as discrimination or harassment. The government’s 
main concern in establishing this definition is to assure that publicly funded 
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research is accurate and appropriately represented by clearly stating that three 
practices, commonly referred to as “FFP,” are wrong. (Office of Research 
Integrity, “Introduction to…Research”) 
 
*The “accompanying box” in this pamphlet reprints the ORI’s 2000 statement 
(http://ori.hhs.gov/policies/fed_research_misconduct.shtml): 
 
I. Research Misconduct Defined. Research misconduct is defined as fabrication, 
falsification, or plagiarism in proposing, performing, or reviewing research, or in 
reporting research results. 
• Fabrication is making up data or results and recording or reporting them. 
• Falsification is manipulating research materials, equipment, or processes, 
or changing or omitting data or results such that the research is not 
accurately represented in the research record. 
• Plagiarism is the appropriation of another person’s ideas, processes, 
results, or words without giving appropriate credit. 
• Research misconduct does not include differences of opinion. (Office of 
Research Integrity, “Introduction to…Research”) 
 
March 2009 – The Council of Science Editors publishes “White Paper on Promoting 
Integrity in Scientific Journal Publications, 2009 Update.” It addresses roles of editors, 
peer reviewers, authors (and allocation of credit), funding agencies, and relationships 
among them all (Scott-Lichter).  
 
2009 - National Academies’ Committee on Science Engineering and Public Policy 
release updated third edition of On Being a Scientist: Responsible Conduct in Research. 
It claims to further address issues affecting the early 21st Century scientist. The order of 
chapters and chapter sections changed dramatically. Authorship-related chapters are now: 
Authorship & the Allocation of Credit; Intellectual Property; and Competing Interests, 
Commitments and Values. The Research Misconduct chapter now reads: 
Some research behaviors are so at odds with the core principles of science 
that they are treated very harshly by the scientific community and by 
institutions that oversee research. Anyone who engages in these behaviors 
is putting his or her scientific career at risk and is threatening the overall 
reputation of science and the health and welfare of the intended 
beneficiaries of research. 
Collectively these actions have come to be known as scientific 
misconduct. A statement developed by the U.S. Office of Science and 
Technology Policy, which has been adopted by most research-funding 
agencies, defines misconduct as “fabrication, falsification, or plagiarism in 
proposing, performing, or reviewing research, or in reporting research 
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results.” According to the statement, the three elements of misconduct are 
defined as follows: 
• Fabrication is “making up data or results.” 
• Falsification is “manipulating research materials, equipment, or 
processes, or changing or omitting data or results such that the 
research is not accurately represented in the research record.” 
• Plagiarism is “the appropriation of another person’s ideas, 
processes, results, or words without giving appropriate credit.” 
In addition, the federal statement says that to be considered research 
misconduct, actions must represent a “significant departure from accepted 
practices,” must have been “committed intentionally, or knowingly, or 
recklessly,” and must be “proven by a preponderance of evidence.” 
According to the statement, “research misconduct does not include 
differences of opinion.” 
Some research institutions and research-funding agencies define scientific 
research misconduct more broadly. These institutional definitions may 
add, for example, abuse of confidentiality in peer review, failure to 
allocate credit appropriately in scientific publications, not observing 
regulations governing research, failure to report misconduct, or retaliation 
against individuals who report misconduct to the list of behaviors that are 
considered misconduct. In addition, the National Science Foundation has 
retained a clause in its misconduct policies that includes behaviors that 
seriously deviate from commonly accepted research practices as possible 
misconduct. 
A crucial distinction between falsification, fabrication, and plagiarism 
(sometimes called FFP) and error or negligence is the intent to deceive. 
When researchers intentionally deceive their colleagues by falsifying 
information, fabricating research results, or using others’ words and ideas 
without giving credit, they are violating fundamental research standards 
and basic societal values. These actions are seen as the worst violations of 
scientific standards because they undermine the trust on which science is 
based. 
However, intent can be difficult to establish. For example, because trust in 
science depends so heavily on the assumption that the origin and content 
of scientific ideas will be treated with respect, plagiarism is taken very 
seriously in science, even though it does not introduce spurious results into 
research records in the same way that fabrication and falsification do. But 
someone who plagiarizes may insist it was a mistake, either in note taking 
or in writing, and that there was no intent to deceive. Similarly, someone 
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accused of falsification may contend that errors resulted from honest 
mistakes or negligence. 
Within the scientific community, the effects of misconduct—in terms of 
lost time, damaged reputations, and feelings of personal betrayal—can be 
devastating. Individuals, institutions, and even entire research fields can 
suffer grievous setbacks from instances of fabrication, falsification, and 
plagiarism. Acts of misconduct also can draw the attention of the media, 
policymakers, and the general public, with negative consequences for all 
of science and, ultimately, for the public at large. (Committee on Science, 
Engineering, and Public Policy 16-18) 
July 2010 – The Society for Neuroscience publishes, “Guidelines: Responsible Conduct 
Regarding Scientific Communication” – a publication acknowledging the importance of 
ethical communication in science. A summary of the guidelines was also published in the 
AAAS’s (American Association for the Advancement of Science; of which the Society 
for Neuroscience is a member society) quarterly Professional Ethics Report in fall 2010. 
The Guidelines address several issues in communication and authorship ethics (Society 
for Neuroscience). 
  
May 2011 – This date marks the most recent update of NIH’s Web site, which gives this 
definition of research misconduct: 
Fabrication, falsification, or plagiarism in proposing, performing, or reporting 
research, or in reporting research results. 
• Fabrication is making up data or results and recording or reporting them.  
• Falsification is manipulating research materials, equipment, or processes, or 
changing or omitting data or results such that research is not accurately 
represented in the research record.  
• Plagiarism is the appropriation of another person's ideas, processes, results, 
or words without giving appropriate credit.  
• Research misconduct does not include honest error or honest differences of 
opinion. (National Institute of Health) 
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Appendix B 
Summary of the Process of Responding to Allegations of Research Misconduct 
 
Information is summarized and quoted from the Office of Research Integrity’s “Sample 
Policy and Procedures for Responding to Allegations of Research Misconduct.” 
 
1. Complainant takes allegations to institution’s Research Integrity Officer (RIO) 
2. “The RIO will immediately assess the allegation to determine whether it is 
sufficiently credible and specific so that potential evidence of research 
misconduct may be identified, whether it is within the jurisdictional criteria of 42 
CFR § 93.102(b), and whether the allegation falls within the definition of research 
misconduct in 42 CFR § 93.103. An inquiry must be conducted if these criteria 
are met.” (9) 
3. RIO notifies respondent; inquiry begins; research records are sequestered. RIO 
can consult with ORI regarding questions about records. 
4. At most institutions, RIO assembles committee (or there is a standing one) that 
has no professional or personal conflict with the respondent to review the case. 
Note: “that the purpose of the inquiry is to conduct an initial review of the 
evidence, including the testimony of the respondent, complainant and key 
witnesses, to determine whether an investigation is warranted, not to determine 
whether research misconduct definitely occurred or who was responsible” (10). 
“An investigation is warranted if the committee determines:  (1) there is a 
reasonable basis for concluding that the allegation falls within the definition of 
research misconduct and is within the jurisdictional criteria of 42 CFR § 
93.102(b); and, (2) the allegation may have substance, based on the committee’s 
review during the inquiry” (10-11).   
5. Committee does research (within 60-day period) to see if an investigation is 
warranted – not to see if misconduct occurred. But if the respondent admits to 
misconduct during this process, the case may be closed (with permission from the 
ORI). Committee prepares a report and the respondent and complainant may 
comment on it. 
6. The DO (deciding official) determines if investigation is warranted (this 
completes inquiry process). Within 30 days, the RIO sends the DO’s decision and 
a copy of the inquiry report (which includes the institution’s policies and 
procedures) to the ORI. If the DO said an investigation is warranted… 
7. Investigation begins. “The purpose of the investigation is to develop a factual 
record by exploring the allegations in detail and examining the evidence in depth, 
leading to recommended findings on whether research misconduct has been 
 73 
committed, by whom, and to what extent.  The investigation will also determine 
whether there are additional instances of possible research misconduct that would 
justify broadening the scope beyond the initial allegations.  This is particularly 
important where the alleged research misconduct involves clinical trials or 
potential harm to human subjects or the general public or if it affects research that 
forms the basis for public policy, clinical practice, or public health practice.” (13) 
8. A new committee (made up of people from the institution, possibly outside 
members, possibly a standing committee for such things) conducts investigation. 
9. Investigation committee and RIO prepare final report. Report has various 
requirements, including, “Each statement of findings must: (1) identify whether 
the research misconduct was falsification, fabrication, or plagiarism, and whether 
it was committed intentionally, knowingly, or recklessly;” (17). Respondent and 
complainant can add comments.  
10. DO decides whether the institution accepts the report, findings and 
recommendations of the committee, and then determines actions that need to be 
taken (if any). DO informs ORI. RIO notifies respondent, complainant, funding 
agencies and anyone else who needs to know the ruling. 
11. If institution allows, respondent can appeal. Institution must request an extension 
from ORI to conduct the appeal. 
12. The institution submits to ORI a copy of the investigation report, findings, 
judgment as to whether misconduct occurred (and by whom), and a description of 
actions that will be taken against the respondent. 
13. Per ORI, the RIO must keep “records of research misconduct proceedings” for 7 
years (19). 
Note: The RIO (who oversees this whole process at the institution level) has an 
obligation to notify “….ORI immediately if, at any time during the research 
misconduct proceeding, it has reason to believe that health or safety of the public is at 
risk, HHS resources or interests are threatened, research activities should be 
suspended, there is reasonable indication of possible violations of civil or criminal 
law, federal action is required to protect the interests of those involved in the research 
misconduct proceeding, the institution believes that the research misconduct 
proceeding may be made public prematurely, or the research community or the public 
should be informed.” (23) 
 
ORI oversees the whole process with the RIO acting as an in-between. The RIO, 
among many other duties, must “[maintain] and [provide] to ORI upon request all 
relevant research records and records of the institution’s research misconduct 
proceeding, including the results of all interviews and the transcripts or recordings of 
those interviews” (29). 
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Appendix C 
 
Information about Being in a Research Study 
Clemson University 
 
The Scientist as Author: 
Exploring the Importance of Authorship Ethics in Science 
 
 
Description of the Study and Your Part in It 
 
Steven Katz, Ph.D., and Claiborne Linvill, a Master of Arts student in Professional 
Communication at Clemson University, are inviting you to take part in a research study. 
The purpose of this research is to learn how you, as a practicing scientist, understand 
research misconduct definitions and the role of authorship in research. 
 
Your part in the study will be to help us understand the opinions and practices of a 
professional scientist. 
 
It will take you about 30 minutes to be in this study. 
 
Risks and Discomforts 
 
There are certain risks or discomforts that you might expect if you take part in this 
research. They include sharing stories about difficult ethical situations you or others may 
have been involved in. Please note that your choice to share this information is 
completely optional, and your name will not be associated in any way with the 
information you provide.  
 
Possible Benefits 
 
We do not know of any way you would benefit directly from taking part in this study. 
However, this research may help us better understand how scientists view their role as 
authors, and may potentially reveal methods to improve integrity in scientific research 
and publication. 
 
Protection of Privacy and Confidentiality 
 
We will do everything we can to protect your privacy and confidentiality. We will not tell 
anybody outside of the research team that you were in this study or what information we 
collected about you in particular. Your name will not be linked with the interview in the 
research report, and your name will be removed from the final interview transcripts. 
Claiborne Linvill will retain the recordings and transcript from this interview privately; 
they will not be shared. After one year, the recording will be destroyed.  
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Choosing to Be in the Study 
 
You do not have to be in this study. You may choose not to take part and you may choose 
to stop taking part at any time. You will not be punished in any way if you decide not to 
be in the study or to stop taking part in the study.  
 
You may choose to stop taking part in this study after today. If you do, we will remove 
your information from the study. However, if we have already completed our research 
analysis, we will not be able to remove your information from the study. 
 
Contact Information 
 
If you have any questions or concerns about this study or if any problems arise, please 
contact Claiborne Linvill at Clemson University at 864-656-5427 or 
clinvil@clemson.edu. If you have any questions or concerns about your rights in this 
research study, please contact the Clemson University Office of Research Compliance 
(ORC) at 864-656-6460 or irb@clemson.edu.  
 
Consent 
 
I have read this form and have been allowed to ask any questions I might have. I 
agree to take part in this study. 
 
Participant’s signature: ______________________________Date: _________________ 
 
 
A copy of this form will be given to you. 
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Appendix D 
 
Interview Script/Questions 
 
Thank you for agreeing to participate in this interview. First, I’d like to record this 
interview so that I can transcribe it later. I will keep the recording and transcription 
private. Your name will not be associated with the interview in my final report and will 
be removed from the transcription before it is printed. Do I have your permission to 
record this? 
 
Thank you. Do you have any questions so far? 
 
The purpose of this interview is to help me get a scientist’s point of view for some 
research I’ve been conducting about ethics in science. I am not going to ask you to 
confess any infractions or expose any of your colleagues; instead, I’m going to ask you 
some questions about your opinions on some issues related to research and publications. 
You of course can answer however you choose, and feel free to ask questions or add 
information as you see fit. 
 
Do you have any questions before we get started? 
 
---- 
First, let’s begin with some basic questions. 
Please state your name: 
What is your title at Clemson? 
What is your field of research? 
How long have you been publishing your research? 
In what journals have you published your research? 
Have you co-authored any articles with other researchers? 
Have you ever received funding for your research from organizations other than 
Clemson? If so, which ones? 
--- 
How would you define research misconduct? 
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How did you come to this definition? 
When you think about ethical research practices, does any aspect of communication come 
to mind? 
How would you define ethical communication in science? 
How did you come to this definition? 
Are you aware that governing bodies like the Office of Research Integrity and the Office 
of Science and Technology Policy have published definitions of research misconduct? 
 If yes, do you know what the definition is? 
Do the rules regarding research ethics affect how you communicate as a scientist? If so, 
how? 
As a scientist, are you concerned about ethical communication practices? 
--- 
Is authorship an important issue or concern in your research and publications? 
What do you think researchers should consider when making authorship decisions? 
Have you ever researched authorship guidelines?  
 If so, how? 
Have you ever felt unfairly represented as an author? 
  If yes, how? 
Tell me about a time when you felt fairly represented as an author. 
Do you know of any circumstances in which a colleague was treated unfairly as an 
author? 
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Appendix E 
 
Interview 1 
 
March 18, 2011 
 
CL: I’ll start easy, with some basic questions. State your name: 
I1: [name removed]. 
CL: And what is your title here at Clemson? 
I1: Professor 
CL: And your field of research? 
I1: Computer Science. 
CL: And, how long have you been publishing in this field? 
I1: Do you want me to include grad school? 
CL: Sure, if you were publishing in computer science then. 
I1: Yeah, so, I guess I will go back to…I better check…around ’98 or something like 
that. What does that make it?  
CL: 12 years? 13 years? 
I1: [laughs] Something like that. My earliest was…I think it was even earlier than that, I 
guess around ’95 or something. So, whatever that is. 16 years? 15 years, let’s say. 
CL: OK, I can look at some of this on your CV online. But can you name some of the 
journals that you’ve published in? 
I1: I’ll look online for you [types in computer]. Not that there’s been a huge many of 
them. In our field, computer science, for the record, we value conference proceedings – 
peer-reviewed conference proceedings – about as much as journal publications. Therefore 
my publication record reflects that, and so I have more proceedings papers than I do 
journal publications. And that’ll vary depending on discipline, as you may find. 
CL: that’s good to know, thank you. 
I1: I have published in journals. For example, I have here Transactions and Applied 
Perceptions. Usually what we do is I try to publish in our professional organization 
society, which is the Association for Computer Machinery, or ACM. And so the 
Transactions and Applied Perceptions, the TAP Journal, is one such publication of 
ACM’s. There’s also Behavior Research Methods, Instruments and Computers, Journal 
of Human Factors, those are the main ones really. 
CL: Human factors is also psychology, IO, right? 
I1: Hm. I sortof have one work in computer graphics, which is more my teaching domain, 
but I also do a little bit of research in that. Sorta my main focus is eye tracking, which 
evolves into human factors and computing. That’s sorta the CHI field: Human/Computer 
Interaction. HCI. It used to be called CHI for Computer/Human Interaction, but they said 
“human comes first,” so… 
CL: Interesting. OK. Have any of these proceedings or journal articles been coauthored 
with other researchers? 
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I1: Oh yes, I think just about all of them have been. I like to collaborate and a lot of them 
are with other coauthors and a good deal of them are grad student-authored as part of 
their graduate work. 
CL: Have you ever received funding for your research from organizations other than 
Clemson? 
I1: Yeah. National Science Foundation, NASA, a little bit of funding from the military, 
the DOD, you could say as the sort of umbrella. 
CL: Right. 
I1: NSF is my main one. So… 
CL: Great. Wonderful. OK. So, with that all cleared up, let’s jump in. [I1: Sure] My 
question to you is, how would you define research misconduct? 
I1: [pauses, thinks] Uh…. 
CL: It can be top of your head, it doesn’t have to be formal. 
I1: I dunno, the first thing that jumps into my head is plagiarism, would be one of the 
main things. There’s I guess two forms. One is you ripping off somebody else. Or self-
plagiarism, which isn’t quite as bad but it’s still frowned upon. Those are the two main 
issues, I guess, I would say. I don’t know…from an institutional perspective, though, I 
guess if you’re asking… I guess research misconduct from their point of view, maybe, 
I’m guessing, would be misuse of funds maybe in some way.  
CL: OK. There’s no right or wrong answer, here. I’m just looking for how you would 
define it. How did you come to this definition? Were you taught it somewhere, did you 
pick it up? Or is it just from your field? 
I1: That’s a good question. Um… You know, the plagiarism thing has really been passed 
down, I guess. I guess it was really, in some ways taught, but in an informal sense by 
professors in grad school, I suppose. And this was done via, as an example, one of my 
best classes that I remember was this class on the human-computer interaction, and what 
we did mainly that semester was read a ton of conference proceedings papers from this 
one particular conference, a good conference. So it was an example of good papers, 
right? And just via commentary, what that prof said was, you should know who these 
people are, who are the main authors, what they do, where are their research labs, and 
things like that. And sort of by and by, he would often comment, since he knew these 
guys, or a lot of them, he would say these are good, these are bad, and here’s what’s not 
to do. So that’s how I sort of picked it up. 
CL: By example… 
I1: yeah, by example. Things you hear, that kind of thing. 
CL: When you think about ethical research practices, doing your research ethically, does 
any aspect of communication come to mind? [pause while I1 thinks.] You mention 
plagiarism, which is writing… 
I1: Yeah, cause that’s dissemination of your results, right? [CL: right.] Communication, 
you mean like email? Skype, that kind of thing? 
CL: More like, it could be, but also how you communication with your colleagues, how 
you write, publish, make decisions about working together… 
I1: Well, yeah, all of that. I sorta don’t get the question. 
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CL: That’s fine. The fact that you said plagiarism first means that was a big part of your 
study.  How – I guess this is related – how would you define ethical communication in 
science? Is that any different from ethical research? 
I1: From unethical communication? I don’t know, really. It’s kinda… I don’t know how 
to define that. Ethical communication? [pause] 
CL: That’s fine. OK.  
I1: Communication to me is just, sorta, person to person kind of thing. So it’s not really 
like broadcasting, right? CL: right. Me to others, me to another collaborator. So what do 
you mean by ethics there? How do ethics enter the picture? 
CL: Well, that’s sorta what I’m wondering. If you think they do. 
I1: I guess… Well. Let’s see. I’m involved right now in a program committee sense…so 
there’s communication there. I guess there’s some levels. There’s just personal 
communication, where I can email a friend of mine at another university and say, hey do 
you know of any papers that talk about this topic? But that’s just kinda you pick up the 
phone and call a friend. So I don’t think ethics enters too much into that. So I guess 
where the ethics might come into play is in this program committee where I’m talking to 
a small number of people, my, let’s say, other associate chairs that are running or 
organizing the conference and we’re discussing other papers. So for example there, the 
ethics there would be in the way how we discuss the papers that we are reviewing. And 
that is usually done in a double-blind way in our conference proceedings. Not all 
conferences function like this, but these ones do. And so we, we discuss the papers in a 
kind of closed form, so there’s a bulletin board that goes on where we talk about the 
reviews and the rebuttals and things like that. And the way it works is, we don’t really 
know who the other reviewers are. So as reviewers, we don’t know really who we’re 
talking with. So it’s kinda anonymous. So that’s one way the ethics come into play, I 
suppose. 
CL: So both the authors and the other reviewers are all blind. 
I1: Yeah, reviewer-to-reviewer and reviewer-to-other-author are all blind. Sometimes the 
authors will mess that up and inadvertently or maybe that had a motive for doing it, they 
stick their names on the paper so you know who the authors are. But really what’s 
supposed to happen is they’re supposed to mask their identities so we don’t know who 
they are reviewing and they don’t know who reviews them. So that’s one ethical kind of 
conduct for the peer-review system. 
CL: That’s perfect. Thank you. Now, did you know that the Office of Research Integrity 
– ORI – or the Office of Science and Technology Policy – OSTP – have published 
definitions of research misconduct? 
I1: Nope. What do they say? Do you know what they are? 
CL: I do. They define it as FFP: falsification, fabrication and plagiarism.  
I1: AH, OK, great. 
CL: And then they define what FFP mean. And different bodies – some of them say, just 
in your research, and some of them say – well, one of them has a clause that says, “and 
anything outside accepted scientific practices.” 
I1: I see. I totally missed this. I just wasn’t thinking about it. 
CL: That’s fine, that’s what I’m looking at. 
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I1: Yeah, but of course that – that’s just something we assume we know what not to do. 
Doctoring your data, right? It just goes unsaid. [CL: No, that’s good.]  So I didn’t say it! 
In fact, we’re conducting a study right now, and all that stuff comes into play. The ethics 
issues come into experiments. So I do a lot of human subject experimentation, we’re 
doing that now in the lab. In fact, you can be a subject. We’re looking for subjects. 
CL: I will. I owe you one. Karma. 
I1: Yeah, we’ll we’re rather desperate because, here’s an example. Our grad student 
messed up the order of the presentation of the stimulus, and so all the 16 subjects that we 
just ran, all that data is out the window and we gotta start over. Which is really annoying. 
CL: But you made the choice to start over. 
I1: You have to. Because in this case, it’s not so much ethics, but terms of the actual 
experiment design. If we don’t counterbalance the presentation we have a learning effect 
and it will mess up the data. That’s one thing. But the ethical consideration comes into 
play when you decide do you want to doctor to the data. Do you keep certain pieces, how 
do you analyze the data? Do you throw out data that doesn’t – the outliers that don’t fit 
your hypothesis, that sorta stuff? I know not to do that kind of nonsense. I’m pretty – at 
least I hope I am – I’m pretty good about not messing up data in that way. So I’m aware 
of all that. I stick to a pretty strict code of conduct, let’s say, where I don’t mess with data 
and if the data shows up something that doesn’t agree with what I was expecting, well 
that’s the way it goes.  
There’s no way I’m going to mess up my scientific reputation by [laughs] by screwing 
data up like that. 
CL: Exactly. Those rules you mention that everybody knows – do you ever think about 
them, do they affect how you communicate with your colleagues? 
I1: It does in the peer-review process. I know what? I don’t think we ever really… it’s 
sorta a remote possibility that someone would do something like that. It’s really 
unexpected. So the only thing we really look for is really more into the design aspects of 
an experiment. We’re looking at how their results are, they look, and whether their study 
was conducted in a proper sort of experimental methodology. But you know we mostly 
assume that everybody is following the same conduct and nobody’s messing with their 
data. 
CL: Is that part of some kind of scientific community? 
I1: I would think so yes. I mean, there are written rules, but…[laughs] 
CL: But you said it wasn’t the written rules that defined it for you, it was just… 
I1: Yeah, it was experience, and I guess it’s one of those things you pick up at school or 
grad school or whatever from good professors that teach you the right thing. So yeah, 
that’s sort of how I got it, right? 
CL: That makes sense. Let’s see. Is authorship, as a part of this community, is that an 
important issue or concern that comes up in research or publication? 
I1: [laughs] Have you heard the term publish or perish? [CL: I have.]. So yeah, it’s 
important. It affects tenure, promotion considerations. It affects your reputation in the 
field. All that stuff. You know, I’ll tell you – I share this with my students and whoever 
asks, and since you’re asking… One of the comments that my advisor made, which has 
really stuck with me, was when I was leaving grad school for an academic position, I said 
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to him, you know Bruce, I don’t know how this is gonna work out, maybe I won’t be a 
good professor, but my understanding is that when I go for tenure, I have to send out for 
external reviews. What if people don’t know who I am? And his response was, well that 
tells you something, doesn’t it? [CL: right]. So the way to get people to know who you 
are is to publish. And go to conferences, present your work. That’s how it works. [CL: 
right]. You’ll keep your job if people get to know who you are and your work has been 
good. 
CL: How do you think researchers – or how do you as a researcher – what considerations 
to make when making authorship decisions? 
I1: Well, I guess, timeliness is one. Where to publish. Things of that nature. 
CL: What about with coauthors? In terms of allocation of credit, order of names, who’s 
leading the research… 
I1: Sometimes it can be as simple as alphabetic order. 
CL: Really? 
I1: Yeah, in fact the most recent paper that my colleague next door here, we were 
involved in a pedagogical study from which a paper resulted – we presented our findings. 
He put everything in alphabetical order and it ends up being that I’m the lead author but I 
really wasn’t. And so, if you look at it, it’s just alphabetic. 
CL: And everyone was OK with that? 
I1: Yeah, I mean we all participated. Usually what happens I the author will distribute the 
paper and you can make comments or whatever and say “ I don’t like this” or “strike 
that,” so everybody’s got a chance to provide feedback or change things or make their 
own contributions. 
CL: In your field, is it the first author or last author who is the main one? 
I1: The main? Usually the first. 
CL: In some fields, the “famous” professor gets tacked on last. But different fields do it 
differently, I’m learning. 
I1: I see. Yeah. I don’t know. It depends on the paper. This one – well, we’re all famous 
professors, so it doesn’t matter [laughs]. 
CL: Have you ever researched authorship guidelines? Like looked up what your 
proceedings, journals or conferences expect out of authors? 
I1: Nope. Do you know of any as examples? Like you said the famous one goes last? 
CL: Well I know that some of the journals write out exactly what role you should have to 
be called an author as a way to prevent people from just tacking on names. I think there’s 
an issue where people get listed, especially when they oversee grad students, sometimes 
get listed as an author when they may not have done any research.  
I1: The token author? 
CL: Exactly, token authorship. So I know some of the journals have authorship 
guidelines regarding credit and order. 
I1: Uh-hunh. I’ve just learned as you go. Does it make sense to put somebody on there if 
they haven’t contributed anything to it? Just in the case that they might get emailed or 
asked about this paper and say “I don’t know what you’re talking about.” I don’t want to 
be embarrassed in that way, so you don’t do that sort of thing. 
CL: Have you ever felt unfairly represented as an author? 
 83 
I1: Um…no, I can’t say that I have. 
CL: OK.  
I1: Like I say, usually most of my collaborators send me the paper and I have the option 
of saying, well, if I don’t like the paper, just take my name off. That’ usually…I have that 
option. I don’t like what you wrote there, just take my name off.  
CL: Um….I was going to ask if you could tell me about a time you felt fairly represented. 
Is that the alphabetical example you gave me? 
I1: That’s fine. 
CL: Was that fair to you? 
I1: Yeah. Most times I think are fair, in the sense that if the collaborator gives me a 
chance to review where I am – not where I am in the author list – but gives me a chance 
to review the paper, put it that way – in that case, I don’t really care where my name is. 
CL: you don’t? 
I1: No, not really. Not anymore. Not after tenure. [laughs.] But actually, I don’t think – it 
depends, I guess it matters the discipline or university. I don’t think in our department 
they really care as to how many papers I was first author on. I don’t think they counted it 
that way. And these days also, interdisciplinary collaboration is kindof a good thing, so it 
doesn’t really matter here, from our prospective, in this particular department, where my 
name shows up on the paper. That’s just been my impression. Nobody’s told me 
otherwise. 
CL: OK. That might answer this question. I was going to ask if you know of any 
circumstances where a colleague – in your field or out of your field – felt unfairly 
represented as an author. Do you hear about that kind of drama? 
I1: [thinks] 
CL: Or in your committee of reviewing papers, does it ever happen? 
I1: I can’t say it never happens, but I’m not aware of any particular instances. Um…. 
[thinks]. Oh yeah… I do remember a case. This is plagiarism. It happens. So actually, 
you know, by reputation and sort of by friendship you kinda what to befriend people that 
are good if not better than you. I knew people – I’ll leave names out – that they had 
written something and there was this other guy who wanted to write this book. And so 
there was this issue of him wanting to use the first party’s paper as a chapter – this was a 
few years ago, so I don’t remember exactly what went out, and I wasn’t involved in this. 
But somehow this guy had used these peoples’ work in his book, and I don’t think he 
actually attributed that work to them. And it was almost verbatim. And so this is 
like…[CL: obvious.] “What the heck is this?” They were pretty upset about it. He 
claimed “ooh…I don’t know…” something. I don’t know how it got resolved, but 
basically that kind of thing…if you do that, and this guy did, people in your community, 
and my community, in the eye-tracking field, is somewhat small, and so you know you 
sortof get wind of this and then the name sticks and you remember this person and the 
next time he asks you for something you kinda “well, I don’t know…” You know, you 
sort of shy away from collaborating with people. So, you kinda get, informally black 
balled as it were. If you commit these kind of things. 
CL: So even if official government body didn’t come down on him, researchers will. 
I1: Yeah. 
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CL: He’ll hear about it. 
I1: Yeah. 
CL: That’s all the formal questions I had. Did you want to add anything or have any 
formal questions for me? 
I1: No, that’s about it. So maybe…what’s the…debrief me. Is there anything else that, I 
don’t know, you feel there’s more involved…like what’s going on. 
CL: Well, I’m going two directions with this. What’s been of interest is the Office of 
Research Integrity. This definition, the FFP definition, people in my field who study 
communication writing feel that it’s not representative of all the depth of issues that come 
up regarding communication, like the peer-review process, more definitions of plagiarism 
than just copying, the way people work together, authorship order. There’s a ton of 
journal articles of different scientists arguing how authorship works. [I1: really?]  So 
there’s been a call from a few people to add more authorship considerations into the 
definition of research misconduct. There were actually a couple of formal briefs by 
committees in government saying we might need to revamp this definition of research 
misconduct to include more than just FFP (which is falsification, fabrication and 
plagiarism). And then a big study came out where they had scientists self-disclose small 
misbehaviors they’d done – not big stuff like that guy plagiarizing an entire chapter –but 
little things like “I might have slightly done this to the data,” or “I may have taken a little 
bit of my grad students work” or something they thought was small – and they actually 
reported at really high rates that this was happening. So in that kind of environment and 
several people calling, the ORI is still putting out – as is the NIH and some of the major 
organizations – are still sticking to “research misconduct is only FFP, and we don’t want 
to consider anything else.” So I’m looking at, from the writing point of view, what does 
that mean for scientists? Does that mean that authorship stuff is not important? How 
much does it matter? Is it really affecting how scientists work? Because my other thing I 
realize is that I went in with a bias assuming scientists care. And I’ve realized they might 
now. As you said, they regulate each other. 
I1: But we do care.  
CL: But you might not care what a governing body says about it. I don’t know.   
I1: I don’t know exactly. How to fit in the government oversight into this. I guess I would 
say that – I’ll give you sort of an analogy from my skydiving days. So skydivers are 
peculiar lot. They have their own community and all that. And while there are official 
guidelines – what is it, the FAR? I forget cause I haven’t done this in a while – the FAA 
governs everything that happens in the air, I guess, including skydiving. So the FAR Rule 
95.1 or whatever it was. So there are guidelines and specific rules for skydiving. But 
skydivers are really…I can’t find the word….but they really like the fact that they’re 
mostly self-regulating. And I think the scientific community would, in my opinion, echo 
that kind of sentiment. The self-regulation. I don’t know, in some ways I would sort of 
even prefer that we as a community sort of sift out these bozos that don’t operate 
properly, let’s say. Versus having some government body coming in and saying 
whatever.  
CL: Right. 
I1: So that’s sort of my opinion. Seems to be working for us.  
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CL: OK. I think it’s interesting your field seems to practice more congenial than some 
others about authorship order and… 
I1: Well let me add also that we have um – I don’t know if other fields use this kind of 
stuff or not – but we have computational tools that we use. For example, for tenure 
promotion considerations – you know, what’s important is, well, in some ways, some will 
argue this – whether, is it the number of publications – no, not really – it’s the quality of 
publications. It’s not quantity, it’s quality, right? If you have a seminal paper somewhere 
that gets referenced by 1,000 people that’s great, that’s what they want. In fact, what I’m 
talking about there, being cited by 1,000 people, you can get on whatever, Google 
Scholar, there are these numbers – I can’t remember what they are, H numbers? [CL: 
right, I’ve seen them]. So, you know, you can look at your paper and find out what its H 
number is, or yourself and find out an H number, so that kind of stuff plays a part too. I 
don’t know where I was headed with that, but I wanted to mention that this is also 
available to us and in some ways, you can use these tools to compare papers for 
plagiarism or things like that, or look at authorships or whatever, so I don’t know if we 
use those things and other disciplines don’t… [CL: right.] But the stuff’s there, so we’re 
aware of it as well. 
What is it…there was one joke out there… So also where you publish is important to us. 
So we publish in peer-reviewed places and full articles – not just abstracts, right? And so 
the joke…there’s this conference out there, I don’t know the names, but some program 
was written that would sortof just send out – the monkeys in the room,  a room full of 
monkeys – this thing would assemble, you know, syntactically correct sentences that art 
kindof meaningless and construct a full paper that fell into the typical sort of paper 
format: abstract, intro, background, methodology, results, conclusions – that kind of stuff. 
[laughs.] So they would construct these bogus papers and send them to conferences and 
these things would get accepted. 
CL: I think every field has people who do that. 
I1: So we are looking at that and say, I’m not going to send my paper there, because it’s a 
joke. So that kind of thing matters too. Authorship, places where you publish… 
CL: Peer-review process… 
I1: Yeah, where do my “esteemed colleagues,” as it were, where do they go? 
CL: Well, and a lot of that is threatened also – this is out of the scope of my research – by 
online publication journals now, too. There’s some argument as to whether or not they 
are fully peer-reviewed and are you skipping the process, and… 
I1: Yeah, and for that same reason I’ve shied away from those, the online journals. I 
really don’t know much about them, how they work, how well-respected they are, you 
know? So I really haven’t submitted any to those things yet. 
CL: Ok. So the authorship credibility is important? 
I1: Sure. 
CL: Well, I appreciate your time very much. 
I1: My pleasure. 
[recording ends.] 
 
[The morning after the interview, the participant sent me the following email]: 
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Fri, Mar 18, 2011 at 9:49 AM 
 
Claiborne, 
 
I forgot to mention one more interesting ethical story that happened 
at a conference, regarding attribution.  One important aspect that 
I failed to mention about authorship is proper attribution of other 
peoples' work---while you can't plaigarise [sic] their work, you can of 
course, and are expected to, cite their work.  In fact failing to 
do so is frowned upon. 
 
One example of this, which was inadvertent and excusable, was during 
a conference.  A fellow submitted a paper of a particular method he 
had come up with independently.  After the review process somebody 
piped up saying it was the same approach they had published a few 
years ago and this new paper had not cited the old paper.  In this 
instance, the omission was excusable because the author admitted he 
had not been aware of the previously published work.  Although it 
was too late to put into the paper, he did acknowledge this omission 
during the talk and apologized. 
 
This kind of thing does happen from time to time, particularly if a 
relevant paper was published in an "obscure" source.  Interestingly, 
this sort of thing may occur more frequently as interdisciplinary 
boundaries are crossed.  For example, a computer science author might 
not be a aware of a paper appearing in a Psych journal that they 
typically don't consult on a regular basis. 
 
Anyway, just wanted to throw that in, as it was a sort of uncomfortable 
situation for me, as I was chair of the conference, but in the end 
the situation was resolved I think to the satisfaction of all parties 
concerned. 
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Interview 2 
 
March 22, 2011 
 
CL: So this is [name removed], and it’s March 22, right? [I2: Right.] OK. Alright. I’ll 
first give you my whole – the purpose is that I’m trying to get a scientist’s point of view 
on some research I’ve been doing on authorship ethics and research misconduct. [I2: 
OK]. I’m trying to say what scientists think about things, and then I hit a wall realizing 
that I actually need to talk to scientists about what they think about things [laughter]. So 
that’s my line of questioning – totally your opinion, so answer however you want, ask me 
questions.  
So we’ll start with the basics, where I ask you to please state your name. 
I2: My name is [name removed]. 
CL: And what’s your title at Clemson? 
I2: I’m an assistant professor of bioengineering. 
CL: And what is your field of research? 
I2: So I’m in the department of bioengineering. I do nano- and micro-scale mechanics of 
biological systems. [CL: OK]. That’s not very glamorous sounding. 
CL: It sounds very glamorous.  
I2: I also do a little bit of instrumentation work. Mostly having to do with developing 
rural countries. 
CL: OK.  
I2: I do two separate things. 
CL: How long have you been publishing your research? 
I2: I think my first paper came out in 2001…somewhere around there? 
CL: So about 10 years? 
I2: 10 years, yeah. 
CL: I can check your C.V. online, but what are some of the journals you publish in? 
I2: I’ve published in the Journal of Biomechanics, the Annals of Biomedical Engineering, 
the ASME Journal for Biomechanical Engineering, I think. They all sound the same. I 
also publish in more chemistry journals. So Langmuir…um…I’m totally blanking on 
those names. I do some like, molecular stuff, so that’s in there. Um…shoot. ACS 
publications… Langmuir …and then some materials ones, like Bio… not Biomaterials, I 
haven’t published there, but like Biomedical Materials Research, or something like that.  
CL: OK. 
I2: Let me think. Um…  Materials. Trying to go back through the different journals I’ve 
published in. Oh, Journal of Engineering, Fibers and Fabrics is the last one. That was 
kindof a side project having to do with wool fibers. [CL: Fibers…?]. Yeah, that was a 
grant. 
CL: With all these articles, were any of them coauthored with other researchers? 
I2: All of them were. 
CL: OK, and have you ever received funding for your research from organizations other 
than Clemson? 
I2: Yes. 
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CL: Which ones? 
I2: [laughs].  
CL: Or some… 
I2: Government agencies including NIH, NSF. I’m getting some DOE funding. Um…the 
South Carolina Space Grant, which is NASA for South Carolina. Those are kinda the 
government agencies. In grad school I was on a Whitaker Foundation Fellowship. Um, 
I’ve gotten the wool stuff was funded by industry, by a local wool manufacturer. 
And….I’m missing some…probably AHA, some longer, like, whatever these are called. 
CL: Government? 
I2: Societies, not governments. Funding societies? American Heart Association – so 
whatever those are called. 
CL: OK. Perfect. Thank you. OK, so jumping in to – all that established – how would 
you define research misconduct? 
I2: Whew. Uh… um… So, there’s a couple of things I would define as research 
misconduct. Definitely, since we were talking about papers, if you don’t either give 
someone credit or credit is due – if they aren’t listed as an author even though they did 
work that deserved to be an author. Plagiarism is a big one. Like not citing something. 
And then fudging or lying about your data. Um… Which I have not been involved in, but 
I have friends who caught someone doing that when they reviewed papers. Yeah. Well, 
it’s not – it’s a weird thing, but it’s definitely for bio stuff, when you have images, you 
can’t fudge the images, you can’t sharpen, blur the image. 
CL: Right. Interesting, OK. How did you come to this understanding or definition? 
I2: Um, I guess in grad school? With interactions with my advisor, like what’s 
appropriate, not appropriate type behavior. I think a lot of it is somewhat common sense 
if you sit back and think about it.  
CL: OK. When you think about ethical research, or practicing ethical research, does any 
aspect of communication or how you communicate with others come to mind? 
I2: Yeah. So I think even when you’re doing say an oral presentation or something, you 
shouldn’t pass off somebody else’s work as your own. So like, definitely citing previous 
work and making a clear distinction of what is yours and what is somebody’s work 
you’re basing your stuff on.  
CL: Yup, OK. And was this – did your understanding of how to communicate well as a 
scientist also from grad school? 
I2: Yes, my advisor. Definitely my advisor taught me. The other one you learned also in 
class, maybe they covered some things of like ethics and things in class. But yeah. 
Communication ethics is from my advisor. 
CL: OK. Are you aware that governing bodies like the oversight groups like the Office of 
Research Integrity or the Office of Science and Technology Policy, do you know that 
they have published definitions of research misconduct? 
I2: Yes, and they… I usually check those, especially when I’m submitting a grant or 
something, to make sure. Because sometimes there’s subtle things you just want to make 
sure you’re not doing anything bad. 
CL: Have those rules ever affected how you choose to communicate? 
I2: [pause] 
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CL: That’s hard – I know that’s hard. 
I2: Yeah… yes and no, I think like in terms of citations and stuff and grant proposals, I’m 
always really careful. Because I know, some of them they actually have published what 
they think is misconduct and they tell you how they check. So.. you know…just to make 
sure I didn’t accidentally … when you’re typing up a grant or even a paper, I always 
double-check through the thing we can do for students’ papers, also – like Turn It In, as 
like an app that checks for plagiarism. Because I feel like sometimes when you’re writing 
a paper, you’ve read all this stuff, and just to make sure I’m not actually plagiarizing by 
accident so… 
CL: Well that’s smart. 
I2: Yeah. That’s not happened before, but it puts my mind at ease. 
CL: Right, right. OK. Would you say that, as a practicing scientist, you are concerned 
about ethical communication in science? 
I2: Yes, yeah.  
CL: Sounds like you’re pretty on top of that… 
I2: Yeah, it comes up a lot, actually. And there’s definitely some people who, when I got 
here, I was, you know, I was told – not at Clemson, but around, in the community – I was 
told to be careful when I talk to that person, because they steal people’s work, they’ll ask 
you for looking over a proposal or something and then you suddenly find your data in 
their papers, and stuff like that. So. I think actually when I started the faculty position that 
became more, like… Most of the time, I’m OK sharing stuff, but there’s definitely some 
times that made it clear that there are some people who apparently don’t follow, you 
know, proper conduct [laughs.] 
CL: Right, that would totally change how you chat about your work [I2: Right]. 
Interesting. OK. Would you say that authorship is an important issue or concern in your 
research and publications? 
I2: Yes. And I know when you’re a grad student and post doc, it’s good to be first author. 
And once you’re a faculty member, at least in our field, you want to be the last author, 
the corresponding author. For tenure, that is an issue. They want to see that you have a 
published track record as you being the corresponding author and the way that shows in 
our field is that that’s the last author. 
CL: So the last author is “corresponding author” [I2: yeah] and that’s the most prestigious 
[I2: yeah]. 
I2: Which is not the same in all fields.  
CL: No, it’s not, I’m learning that. 
I2: In computer science, where my husband works, it’s just alphabetical. Makes things a 
lot clearer, I think. I mean, there’s a star beside who’s the corresponding author, but at 
least there’ not quibbling about orders of peoples’ names. 
CL: Right, right. What do you think that researchers should consider when they make 
those authorship decisions? 
I2: Well, I guess who did the bulk of the work, like whose work is it? So that’s usually 
the graduate student or the post doc or whoever it is. And then, whose lab was that in? 
And that’s usually the grad student/post doc advisor. So usually it’s easy to figure out 
who’s first and last. It’s the ones in between that’s tricky. So usually I have my student 
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and I sit down and figure out who helped out and who did part of some work that should 
get authorship. Also, who had significant input on the discussion. So sometimes, even 
though it’s not like someone did like…you know, sometimes you take your samples and 
they get imaged by somebody else, and that’s definitely authorship, but sometimes it’s 
like, we had a bunch of discussions with this person and we should put them on the 
paper. Yeah. 
CL: That’s perfect. You’ve mentioned you researched the general misconduct policies. 
Have you ever researched authorship guidelines? 
I2: The journals sometimes have them. But I haven’t looked all that recently because they 
tend to be all the same in the ones I publish.  
CL: OK.  
I2: It hasn’t really been an issue on any of my recent papers. 
CL: So do you just kinda go online to the journals? 
I2: Um-hm. You can also tell from how the authors are laid out on previous papers in that 
journal. 
CL: OK. Um. Have you ever felt unfairly represented as an author? 
I2: Hm. Yes… [chuckles]. Yeah. Um… [pause].  
CL: Are you comfortable talking about that? 
I2: Yeah, no, I’m trying to think…. I think most of the time it got sorted out before the 
thing actually got published. Um. So that’s why I’m trying to say whether it’s yes, really 
– or sorta like in the process and then we sorted it out and it got worked out. I don’t think 
there was anything – there’s probably one or two minor things where it’s like a 
conference proceeding or, you know, not like a paper, where I was like, well, I probably 
should have been an author. But by the time the paper comes along, we’ve had more 
discussions and then… So maybe then the answer is no. Does that make sense? 
CL: Yeah, but would you mind…the one that got sorted out…what were y’all sorting 
out? 
I2: Well, I know I’ve… it’s gone both ways actually. So I know I’ve gone to things 
where, like I’ve gone to talks at conferences and I’m like, “My name wasn’t on the author 
list,” I think that usually they acknowledged me in the acknowledgements. But I’m like, 
“You know, I did a lot of that work. In fact, you acknowledged me a lot.” So by the time 
the paper comes and we write the paper then I’m an author on that paper. [CL: OK]. And 
so conference proceedings in our field aren’t as…prestigious…they’re not, they sorta 
count, but not really, so it’s not as big of a deal. Um. I’ve definitely like, in grad school, 
there was one paper where it was like, “Should I be first author or should the other person 
be first author,” and I was like, “It’s my paper.”[CL: Yeah.] And I was first author. There 
was, there’s a paper where I was listed as an author where, I mean I helped with 
discussions and helped on a little bit of coding of the computer code, where they put me 
as an author. And I was very grateful, but that surprised me. I didn’t expect to be an 
author on that one. 
CL: Ah, so it works both ways. 
I2: Yeah, it does. That’s why I was saying there’s probably both ways. I probably would 
have been OK just being an acknowledgment in the acknowledgments section. So that’s 
like journals and stuff. I’ve definitely – the weirdest one on the other direction – was 
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there was a big presentation about this big grant that got awarded for the state, where they 
had like a big center grant, or something like that. And I remember, I’m sitting in the 
audience, and they’re talking about it, and they’re like, “And these are what the different 
components are, and who’s working on this component.” And I remember looking at the 
slide and going “oh look, a [her last name] at Clemson who’s doing work that’s really 
relevant.” And then the next slide I’m like, “Wow, really the same as what I am doing.” 
And it occurred to me that that was me [laughter]. So they put me on this grant, which 
was great, I get money everything, but they never asked me until after  that whole 
presentation and after it got awarded, which… So part of me is like, “yay, I got money,” 
but part of me is like “they really should have asked me before.” You know… And also, 
like, where did they get those slides? Oh [CL: right, photo rights…] Yeah. So it was a 
little off…  So that was definitely a weird one. I mean it worked out…you know, it pays 
for a student or whatever. But that I was definitely… Plus afterwards, all the people were 
like, “So you were on this grant, what was this all about?” I’m like, “I don’t know.” 
[laughter]. And afterwards they were like, “I hope it was OK that we put you on this 
grant. “ I’m like, “yeah…?” 
CL: A phone call the week before would have made a world of difference. 
I2: Yeah.  
CL: interesting. [I2: yeah]. On the flip side, can you describe to me a time where you felt 
fairly represented as an author. [pause]. I mean, I’m sure it’s something that 
happens…[crosstalk] 
I2: Yeah, most of the time I think that that happens. I definitely…it’s easier to think of 
being fairly represented as an author when it’s either from one of your lab groups or one 
of my students being an author or me being the first author. But I’ve definitely had great 
collaborations where I’m not the last, I’m not the first author, but they definitely, I felt 
like they put me in the right spot. Usually, when it gets to the point that we’re writing the 
paper, very early on – before the paper is written – usually we have a discussion of what 
should the authorship order be. Who should be on the paper. And so people have been 
really good about that. 
CL: So the discussion of order was before… 
I2: Yeah. Like, I mean, the work’s been mostly done. Probably we’ve had a couple 
conferences and things. But like, for the actual paper, figuring it out. Yes. So it doesn’t 
cause problems. And I think there was one paper where, when I was a post doc, where I 
really helped train that student to do the stuff, I even did most of the first round of data 
stuff because he wasn’t used to the technique. And then he was writing the paper, and he 
wanted to put me first author. And I probably could have been like, “Yeah, sure,” cause I 
did it.. But I think it was definitely…I told him to put himself first and me second just 
because I thought it was his work. I mean, the second half, he did it. I supervised or 
whatever, so… I think as long as people have good discussions beforehand…? [CL: 
yeah]. Like, not the “I’m submitting in 24 hours, does this look OK to you?” format, I 
think it’s fine. 
CL: Right. Um…do you know of any circumstances in which a colleague, a friend of 
yours, was particularly treated unfairly as an author? 
I2: Yes. 
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CL: would you be willing to share? 
I2: You should probably talk to my husband. 
CL: I might. If this goes beyond pilot research, I will. 
I2: So my husband, in his master’s research, his former master’s advisor, um… so… 
Brian had a master’s thesis, and he wrote it up and then he had the paper, it took forever, 
but he left and things weren’t great with that adviser anyway because he was doing other 
things. And then, I think we were already at Clemson, either that or right before, he got 
an email from some guy in Italy that was like, “I noticed this paper by your former 
advisor. I don’t understand this particular proof. I know you worked with him before, 
could you help me out?” And it turns out the guy had published pretty much Brian’s 
thesis without acknowledging him at all on the paper.  
CL: Wow. 
I2: Yeah. So the funny flip side of that is that there was a bug in Brian’s thesis. So then 
Brian was able to write a paper that was basically like, uh, a revision, or a, you know like, 
pointing out this error in this other paper because he wasn’t an author on the other one 
[laughs] [CL: right].. Yeah. And that particular advisor, actually, eventually left the 
university because, and was I think right when Brian was doing his doctoral work the 
second year he was asked to come in for an interview because there were other issues of 
that particular advisor not conveying proper credit to students. [CL: wow].  
And then I know of some people here whose work got kind of scooped/stolen from 
proposals… And it’s funny cause now you interact with them, and they’re really, you can 
tell who those people are because they won’t share their proposals. Even if you’re on a 
proposal with them, there are certain people where I’ll never see the whole proposal. 
They’ll give me like, “This is the section I want you to write; this is the overall big idea,” 
but I’ll never actually see the whole thing. Because they’ve had bad experiences in the 
past. Which I think is bad because it kind of, you know, I’m sure we would actually work 
better if we could actually see the whole thing.  
CL: Right. So like, collaboration, discussion, gets limited [I2: yeah] 
I2: And then there’s that one guy who I was warned about when I got here who I got 
warned about because he basically stole people’s work. [CL: right]. So…yeah. 
CL: OK. Is there anything else you feel related that you want to add, or any questions, 
or…? Anything I might have missed in asking? 
I2: So actually, since we did mention that Turn It In thing, which is useful for checking, I 
think one of the issues with it is that the default is that it will post everything to its 
repository. So, and it’s kinda scientific and things like that. But I’m always careful when 
I use it to uncheck that box because, like, for students’ work, and all this stuff, I don’t 
know where it’s going, and copyright issues like that. They shouldn’t be getting a copy. 
You know what I mean? 
CL: it’s almost, like, published on Turn It In? 
I2: Yeah. Even though it’s not…no one can actually pull it up that way. But then their 
paper’s on there, and someone else… Even, say like an internal paper or something and 
you write it up and you just want to check it and it’s posted. And then later you write a 
journal version of it. You know that journal uses the same service to check and if your 
student paper is up there and has very similar… So that’s one of the issues with these 
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online systems.  Just because a lot of times it’ll show up stuff that isn’t really plagiarism. 
Like it’s… yeah, I think it has probably a high false positive rate. And internally, when 
I’m looking at it for student work, it’s not a big…I look at what it is actually saying is 
plagiarism. And most of the time you’re like, “oh, well, that’s the bibliography section.” 
[CL: right]. But you never know when it’s like a grant or a journal, they’re going through 
so many papers and things all the time that anything that comes out positive is going to 
look bad, so. And then there’s an issue that’s coming up now with things being so, kind 
of, automated. 
CL: Interesting. I didn’t really think about that. So just so you know, kinda to debrief: 
This started with me looking through the history of ORI and OSTP and the definitions 
they put of research misconduct as just falsification, fabrication and plagiarism. [I2: 
yeah]. And those are the only three things. And yet, I have a sense at least from the 
research we do over in Professional Communication that there’s a lot more – especially 
with authorship – issues that really affect scientists. [I2: yeah]. So why is plagiarism or 
fabrication considered the only authorship issue when there seems to be a lot more going 
on. [I2: yeah]. And a couple different journals and a couple different societies have 
started to put up codes of conducts concerning authorship [I2: yeah], but they haven’t 
been adopted by the major oversight boards. In fact, the major oversight boards every few 
years redo their definitions and they continue to just say FFP: fabrication, falsification 
and plagiarism. So I’m kinda looking at, do scientists care? Do they want more 
authorship guidelines? Do they not? How important is this? 
I2: And I think it’s more of an issue when you go between fields. And not even like in 
that unrelated of a field. Because, you know, the stuff we do and then the stuff my 
husband does in more computer science/math, I think even physics, where they do 
alphabetical order, so you’ve got a paper, and if you have people from different fields, 
then there’s this whole, “which order author do we do for this journal versus…” And it 
would just be easier if it was standardized across the board. I know I’ve had friends in 
physics stuff where they have, they go work at like some Brookhaven or one of those big 
things. And then you get put on the Author List. So while you’re there and doing work, 
your name’s not on that Author List. But then like years later, any publication that comes 
out for like three years, your name is on there. It seems very weird. 
CL: So it’s just like you were an author group? 
I2: yeah, it’s this big long list of people. It’s just weird. So I think having some kind of 
guidelines or at least like definitions of how these work in different areas or journals 
would be good. 
CL: Do you have to change at all? You said you publish in three fields, bioengineering, 
materials, and…I forget the third one [I2: Oh, chemistry]. Chemistry. Have you had to 
change your authorship? 
I2: No, no, not in those. I have one that I’m working on that I should be getting out this 
week that’s with the math department on, and it’s probably going to go to kindof a sortof 
bioinformatics journal. Those are really weird because depending on the bioinformatics 
journal, the authorship order changes. Like, if it is a slightly more math journal, then it’s 
alphabetical order. If it’s a little more bioinformatics, then it’s the order like we do. And 
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so, it’s kinda odd. Because that’s all the same field. It’s like all – they cite each other, and 
it seems weird. 
CL: Formatics? Is the word form with “atics”? 
I2: Yeah. INformatics. Like computer science kind of things. Algorithms having to do 
with bio. So yeah, it’s kinda odd in that field because depending on which direction you 
come at it from, if you come at it from the informatics side or the bio side, your 
authorship order changes. Which is weird. 
CL: most of the examples you gave me, people were… you said you kinda learn, you said 
people tell you not to work with these people. You said the one professor probably ended 
up leaving that institution because of not citing work. Do you feel like most of the 
regulation comes from top-down, or comes from like peers? 
I2: Well, there’s definitely regulation from top-down. So the guy who left it was because 
it finally got to the point where they got someone from the top came down and did an 
investigation. I think for people that are skirting the line, where they’ve done a couple 
things and it’s like, annoying, it’s hindered stuff, people are mad but they’re not mad 
enough that they’re going to say anything, then it comes at the peer level. Where you 
basically get told “careful” when you’re working with that person. [pause]. 
CL: OK. 
I2: It’s like in class, right? If you have like cheating in the class, how bad is the cheating? 
If the cheating is bad enough, then someone will step up and say something to the 
teacher, teacher comes down and kicks the teacher out. If it’s like “well, he’s kinda 
leaning over my paper, he’s probably reading some of the answers, but it’s more trouble 
to raise my hand, say something, and prove that he’s doing it than it is to just kinda sit on 
the other side of the room” [CL: right]. Then that’s kinda what I think happens in the 
field. 
CL: Well, I think that’s about all I have. Is that good? 
I2: That’s fine. 
CL: Thank you so much. 
[recording ends. I2 went on to share with me a lot more details about the colleague she 
mentioned who she was told not to talk with because he had a reputation for stealing 
ideas. She told me about his recent firing and how he had gone to the press about it. But 
she also said she was giving me all these details because the recorder was off, so I can’t 
explain more.] 
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 Interview 3 
 
March 25, 2011 
 
CL: Ok, again I’ll come back so if we end up publishing this, I don’t think I will, cause I 
think this will just be pilot… 
I3: Be confident! 
CL: We’ll see, but if you have any questions let me know. The point of this, I’m looking 
at research misconduct and I realized I didn’t really know what scientists thought about 
it. So I can speculate from my field of research about communicators, what we think 
about it, but I need a scientist’s point of view. So this is all about your opinions, your 
thoughts, there are no wrong answers or anything. But feel free if you have any questions, 
if you think I’m not asking the right question, feel free to jump in.  
So we’ll start with an easy one: your name please? 
I3: [name removed]. 
CL: Ok, What’s your title here at Clemson? 
I3: Assistant Professor Biological Sciences. 
CL: Is that your field of research?  Is biological sciences… does that describe it? 
I3: No, I would say it would be kind of an intersection of biochemistry, microbiology, 
and parasitology …and some cell biology. 
CL: That is a lot of ‘ologies. 
I3: It’s hard to categorize it, it’s usually easier to just say the department. 
CL: But your field of research… 
I3: Yeah I would say my hats would be biochem, microbiology, parasitology, cell 
biology. 
CL: Ok, perfect. And how long have you been publishing your research? 
I3: My first paper was published in ’97 I think. 1997. 
CL: That’s 15 years? 
I3: Yeah OK, there we go. 
CL: Ok I can definitely check your CV online, but can you name a couple journals 
you’ve published in or conferences, whichever is more important in your… 
I3: Journals are more important.  
CL: Journals are more important, OK. 
I3: On the lower end of the scale would be FEBS Letters. And on the higher end of the 
scale would be the last paper we just published, Molecular Microbiology. 
CL: OK. 
I3: Oh and I’m second author on a Science paper. 
CL: Of all these articles, are any of these co-authored with other researchers? 
I3: All of them were co-authored. 
CL: OK, and have you – you’ve already mentioned this to me but to be official – have 
you ever received funding from another organization other then Clemson for your 
research? 
I3: Yes. 
CL: Which ones? 
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I3: Yes, the NIH and I guess the NSF for the communications laboratory curriculum, 
course curriculum laboratory improvement grant, the CCLI grant. 
CL: OK, all right, those were the basics and now we’re jumping in. How would you 
define research misconduct? 
I3: I would say, I think it boils down to dishonesty. So, and I kind of break it into, I guess 
there’s misconduct during the doing of the experiment or during the analysis usually. Not 
usually during the experiment but during the analysis. And then there is sort of in terms 
of writing up the analysis or communicating through posters or whatever...and then I 
think there is a third category which is more about undermining other people’s work or 
disregard of regulations and rules, things like that. So you know throwing reductivity 
down the sink I consider research misconduct. 
CL: Yeah. 
I3: Yeah. 
CL: Yeah, OK great. 
I3: Pretty broad definition but… 
CL: No that was pretty quite thorough actually. How would you say you came to this 
definition? 
You know when I first started working in a lab the first thing you do is go through all 
kinds of training and so you become...and I think back to that day when they didn’t 
require this module Responsible Conduct of Research, RCR, Responsible Conduct of 
Research training, but I had to undergo like five safety training, chemical training and 
radioactive safety training. And so you immediately become aware of the, you know 
there is a lot of rules and regulations surrounding what you’re doing so that’s kind of the 
first part of it. And the second part of it was in terms of keeping an accurate lab notebook 
because you need to be able to go back and have the facts at your disposal…and how you 
did this experiment. And that was when I was an undergraduate.  
CL: I was about to ask, you said you first learned your training in a lab, that was as an 
undergraduate? 
As an undergraduate doing research and then in graduate school we got into, but I didn’t 
really receive, what you would call ethical training. And I didn’t publish as an undergrad 
so I didn’t get into whole “how you write papers,” you know, that kind of thing. But then 
when I was in graduate school because of the NIH training grant that supported graduate 
students, they requite ethical training and so we had to go through a series of workshops 
and they would talk about…honestly they talked far more about egregious instances of 
misconduct which were very obvious. Like, you know, complete fabrication of data. And 
you know, none of us were even close to do anything like that. Where it gets really tricky 
are the gray areas that are very subtle. And I felt like, especially now when I’m training 
graduate students and we are trying to write up our research, you know we run into a gray 
area every day practically in terms of at what you know...so my own motto is, “What’s 
honest?” What’s the honest representation of what do we think is going on with the 
system, not what do you want to be going on or what do we think, what is our data telling 
us? Because you run an experiment five times, you’ll get three results that look the same 
and two that look different, so what do you do with those two, do you fold them in? Or 
do you leave them out?  And sometimes, and really the pressure to publish will force you 
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to pull those out, but if you’ve done it many, many times and it mostly looks like the 
three that match versus the two that don’t, then do you, if you add those in, you open up 
questions from the reviewers saying “ohhh the data is very blah blah blah.”  
And in my field, this sort of molecular sciences where we tend to do a lot of stuff in test 
tubes, there is not so much…really the noise in the system is much smaller than if you go 
into the ecological or geo-chemical, when you go into the natural world ecology and 
behavioral biology where there is a lot of variation, they have ways of dealing with that, 
but if we were to employ those loads of analysis in my own research the reviewers who 
are not in that field are resistant to that, and they’re like, “I don’t understand why don’t 
they just draw a line with bar graphs instead of writing a linear progression.” Something 
that – and social science is the same way – you tend to do more statically running 
regressions comparing whether the two regressions are different or not. Things like that, 
but here they want you to go point by point by point instead of a regression. 
CL: Details matter. 
I3: Yeah, so we are running into some of those issues now where our data is noisy. And 
the data is all saying the same thing but to a greater or lesser degree in terms of numbers 
on a scale. So it makes it very difficult to make a nice neat graph the way they’re 
supposed to. So even now, I’m in the middle of deciding what is that right thing to do as 
far as, it’s important to tell the story, it’s important to get published, not just because it’s 
good for our careers but because you did the work and no one else is doing the work, and 
it’s important to get it published in a timely fashion. So how do we take the data that we 
have and make a cohesive story out of it that represents the truth? Without being 
dishonest ? And we go back and forth on whether we should show all of the data, and run 
all of the regressions, and let the chips fall where they may with the reviewers, or should 
we take the subset of data that tends to hang together more? And that’s a tough decision, I 
mean, mostly because, you know, it’s not just one person doing these experiments, this is 
several people over several years doing these experiments, and so it makes sense that 
there is a lot of noise, but it’s hard to explain that in the context of the Science paper 
where there is no place to say this was done by several undergraduates. You know, there 
is gonna be noise because they’re not perfect. 
CL: So it sounds to me kind of like that even though you started with basic training the 
real experience of what to do everyday is still as you go. 
I3: Yes, as you go through. As you do experiments.  Did you run a control with that set of 
data? No? Then you can’t use the data, so you learn as you go. “Oh I have to re-do the 
whole experiment with the control.” So there are rules that you learn as you go through 
but, and, that’s mostly where people go mired up in research misconduct. The spectacular 
cases where they are fabricating data, most researchers are pretty honest about it. But 
most of us, really idealistically, we are truth seekers. What is the truth about the system? 
And part of that is because there are other people working on it, so if you don’t publish 
the truth, it will be found out. Some people are OK with that, they will publish anyway 
and just to get their papers out and later when they have to retract them or they get 
disproven by three other groups because they did not do their experiments carefully 
enough, but they are like, “that’s OK, because I already got credit for that paper.” But 
those people get to be known in the community as, “oh they’re just publish anything,” so 
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eventually truth will come out. But the thing is that half the time, even if they’re careless, 
they’re still right.  
But yeah, and now actually there is lot… Now, any NIH funded project is required – not 
just training grants but any NIH funding project – is required, so everybody in my lab 
goes through a lot of bio-safety training as well as RCR. But in terms of how to present 
your data, that is still very one on one, where in the lab meeting, you know, “Did you do 
the experiment right? Oh now we have two experiments that say one thing and two 
experiments that say the other is. The answer is we don’t know the answer then. We have 
a noisy system and we need to nail that down before we can make a….” 
CL: So you can’t really publish an article that says, “We don’t know the answer because 
of…” 
I3: Yeah in fact, there is a common refrain saying that you can’t publish negative results. 
It’s rare. Sometimes you can but it’s very hard to prove a negative, so if you delete a gene 
and there is no effect that you can find, sometimes you can publish that, but it’s usually in 
a much lower-tier journal. Where is if you can find a phenotype or find an effect from 
whatever manipulation you’re doing then now you’ve got something you can hang your 
hat on. But so they, there is a very strong push to have something and I think you know, 
there are a lot of areas of research that are fairly subjective, like prophecies, because 
you’re looking through a scope and I guarantee you can make up, based on the field of 
view on the microscope you pick, you can sell any story you want with those pictures. So 
people have gotten to be very like, “Twenty fields were selected at random,” meaning 
you’re not looking at through the scope, you just randomly move the slide around then 
look through, focus, take a picture and then move the slide. So you are sort of trying to 
blind yourself when you are selecting the field. If you say, “oh this looks good,” then you 
self-select into whatever story you want. At the same time, if you are going to pick a 
picture for publication, you pick the one that is maybe not representative, but one that 
tells the story the best. But everybody knows this, so when you read a paper and read an 
image, you know the image they are showing you is likely to be the best image they have 
of that particular. 
CL: OK that makes sense. Thank you. You just covered a lot of ethical research practices.  
I3: Sorry. 
CL: No that’s great. What I was looking for…would you put in any aspect of 
communication into this? 
I3: Absolutely because often times when we’re doing the experiments we’re already 
thinking about how are we going to write this up for publication and often times it would 
be ok if the experiment goes one way how would we spin that or how does that fit into 
the story and if it goes the other way then how does it fit into the story? And in some 
cases you’re like either way its not going to fit into the story very well, so do you do the 
experiment? And we have these discussions because do we do the experiment because 
every experiment takes time and money. So it’s like do we do the experiment? Should we 
do the experiment? Is that the responsible thing to do? We don’t want shirk from doing 
our responsible duty but do we do that experiment or not? And sometimes the answer is 
that it’s not going to add anything or take anything away and it’s really expensive so 
we’re not going to do it. Or its pretty easy we’ll go ahead and do it because we should go 
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ahead and dot that I. But money can drive these decisions, its not always ethics, it’s also 
ok if we have to do this one time it’s going to cost another thousand dollars or something. 
That, or a thousand dollars of other experiments for something else. And sometimes its 
how in a hurry are you to get your publications out so it seems like there are a lot of 
forces but I mean I think in terms of choosing how to when you are communicating your 
science you tend not to communicate in the order in which it was done. It’s not like you 
did this experiment first and then this one. Usually you figure out your storyboard of how 
are we going to make a cohesive logical story so it makes sense logically. A lot of time 
you get here and you’re like ohhh and then you end up doing these other experiments but 
if you tell it that way I’ts confusing so you re-order it so it makes more sense. I think 
nobody thinks that’s unethical because the ideas to make it easy for the people reading 
your paper to understand ultimately what you do or what the results are. But sometimes 
when we’re doing journal clubs we’ll kind of Monday quarterback it by saying ohh I bet 
they did this experiment first and had to go back. You know, you can sometimes tell 
when you read the papers. Usually you try to make story art that makes logical sense. Its 
really you are constructing it out of these pieces of data and it’s almost never in the order 
in which you do it. And that’s true for posters as well. So the two main forms, well three, 
one is the paper but that’s the high stakes one that gets you the most recognition, and then 
conference presentations that can be in oral, PowerPoint, or poster, The stakes for that are 
less field because rarely in my field are they published. Sometimes depending on the 
meeting there will be something where they videotape the slides, so that has more 
permanence to it, but there is even a rule often at conferences where you are not allowed 
to photograph or tape conference presentations. The idea being you can present 
unpublished data for preliminary data there and no one is going to record it and use it to 
scoop you. They could still take it, but so people are careful about what they say. They 
may not tell you the whole story at a conference if there are competitors. So that’s 
another area where if your competition is there, and I’m not in a highly competitive field, 
but when I was in graduate school I was and there we were coached on how much to say 
and what not to mention. And in fact things would be left off of a poster so if someone 
came along and basically wrote all of the experiments down you couldn’t necessarily re-
produce the experiments or you’re leaving out some key thing so you can’t be scooped. 
And that’s considered fair actually in the field, because you’re trying to protect your own 
intellectual property. It is not fair however when you publish it, when you publish it you 
are supposed to put enough data in there and enough information so that someone reading 
the paper could reproduce your experiments. 
CL: That makes sense. 
I3: Yeah and you’re also supposed to, if it’s NIH funded and probably NSF funded, if 
you have cell lines that you have made or antibodies or any kind of re-agents you’re 
supposed to be willing to share them with other scientists so they can reproduce the 
results. 
CL: Right. 
I3: So sometimes scientists are very slow to give those things out. They’re not saying no, 
but then they just never give it out. So that’s kind of a grey area that is considered bad 
behavior but nobody would ever report them to the NSF or something about it, its like oh 
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he’s a jerk, he never sends out signs. You know, unless there is something you can do for 
him. You know, something like that. That’s more prevalent in high competition fields. In 
low competition fields it’s more of a sharing philosophy. So I don’t have to deal with that 
now thank goodness. 
CL: Ok, so do you have a definition of ethical communication in science? You touched 
on a lot of things already. 
I would say, definitely to put enough information in the paper so that they can, so that 
someone else can reproduce. In other words don’t hide important information. Two, tell 
the story clearly, you know, don’t obfuscate the process and try to...sometimes people 
right very densely and I think in some ways it is to sometimes failing to their own writing 
capacity but sometimes I think its purposely confusing to throw people off the scent so to 
speak. I think the third thing is that when you’re showing the data; I think its ok to show 
slightly messy data. And if I had my way, words and all, because honestly we all know 
what raw data looks like. We all know how these things go, so I really don’t like the idea 
of throwing data out because it doesn’t make a pretty picture, but the fear is, it will never 
get published if you don’t have at least a semi-pretty picture. So I really don’t like that. 
And there are conventions on how to show certain kinds of data and you can run into 
fights with the reviews if you break with convention. 
CL: Interesting. 
I3: So yeah, and that’s kind of annoying sometimes. But essentially I would say to be 
honest and tell the truth and be clear and be complete. 
CL: Perfect. OK. And you learned this basically from practice? 
I3: Yeah I would say most of it’s just through the process of writing papers and doing 
research and discussing it. I mean it’s a very, people have this view of researchers as sort 
of the sole of people of the bench and it’s actually a very social endeavor in these little 
lab groups. And you know we give lab meeting we show our raw data to our lab members 
and they’re like wait a minute you didn’t think about this so you get hazed initially within 
the group, things get tightened up, and a lot of it is there is a lab culture so every lab I 
was in there was a culture that valued truth and doing it the right way. And you know 
representing the data well and not being afraid of messy data too much. But you know 
there are other lab cultures, which I haven’t been in, but some of my former colleagues 
have jumped from this kind of culture into a culture that’s publish at all costs. Damn the 
torpedoes, full speed ahead, if something doesn’t fit its probably, it’s just something 
wrong with it we’re going to ignore it and move forward. And that is a whole other kind 
of culture and it’s out there. I mean there are labs that are like this. And some of them are 
very esteemed labs, Nobel Prize winning people at the lab. And yet I would you know 
most of the time they’re right because they’re very smart but I think there methods for 
doing science is questionable. But yet they perpetuate, so there are people out there who 
can perpetuate for quite a long time in the system because they can stay within the grey 
area and they never go full fabricating data or full lying or making up you know entire 
panels of people in a study that doesn’t exist. I mean that kind of fabrication takes an 
awful lot of work already.  
CL: Are you aware that there are governing bodies like the office of…integrity or OSTP, 
science technology policy that have published definitions of research misconduct? 
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I3: Yeah I probably read them.  
CL: OK, do you have any idea what those definitions are? 
I3: Uhhh No, but it is probably like some sort of government-eese like you know, 
representation, fabrication, I mean they probably have different categories of research 
misconduct but I couldn’t quote you…yeah I would have failed the test. I am actually due 
to re-up my training because you have to re-up it with the RCR.  
CL: Thank you for the answers. My other ones..OK, so specifically going from general 
research misconduct into authorship. Would you say that authorship is an important issue 
or concern when you are working on your research publications? 
I3: Yeah it is, because authorship is credit, it’s the coin of the realm basically, so if you 
are not on a paper you get no credit for that work that you’ve done. It is a very touchy 
area, extremely touchy. And so, there are different, even in different fields there are 
different definitions of what constitutes authorship. In fact we were just having this 
discussion in my lab yesterday because I have a student working in my lab, she’s an 
entomology, more field work, she’s doing a molecular component so she’s using my lab 
because I have all the stuff to do molecular work. So she was saying so what would you 
constitutes authorship and I said where there is a range, some are, you have to actually do 
produce the data that’s in the paper and that’s probably the most stringent form of 
authorship. The other is significant intellectual contribution. Which could be ideas, and 
feedback, and guidance, as well as doing you know not necessarily doing research work 
but providing maybe a significant direction to the project or an idea. Some would, the 
grey area, and I think that people differ on that you know like what level of intellectual 
contribution would constitute authorship versus acknowledgement. And some people 
would give people an authorship in return for re-agents, that’s another thing that can 
happen. If you use my antibody then you need to, I need to be an author. And that kind of 
reagent is really in my field, that’s not good in my opinion, that’s not good. But that 
depends on the re-agent. If its an entire you know data set that they spent three years 
collecting and they are just going to hand over to you and you’re gonna do a third of the 
work off of that data set that is a significant, I would call that a significant intellectual 
contribution. Or if it’s some you know knock out mouse there is room there for, your not 
supposed to even, you know mice are supposed to be freely distributed but I mean it 
could be, for example, a friend of mine who works at Hopkins, a colleague of hers made 
the mouse for her and has maintaining the mouse line for her so he is going to be an 
author on the paper even though he didn’t really contribute intellectually to the paper this 
was a significant help to getting the research going so she felt he earned an authorship in 
there. But you know some people will do it if like almost like a reward. Oh ill put you as 
an author on this paper because you drove me to the airport. I mean I dunno…probably 
not that shallow but I mean I had a colleague who I helped him out with a couple of 
things and he wanted to put me an author on the paper and I said I don’t feel comfortable 
doing that because I don’t feel like I’ve contributed enough to warrant it. So but that’s 
kind of, sometimes you’ll ask do you want to be an author on the paper or not and in our 
field which I think is not true for others but the order is important so the first author is the 
primary, that’s the one who made the most contribution so the special spot is the first 
author and last author in my field. So the last author is the lab head and the first author is 
 102 
the one who did all of the work or most of the work, and then the ones in the middle are 
sort of by second author did the second most amount of work, the third author did the 
third most, and the senior positions if there is more than one lab head, if your next to last 
that shows less of a contribution then…but a lot of times when a collaboration has started 
a very important part of that collaboration is to determine at the beginning that if this 
works out like we think then I would put you as third author on this paper or I think since 
its about half and half why don’t we have your graduate student be first author on this 
paper and I’ll be last author. And then they can be next to last and so there is some sort of 
negotiation and problems arise when that negotiation doesn’t take place or if science you 
know goes funny ways and sometimes the person that is third author ends up generating 
most of the data for the paper then there must be a re-assessment of author order and that 
can cause a lot of tensions because and that happened not with me but with my best 
friend in graduate school where she was going to be first author in this paper but then the 
post-doc that she was working with ended up doing...just so it ended that by the time that 
it was all done the paper ended up shifting focus on his stuff so he became first author, 
she was not happy about this because she had put a significant amount of work into this 
thinking it would be first author and it wasn’t but you know the lab head is like he did 
more work on the final paper and she’s like well lets put the papers up so he can have his 
piece and I can have my piece. And the lab head is like well no because then its two far 
lesser papers then you know a science paper is what it ended up being so he was like he 
was like no and to this day she is mad about that. So that is probably the twitchiest area 
and the other area that is twitchy that is if you suspect a lab person or another lab mate 
too that is not, that is fudging, which I think is the nice way of putting it. Maybe not full 
fabrication but you know not being completely honest with all of their data and 
eliminating groups or eliminating data points or only showing the best data and you know 
they got it to work three times right but eight times it went another way but they are not 
showing that eight times to anybody, that kind of thing. So then the PI is like ohhh 
everything looks good, you did it three times, you replicated it, we’re moving on. You 
know, so that can happen sometimes. I remember there was a student, I don’t know if it 
ever came to anything, but I was on my way out of the lab and there was a new graduate 
student and I never saw him in lab and no one ever did either but yet when we had lab 
meeting he would have data. We were like when is he working? Because in between 
people who come in at 7 in the morning and people like me who left at 10 at night- it’s 
like is he working from 10 to 7? When is he ever here? That raised some flags and I think 
one of the other students asked him and the thing was is that he would do a bulbous of 
work on the weekend when no one was around, which is a little suspicious in and of itself 
but he was an oddball anyway.  
CL: He was being regulated by his peers a little. 
I3: He is being regulated by his peers. Because we’re like you know, my lab when I was a 
post-doc wasn’t very secretive so you know we would kind of look through their lab 
notebook which is a bit of an invasion of privacy actually but its sort of like he wasn’t 
around and you’d see dates and your like ok I don’t know when he’s working but 
apparently he’s working on stuff so we’ll just let it slide. Because that’s a big deal and 
without any proof you, you could destroy a lab environment a lab working environment 
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really fast so it’s something that you know is kind of a fragile ecosystem so you would 
need a lot of proof to bring that up 
CL: So the big considerations in the office would be who did the work and who did the 
work well? 
I3: Who did the work, you know, some people would also argue that you know who 
wrote the paper because some labs the PI writes every paper, the students never write the 
paper they just make the data and the PI writes the paper. But in other cases the students 
have to write the first draft or it’s kind of more a back and forth process. I think that’s 
better because it trains people how to write. They never learn to write if they never 
struggle through that first draft. But it also means that you know the PI is not is pretty far 
from a project. So if they are writing a paper and wonder, there is a disconnect, a little bit, 
because if you like the last paper I’m probably going to write entirely by myself is 
probably the first draft I’m working on now because there were six undergraduates 
working on it and none of them are actually around of them, and two, they can’t write 
this you know. But I actually did some experiments so I was like ok I’m connected 
enough with the work that I can write a paper. But the other stuff that is coming out, the 
student have to write the paper, I’m like I don’t know how you did that, I don’t know 
what details, I mean I don’t have time to go through your notebook to find the details so 
you have to write the paper. And so there is definitely the first author should, in my 
opinion, have a significant input in the writing of the draft and actually all of the writers 
should read the paper prior to publication and signed off on it. I mean if you’re like a 
middle author you should have at least gotten one or two drafts and made some 
comments on, but usually only one or two people are actually writing a paper. 
CL: Right, but everyone reads it, or should read it. 
I3: Yeah yeah, but unless it’s like where there is a hybrid so then like this lab will write 
these sections of a paper and this lab will write these sections and then they’ll try to fight 
out the discussion. But yeah, but some people feel like if you didn’t help write the paper, 
you shouldn’t be an author either which is where you get into intellectual contribution or 
not. I don’t feel that way, I feel like there are people who should be on the paper who 
may not be actively involved but I do feel like every author should have the opportunity 
to comment on the paper. In terms of group writing is a nightmare so its you know 
usually one or two people and they’re moving back and forth. The drafts are moving back 
and forth. And then when you have a sort of cohesive draft then you send it out to the 
other authors. But most journals require all the authors to sign off; there is a sheet that 
they have to sign off on now a day. And I don’t think every journal does that but some 
journals require that every other sign off. Which means that you have to keep in contact 
with them and they require contact information for each author as well. As I can imagine 
some authors get left off because they are out of the picture for too long and no one 
knows where they are 
CL: So you mention some journals require that, have you ever looked up authorship 
guidelines? 
I3: Oh yeah, actually when I sit down to write a first draft the first thing I do is look up 
instructions to authors and they discuss all of that information and every journal has a 
whole policy sheet from authorship and disclosure rules, and copyright rules, and down 
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to we want your line images to be 300 DPI, they are very specific, so once we figure out 
what journal we want to send it to we, I do that before I start writing a draft actually. 
That’s step one.  
CL: Great, have you ever done that for grant writing too? 
I3: Yeah, I mean because you need to know the format of the grant before you do it. 
Authorship on grants is a little different because generally its there is a PI or maybe a co-
PI and some grants only allow one PI. And some will allow up to three Co-PIs and 
they’re usually getting money so they will get some sort of funds from the grant. And 
then there are additional personnel that are listed but are different. But they have a, but 
grants usually have a, actually you know in some ways they don’t have a lot of rules. I 
mean they have text rules but there is no for example citation format, generally. 
Sometimes there are, some foundations have a specific format, the NIH does that, they’re 
like you know use whatever citation format you want and sometimes they’ll limit the 
number of citations you have. But in terms of, I think its kind of expected that if you’re 
reproducing, if you’re gonna for example, when I first submitted a grant to the NIH, I 
knew a piece of data that wasn’t published but I didn’t mention it because it was not 
published and I thought it wouldn’t be that important but it turns out that when the 
reviewer comments came back they said umm well you haven’t really shown the 
importance of this pathway. And the fact that I knew established definitively the 
importance of this pathway but it was not published, so finally I basically, I said I 
emailed and it was from more formal lab so I was around when they generated the data, 
so I emailed Sophie who was my colleague who did the work and I emailed my former 
boss, Paul, and I said dear Sophie and Paul I have this grant, I would like to use this fact, 
and the fact that I wanted to use was a figure, an unpublished figure that they had, can I 
use this? And they said yes you may use this and they sent me a letter and I had to put 
that letter in the grant and then I put personal communication, I put with permission and I 
put that figure in there but I had to map it to them with yes that we acknowledged this, 
yes you may this thing with permission blah blah blah blah blah for your grant. And the 
reason why they felt ok with that was because they could have said no but you know 
grants are supposed to be shredded after the review process so the grant review process is 
private and so even though the reviewers of the grant have access to that data its not out 
in the wide world. And plus I think that information was already on a poster in some 
meeting or somewhere. But still in that case that was a very specific case where it was not 
my work, it was someone else’s unpublished work and I had to get permission to put that 
in the grant. But I needed that and they helped me out. But if you put that in there and 
didn’t attribute it or back it up I don’t know if the grant reviewers, they might disregard 
it. 
CL: Or could have it been seen as plagiarism? 
I3: Yeah, and now the university is putting our grants through TurnItIn as well, which we 
don’t like because in some ways there are only so many ways you can say some stuff. I 
can run through my canned description of fatty acid synthesis occurs in a cycle of 
conserved reactions…honestly it’s like blahhhh there are only so many ways you can 
write that. So I’ve had discussions with friends about you know this doesn’t happen to me 
so much but I have a friend who works in kind of a boutique area and she has written 
 105 
more reviews then I dunno than anybody, people are like ohhh can you write me a review 
of blah blah blah. The thing is that with especially review articles it’s very hard to write it 
differently. And by now she has written like 15 reviews and she’s getting to the point 
where she is starting to plagiarize herself because they want one slight different 
perspective but the entire introduction to the field would be, its not like she copies and 
paste, but she really struggles with not following into these grooves, once you’ve figured 
out the fewest words needed to describe a particular phenomenon you tend to follow into 
the same set of words again and again and again. It is sometimes hard to avoid self-
plagiarism. But I have noticed, we call it recycling papers, where essentially the same 
data shows up in 2 or 3 papers and you’re like dudes come on, new data, new paper. And 
usually its like paper in high profile journal, its like your going through and your like oh I 
haven’t seen this one yet and its in a third tier journal and you find out its basically the 
same paper. I mean or a subset of it, and it was published after the high profile, you 
know, its not like you can’t even say we published a preliminary version in the Polish 
journal of cell biology or something and then got more data and re-hashed the whole 
thing in journal of cell biology. Usually it seems to be that they come out in different, 
within the same time frame. And I don’t know if it’s like to get everybody a first author 
paper or… 
CL: Is your field where you submit to a journal, you can only submit to one journal until 
you hear back? 
I3: Yeah. 
CL: Yeah so is ours. You’ve given us a lot of examples of colleague stories, have you 
yourself ever felt unfairly represented as an author? 
I3: No. 
CL: OK you mentioned that story about being offered authorship that you turned down. 
That was a time where you were fairly represented, where you felt almost unfairly 
represented because you didn’t think you deserved the credit? 
I3: Yeah I guess so, He’s a very cool colleague of mine and I would call him a friend as 
well, he is senior to me but he’s just over effusive about everything so it’s sort of the 
nature of his personality. And I was like, “no Dennis, don’t put me on the paper.”  “But 
of you’ve helped so much with this and this and this….” “It was my pleasure but no, 
don’t put me in the paper because I didn’t do any of it.” 
CL: Can you walk me through a scenario where you felt fairly treated as an author? 
I3: Um yeah, so my, I was a little disappointed with how it came out so my authorship on 
my Science paper, I am a second author on that paper but my data didn’t actually make it 
into the paper. By the time we were done writing the thing, my contribution ended up 
relegated to a footnote so to speak, which I was a little bummed out about but Science has 
such a restrictive format that, you know, my little… I mean I basically generated a figure 
worth of data which was sort of following up on some stuff so it wasn’t central to the 
story so by the time we got done, we’re only allowed 4 figures, and originally we were 
writing it for Cell so we were like, “oh great,” but then I don’t know what happened but 
then they decided to try for Science, that meant we had to actually re-write the whole 
paper because the format is extremely different and we had to cut the figures down to the 
bare bones. So that figure basically ended up getting chopped, it’s like your part got cut 
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out of a movie. But it was an important, intellectually it was important because 
it..basically there was an alternate explanation for what we were seeing and my data 
proved that it wasn’t the alternative data, so it was important but it basically ended up 
being a sentence. So in some ways I was proud of my contribution to the project but also 
felt a little like you know, “uhhh you’ve got a second author Science paper,” and I’m like 
“yeah, yeah but except my part isn’t in there anymore,” I felt…. 
CL: Did you help write it? 
I3: Yes, yes I did, I was involved from the beginning. And actually I made up the title 
because I’m good with words; I’m good with titles. 
CL: Yeah, those journals have more interesting titles then some of the other ones. 
I3: Yeah so I came up with the title 
CL: How many authors were there total? 
I3: I think there might just be three of us. First author, and me, and Paul, second author. 
I’m trying to think if there was anyone else involved. 
CL: So was the person who did the majority of the work the lab head, then you in the 
middle as a contributing author and contributing data collector 
I3: Yeah. 
CL: OK. 
I3: Yeah I’m trying to remember if, I don’t think anyone else was on that paper. If there 
was, there might have been someone else on there but I don’t remember now. 
CL: Ok I think that’s about all the questions I have. 
I3: OK cool. 
CL: Just to debrief you a little, what I am looking at is that most of the governing bodies 
justify research misconduct as FFP which is fabrication, falsification, and plagiarism and 
they are the three words that are all over the place however I am finding a lot of 
information all over the place from science commentary and from different commissions 
and especially from journal editors who are really concerned about authorship as a major 
issue of research misconduct so the question is… 
I3: I’ll tell you one other thing; authorship can lead to more egregious, I mean.. 
CL: Are people doing fabrication, falsification, and plagiarism in order to impact the 
ability to publish? 
I3: Well authorship is the only thing that matters in terms of getting credit for the work 
that you do so it’s the ticket to everything else so that’s why its so twitchy why everyone 
is so twitchy on it and why its so important to talk about it from the beginning. But the 
problem is there are not hard and fast rules 
CL: That’s part of the thing, that there is, that from my point of view I seem to think that 
the major oversight board should start defining authorship better since there seems to be a 
concern about it but they’ve heard these concerns and continue every few years to revise 
their definition and it doesn’t include anything about authorship. So before I’ve started 
steam head rolling calling for authorship guidelines I wanted to actually see what 
scientists felt about this. And you see it varies a lot by field… 
I3: Yes it does and that is. And even fields that I think even from your perspective seem 
similar are different. Like omniology is a different field from me. And even like 
ecology… 
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CL: Computer science does alphabetical order, no question, and that is revolutionary… 
I3: And my husband is an economist and there it’s first author is the key position and 
then you know its in descending order of… 
CL: Yeah I don’t think social sciences give any credit to last author, that’s just hard 
sciences. And a lot of the journal editors, there are a lot of associations of science journal 
editors and most journals have their own definitions and the editors talk about this a lot 
and have some incredible guidelines, the Council of Publication Ethics, COPE, has some 
wonderful guidelines on this, but from what I am learning, authors or scientists don’t 
really pay as much attention to that as much as where they want to go or where their lab 
goes. That’s what I’m kind of trying to figure out. 
I3: Yeah we’re kind of embedded into the culture more than anything and I think that one 
thing that people find are well convenienced is this trend in journals where author 
contributions are listed. 
CL: The medical journals started that from what I’ve researched, where you actually spell 
out in the paper whatever they did. 
I3: XYZ designed the experiment, XYZ did the data analysis, X wrote the paper, and Z 
you know edited or whatever and it makes I think that might have cut down a bit even 
though in some journals it’s voluntary and other journals have started making it a 
requirement. I actually favor that because I think that it cuts down on this sort of 
authorship as reward so if you have to spell it out it’s going to look stupid if it’s like 
because it’s like they helped my hand when I did the experiment the first time or 
something. 
CL: Well and I’m kind of finding that medical journals are leading the way, biomedical, 
because they have so many ethical considerations. They are almost the lead on this and 
then other people catch up. And here in the social sciences we do whatever science does 
and so we’re not… 
I3: So there is sort of a cascade 
CL: There are papers that have like 80 people on them, which I know this is happening in 
sciences as well because you have to get credit to everyone that works in the lab or 
everyone who funded you. 
I3: And you know there is this you know with these big genome-sequencing projects and 
things like that where you do have, I know my organism’s genome had like 80 authors 
but that’s because they had 80 people annotating where they would pick someone for 
chromosome 6 and then they would run through and annotate all of the genes so they did 
actually, there realty was 80 people who worked on it. Now I find that instead of listing 
all the authors on the author thing they’ll say consortium to blab blah blah and then as a 
footnote or somewhere they will define the consortium members so then its kind of a 
shared, the consortium is the author and yeah it does allow for ok if you did one gene, 
annotate one gene, do you get authorship on that paper? And people factor that in- oh you 
worked on the genome project? Even though it’s a science paper its probably, oh you 
worked on genome but it’s not like having a science paper where it’s a primary project 
that came out of your lab. The only one that really helped is the guy who started the 
consortium and managed the whole project. He is the one who gets the reward, and my 
field is small enough that we know who that is. But yeah I think what’s weird though that 
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if you ever have to bridge into a different field the convention, its very, I’ve been 
surprised because I didn’t really interact with the colleges or behavioral biologist very 
much and now I see that the way they do science is extremely different on every aspect. 
It’s been interesting, that part has been very interesting because its very different 
CL: Well super, thank you so much. 
I3: It’s been fun. 
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 Interview 4 
 
May 9, 2011 
 
CL: It is just audio.  Okay, the purpose of this interview, I’m working on my Master’s in 
Professional Communication.  And what I'm studying for my thesis is scientific 
communication; how scientists communicate.  So what I've been looking into, some 
ethical issues with scientific communication, but I realized I wanted a scientist's point of 
view.  What do scientists think about what it is that I'm looking at.  So that's why I'm 
going to be asking you questions.  They are entirely your opinion, you just have to speak 
from your personal experience and share as much or as little as you'd like.  And feel free 
to ask me questions back.  [I4: Okay] But that's what I'm looking at and you'll understand 
more and I'll debrief you in the end if you have any questions.  [I4:  Okay].  Do you have 
any questions before we start?   
I4:  No.  But, well what's your sample size?  How many people are you interviewing and 
how many disciplines are included? 
CL:  I - my pilot research was three and I'm hoping to expand to at least ten and I'm 
trying to get as many different fields as possible.  Ranging from computer science to 
various science, chemistry to physics and I'm even going into agriculture and extension. 
[I4:  Okay].  So I'm trying to get a wide overview.  But all of the scientists I'm looking at 
need to be actively publishing and actively researching.   
I4:  Okay.  So it sounds like you'll have maybe one representative from each of those 
fields that you're trying to… 
CL:  That's what I'm trying.  Though I have realized, through my pilot research, even 
within one field, even if I say you know, "Biochemistry,”  there are still so many nuances 
within there that publish within different journals that are actually have some differences. 
I4:  Yeah. 
CL:  So yes, I'm trying to have a representative from each field, but some of them may on 
the surface look like they have the same title, but when I've gotten down to it, they, they 
might have some differences.   
I4:  Oh sure. 
CL:  That's my goal.  And that's when Dr. [name removed] referred you.  She knew I was 
looking for some different fields. 
I4:  Oh some of those that are sort of far out. 
CL:  Yeah.  Right.   
I4:  Okay, yeah, sure. 
CL:  Okay um, okay so first of all, for the sake of this recording, would you please state 
your name? 
I4:  My name is [name removed]. 
CL:  And what is your title at Clemson? 
I4:  Professor of Entomology.   
CL:  Okay.  And your field of research is?   
I4:  Field of research is uh, it's rather wide ranging.  In entomology but tends to focus on 
insects of medical and veterinary importance.  Especially in relation to disease issues.  So 
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insects that are associated with economic problems of animals, disease problems of 
people and animals. 
CL:  Okay.  Um, and how long have you been publishing your research? 
I4:  Almost thirty years.  It's twenty-nine or so. 
CL:  And I can definitely check your C.V. online, but could you name me a few journals 
where you've published your work?   
I4:  Yeah.  Let's see, some of the recent ones, Annual Review of Entomology, um, um, 
Environmental Entomology, Journal of Invertebrate Pathology, let's see, Evolution, 
Epidemiology um, Molecular Biology I think. 
CL:  Okay.  That's great.  [I4:  Okay.]   
CL:  Really prolific.  Um, and were any of these articles uh, coauthored with other 
researchers? 
I4:  Yes.  In fact… 
CL:  Yes. 
I4:  The majority of the articles that I'm involved with are coauthored.  [CL:  Okay.] 
CL:  And have you ever received funding for your research from an organization other 
than Clemson? 
I4:  Many times.   
CL:  Can you name a couple of them?   
I4:  Yeah.  National Science Foundation is the primary source.  Um, the um, Natural 
Resources Foundation of Wisconsin, NATO, um, National Institutes of Health. 
CL:  Okay, so very, that seem to be state or federal type. 
I4:  Yeah, primarily federal.  For my [CL:  Okay] work, most of the funding is going to 
come for me, from National Science Foundation, which is federal.   
CL:  Okay, great.  Um, so those are my preliminary, just establishing where you are in 
the field [I4:  Okay].  Um, how would you personally define research misconduct? 
I4:  Anything that knowingly deviates from, from honesty.  From not presenting results 
that might contradict their study, to falsifying results of the study in anything and 
everything in between.   
CL:  Okay.  Great.  Um, do you know where you learned this definition or where you 
developed your concept of it? 
I4:  Well I mean yeah.  It goes back to my childhood.  I was brought up… 
CL:  Yeah. 
I4:  In a family where, where honesty was paramount.  I went to an undergraduate 
institution where the um, centerpiece of that university, Washington [inaudible 0:05:53.9] 
University, was the honor system.  [CL:  Yeah.] 
I4:  The honor code.  And it was a rigorous honor code.  Not only were you guilty if you 
performed some indiscretion, if you knew about somebody else and you didn't report it, 
you were as guilty.  [CL:  Wow].  And so it really drove home to me the importance of 
honesty.  [CL:  Right] and the bounds.  I mean the, the, you have to adhere to  if you're 
going to have an honest system.   
CL:  Right, right.  Um, when you think about ethical research practice and the definition 
you just gave me, does any aspect of communication come to mind?   
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I4:  Yes.  I, you know I think, yeah, there's a, there's perhaps a fine line and I'll give you 
an example because maybe this would explain it best.  In my field, as in most fields, you 
present your research not only in writing but also orally.  And if it's an oral presentation, 
you typically are timed.  You'd have ten minutes.  And so it's up to you what you present 
in those ten minutes.  And if one is not very careful, it would be possible to leave out 
some of the problems that were encountered that might be relevant to the study.  In other 
words, might provide some context for the results.  [CL:  Right].  And so it's a little bit 
like false advertising if one's not very careful.  And that doesn't mean you have to present 
- I'm not saying you would present every pitfall [CL:  Right] or every problem you ran 
into because a lot of them you're going to work through in order to present [inaudible 
0:07:44.8].  But if any of those problems impinge on the veracity of what you're 
presenting, then I think you need to be straightforward  and indicate that.  But in a ten 
minute talk when you're pressed for time, I can see that well there may be [CL:  gloss 
over]tendency to, yeah.   
CL:  Right.  And okay um, so do you have a - I have a question here.  How would you 
define ethical communication in science?  But it sounds like of importance to you is 
including all the details.   
I4:  Well I think in what whatever you present must be transparent. 
CL:  Be transparent. 
I4:  Yeah.  That if you're going to make a statement if there are any qualifiers that you're 
aware of that would affect how that statement is interpreted, then you would need to 
include it.  We do have certain measures in my field that try to address these kind of 
things.  And an example, are we okay? 
CL:  I think so. I don't know why it did that.  [Inaudible 0:08:54.4]. 
I4:  That, I think was my watch.   
CL:  Your watch.  Oh okay.  Sorry.   
I4:  It just turned 3:00 by my watch. 
CL:  Oh okay. 
I4:  Yeah, so for example, uh, if somebody claims to be working with a particular species, 
well once the study is done, that species they worked with disappears.  I mean it's not 
there for anybody to check.  However, a lot of journalist demand, and the profession 
really, to an extent, demands that those specimens be deposited in museums so that they 
represent a voucher of what you did your work on. 
CL:  Ah, okay. 
I4:  And you know, that's not so much well it's not so much honesty as just um, an 
additional assurance that what you claim you worked on, is in fact what you worked on.  
[CL:  right] and science may demonstrate that what you thought you worked on is 
something else [CL:  Oh true] and then it changes and people can go back and say well 
this is really what they had. 
CL:  Are the specimens kept alive in case…? 
I4:  No.   
CL:  Okay. 
I4:  They're deposited in a museum.  [CL: All right].  They could be in alcohol or on [CL: 
right].  [Inaudible 0:10:08.9].  [CL: Right].  Yeah.   
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CL:  Okay.  Um… 
I4:  And - oh sorry. 
CL:  No, please go ahead. 
I4:  Yeah, and along the same lines, I think it's important to deposit notebooks with their 
material, any field notes you took, any correspondence that you have, I think should be 
hard copied and kept so that there is a paper trail.  I think this is becoming more and more 
important because you know, all of this information can evaporate [CL: Right] if it's an 
email correspondence and you delete everything. 
CL:  Especially if the specimen is gone and the emails are gone, did it ever exist? 
I4:  Yes. 
CL:  Right. 
I4:  Well imagine the trouble historians are going to have trying to - a hundred years from 
now - figure out what somebody was doing at this point.  You know it's not like Charles 
Darwin kept every little scrap of paper [CL: Yeah] and every correspondence you know 
[CL: Right] that he ever had.  So it's a treasure trove researchers can go to.  What are they 
going to have if everything is deleted, deleted.  You get an email, read it [CL: Right] , 
delete it [CL: Right].  I think some of the, some of the honesty or accuracy in 
communication can be assured by keeping copies of that material.   
CL:  Great.  This import - you put in - transparency and in leaving notes.  Did you learn 
that anywhere?  Was it taught to you?   
I4:  You know, it, it was, yea I would say it was pervasive and it was in the books that I 
read from the time that I was a kid up until the present time.  It's either implicit or explicit 
in much of what we read.  There are honor societies, there's a Sigma Xi, if you're familiar 
with that [CL: I am].  A scientific research society that has as its core value ethics and 
research.  And so I've been a member of that since 1979 and  
I try to ensure that my students become members of it.  Because despite all the you know, 
societies you can belong to out there and all of them take your money and [CL: Right] 
and you have to be selective, I think that's one that's extremely important because it does 
emphasize the core value of honesty and research; ethical conduct in general.   
CL:  Just so you know, I'm taking some notes just in case this gets destroyed per your 
point [I4: Okay].  Just [I4: inaudible 0:12:57.8] to make sure I could put back this 
interview if I had to.  Are you aware of governing bodies like the Office of Research 
Integrity or the Office of Science and Technology Policy?  Do you know that they 
publish definitions of research misconduct?  
I4:  Yes.  Yes.  Yes.  As a matter of fact, Academy of Sciences, the Academy of Sciences 
has put out, I think since about '85, a document that's wonderful that is used a guide for 
researchers.  And I structure one of my labs in one of my courses, around that document.  
So we have a three hour lab where the students are asked to read this little pamphlet and 
then we discuss and debate some of the case studies that they present. 
CL:  Interesting.  Okay.  Is that early on in the class?  Is that like a… 
I4:  It, it's a rainy day [CL: Oh, okay] lab because it, the class is one that I try to do 
outdoors [CL: Oh, okay] as much as possible [CL: Right] if we're going to have some 
rain and so forth.  So it may come up around the middle of the class or toward the end.   
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CL:  Okay.  That's interesting.  I have come across that pamphlet when I was looking for 
it.  So do you know what the official definition is of research misconduct from the body 
that produced that? 
I4:  I don't.   
CL:  Okay.  Okay.  Um, do those rules that regard research affect how you communicate 
as a scientist?  Sounds like, I mean you mentioned that some of your communication 
skills come back from childhood and what you've read.  Do you think those were more 
influential than any rules you read? 
I4:  I think that was my, yeah, my foundation.  I think that was my foundation that, that 
you know, those were established early on.  I didn't suddenly come to that realization as a 
undergraduate or a graduate student.  You know, certainly my undergraduate education 
and the honor system reinforced that and you know, through the rigor, if you're guilty of, 
you know about it and don’t report it [CL: Right] and just seeing how you know, really 
the, an honor system did have to have teeth and, and had to be stronger than maybe I 
would have previously thought.  Yeah, building on that and then being exposed to it, 
almost on a daily basis in writings either implicitly or explicitly, you know it becomes 
part of the way you try to conduct yourself. 
CL:  Right.  Right.  Okay.  As a scientist, as you're practicing, would you say that you're 
concerned about ethical communication practices?   
I4:  Yes [CL: Okay] I am.   
CL:  Good.  And then this is related but another kind of tangent from this conversation, 
would you say that authorship, specifically, is an important issue or concern while you 
research and publish?   
I4:  It is.  [CL: Okay]  It's an important issue, it's an ethical issue, it's a moral issue [CL: 
Yep], it's a personal issue, it's a difficult - sometimes - it's a difficult issue.   
CL:  What do you think researchers should consider when they make authorship 
decisions?   
I4:  The individ - probably more than anything, the intellectual contribution to the paper.  
More so than the financial contribution.  More so than the actual physical doing of the 
experiment because a lot of times the person who designed the experiment may have 
worked on it in his mind or [CL: Right] her  mind for ten years and presented more or 
less the cookbook to a student and the cookbook is simply followed [CL: Right].  And so 
that - because the individual might have done most of the work hands on doesn't 
necessarily mean they should be first author.  I sort of think they should be an author.   
CL:  In your field, could you frame for me how authorship order is delineated?  Like… 
I4:  Yeah.  You know it's so highly variable.  But typically, as a rule of thumb, the 
individual that writes the paper or oversees the writing, for example, if multiple people 
are writing, the person who is ultimately responsible for putting the sections together and 
framing the context [CL:  Mhm], that would be the first author.  And because typically 
they have the most intellectual investment in the work. 
CL:  Right.  That's the first.  And then are any other positions within the authorship in 
order of importance?   
I4:  You know, it's variable.  And these are issues that are discussed because they can 
vary depending on the laboratory, depending on the country [CL: Right], depending on 
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the discipline.  You know, for some people, in some countries, being the last author on 
the paper is very important.  Because that would demonstrate that it's your lab that 
everything emanated from, from you.   
CL:  But that's not important in your publications?  Usually? 
I4:  I, I personally tend to order the people in terms of how much they contributed [CL: 
Okay].  Okay.  So the first authorship would be the person with the most intellectual 
input and the person who contributed the most of the actual writing.  And then from there 
to the last author would be the relative amount of the contribution. 
CL:  Okay.  So you're not last author on everything done in your lab? 
I4:  No.  [CL: Okay] No.  But I'm often a second author because there's a qualifier and I 
realize this is not particularly commonly practiced.  But I you know, at my point in my 
career, I don't need publications to advance my career [CL: Right].  But my students, all 
of whom I work closely with, I want them to be first author.  And so even if sometimes I 
might have more of the input, I ultimately put the responsibility on them to be the first 
author. 
CL:  Right.  Okay.  I ask because I notice that's very different in every field [I4: Mhm].  
It's been quite interesting. 
I4: Yeah.  And not just field.  I mean it differs from person to person.   
CL:  Okay.  So I did interrupt.  You were saying what you should consider an authorship 
order and you said number one most important thing was the intellect - the actual 
intellectual contribution [I4: Yes] to the paper.  Is there any other consideration you take 
into account?   
I4:  That - well the intellectual input would include the writing [CL: Right] of the paper.  
So those are, they're not exactly the same thing but they're - I would consider them to be 
very closely related. 
CL:  Can an author be on there who has not written anything? 
I4:  Yes.  Yes.  If that person contributed to the ideas and contributed to the actual hands 
on work, absolutely [CL: Okay].  Not only could they be on there, they should be on 
there.      
CL:  Okay.  Have you ever researched authorship guidelines 
I4:  I have read articles.  For example, in American Scientist. 
CL:  The new one? 
I4:  Yeah.   
CL:  Yeah. 
I4:  Mhm, that's a good example.  And I read those frequently and there are letters to the 
editor then they follow up in the next issue with a comment on those articles.  So you get 
input from other scientists, not just authors of that particular article. 
CL:  Okay.  And then making this a little more personal, have you ever felt unfairly 
represented as an author? 
I4:  My collaborators, and I've had many, have been generous.  What I sometimes find a 
little bit disturbing is that I will collaborate with somebody and it might be a student at 
another university, or it might be a faculty member at another university, we might write 
the paper thinking there might be two or three authors and when I get the paper back 
from them and their comments, another author has been appended [CL: Ah].  And it's 
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usually a higher administrator and the first thing is, who is this person?  And what in the 
world did they do?  So that… 
CL:  Interesting.  Okay. 
I4:  Is not necessarily representing me unfairly.  However, a paper that really had two 
authors who did all of the work, now has three.  And so it would appear as though that 
the individual, the two individuals that did all of the work, really did not do as much as 
they did. 
CL:  Why do you think that third author gets added?   
I4:  Because that individual is typically an, either an administrator or a unit boss, a 
laboratory boss or if it's a student I'm collaborating with, it's their advisor and they may 
demand it.  And it may be a cultural thing.  Once you get outside of North America it 
does tend to be a cultural issue.   
CL:  I've started to see that.   I'm not sure that I'm going to take that in or not, but I've 
noticed the opposite.  The Rutland Institute here is dealing with Australia, apparently, is 
making a lot of new laws about authorship [I4: Hmm].  Because they deal, deal with it 
differently than we do.   
I4:  Yeah.  Yeah.  Well it, it's mainly a problem it seems to me, in third world countries. 
CL:  Okay.  So luckily you only had one or two instances of, of a possible unfair 
treatment.  Can you walk me through a scenario where you felt fairly represented as an 
author?   
I4:  Well, I would say the vast majority of papers on which I have been an author, I feel 
I'm fairly represented.  If I'm not, it's my own fault [CL: Right].  You know because I 
said nothing up front and felt that maintaining a collaboration was better than jostling 
around for second or third authorship.   
CL:  Up front.  So does a conversation happen before you start? 
I4:  Um, you know it's usually implicit.  I have never had a problem with the order of 
authorship.  It's almost always implicit and I have never really been discouraged by the 
order of authorship if I'm not in charge of the paper.  Really, the only issues I've had are 
when an additional name or two are added to the paper and that was never discussed up 
front and I don't know why they're being added [CL: Right].  I've never met the 
individual.  You know, those are, yeah, those are discomforting [CL: Right], but then I 
have to take into account that this is a different culture that I'm dealing with.  It never 
happens in this country - well it did when I was a graduate student [CL: Yeah].  It used to 
happen when I was a graduate student every once in a while.  But you know, in the last 
twenty-some years, it has never happened except when dealing with foreign countries. 
CL:  Where as a graduate student you had to add someone you weren't comfortable 
adding? 
I4:  Yes. 
CL:  Okay. 
I4:  Yes.  Mhm. 
CL:  But you think that's happening less now? 
I4:  I don't know.   
CL:  Oh.  But not to you personally? 
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I4:  Well it doesn't happen to me [CL: Right] because I'm no longer a graduate student.  
But [CL:  Right, right] you know, I came up in a system where some advisors felt that the 
student was an "item" to further the individual's career.  And, and that's something that 
really goes back pretty deep in this country.  I mean I've - some of the government 
publications that came out in the 1800's and early 1900's had authorship by a person who 
never did any of the work, but he ran the lab [CL: Right].  So you know, it was his 
minions that were out there doing all of the work.  Actually in some cases, writing the 
paper, and then he simply puts his name on it.  That was just the way it was done.   
CL:  Do you, the journals you contribute to, have any rules about what constitutes an 
author or do they require everyone to sign off on a final copy or anything like that? 
I4:  More and more, that is the case, yes.  Especially the higher tiered journals.  So there 
are a number of regulations that are appearing more and more.  Some of these high 
powered journals, like Science and Nature, you have to list what, you have to state in 
writing, what the contribution of each author was, briefly [CL: Right] of course.  If a 
paper is submitted to a journal by one of, let's say several authors, then that journal often 
will send an email to all of the authors and say, "The following article was received.  
Either send us an - it'll say either send us an email that you agree to have your name on it 
and you agree with the contents" or it will say, "If you don't agree, if there's a problem 
then you must contact us."   
CL:  But that means whoever is submitting it needs to have contact information for 
everyone involved. 
I4:  And that's required. 
CL:  Yeah.  Okay. 
I4:  Yeah.  So the journal would require that the contact information, emails for all 
authors, be given.  And then when that journal article is submitted for consideration, the 
editor, editorial staff, will send out the email to all the contacts.  If contact information's 
not given, then the paper’s not going to go out until it's  available. 
CL:  Right.  Now are they approving the fact that the paper got submitted or do they 
actually approve the statement of what they contributed  
I4:  They… 
CL:  Does everyone see that statement? 
I4:  They would see the paper [CL: Okay] itself and would know whether or not the 
authorship is correctly represented, whether or not the contents of the paper are as they 
thought they should be. 
CL:  Right.  Okay.  Do you have any circumstances where a colleague of yours, either at 
Clemson or elsewhere, had an unfair authorship situation? 
I4:  Well I've seen it in students a lot.  Yeah.  Where I think that the faculty member, the 
advisor is being too heavy-handed in demanding that their name be on the paper when I 
know they contributed nothing.  Their comment would be, "Well, I allowed the student to 
work in my lab.  They used my facilities.  They used my reagents."  You know.  "I wrote 
the grants that got those…"  It can be justified, but to me it's getting a little slippery [CL: 
Right.  Right] you know, for, because again, there has to be some kind of intellectual 
input either in writing the grant that gets the money that does that particular work or in - 
even if you're doing a cookbook there has to be some intellectual [CL: Oh right] exercise.   
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CL:  Well those were my questions and what I'm looking at is that the official 
government oversight bodies, like ORI and the OSTP, the formal definition of 
misconduct is falsification, fabrication and plagiarism; FFP [I4: Mhm].  It has been ever 
since they've formed a definition in the '80's.  and there is no mention plagiarism is the 
only authorship concerned mentioned in research misconduct.  But I've since found in 
talking to scientists that there is a lot of communication ethics that are actually related to 
research misconduct and perhaps authorship being the biggest one.  And that the demand 
for authorship, as you've said, it's not as important to you, now that you're tenured, but 
that, that press for authorship might actually lead to research misconduct perhaps or - and 
so I'm trying to figure out if we feel the government oversight body should add 
authorship definitions.  If there should be a formal, a formality of what it is.  I mean 
because what you told me is it's not even by feel, it's by person.  And I know some of the 
journals have - there's plenty of information from the journals, the publication editors and 
that sort of thing, that have their own ethics.  But [I4: Mhm] it's what I'm looking at is if 
the drive to authorship is so important that perhaps it should be elevated to a level of 
research misconduct.  And if government regulation would help simplify. 
I4:  You know, my guess is no.  because it probably would be more paperwork and we 
are becoming so bogged down with paperwork that often it's a response to a minority 
doing something wrong [CL: Right].  I mean you see that at the university [CL: Right].  
We got this form because somebody violated you know, principles that [CL: Right] 
everybody recognizes as inviolate.  Nonetheless, no, I don't really think that some 
oversight body is needed.  I think that would bog down in yet additional bureaucracy and 
administration and we certainly don't need that.  What I think works best is two things.  
One, educating students that at the core of science is the business of ethics and actually 
discussing ethics.  We do that in my lab, during our lab meetings.  I've introduced it into 
my classes and discussed it in the classes.  We even do the exercises I talked to you about 
[CL: Right].  And then one of the things I really like is in the journal article, for example 
in a little section, maybe in the acknowledgements, just having a statement there that 
says, so-and-so contribute this and then the next author, whoever it might be, contributed 
this.  Just a brief statement that says to succinctly but accurately as possible, what each 
person did. 
CL:  From my understanding, the biomedical journals have all moved to that.  Science 
and Nature, I think it's voluntary for one or encouraged somewhere around the, may even 
be required at this point.   
I4:  I think it's required. 
CL:  It's required, yeah.  So it came from biomedicine where they really wanted that 
identification [I4: Yeah].  And I think part of that is also disclosure of payment, like if 
your lab is funded by Astra Zeneca or something  that [I4: Right] [inaudible 0:33:06.2]. 
I4:  Well that's actually a separate statement you know. 
CL:  But it's separate, right down at the bottom [I4:  Yeah, yeah].  Okay.   
I4:  Revealing any funding and conflicts of interest and so forth. 
CL:  Right.  So that statement of authorship contribution I think is going to bleed through 
to more journals [I4: Yeah], but I do think, I agree with you, I think it's good 
recommendation to get everyone clean. 
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I4:  Well you know, it's, it, it's, it's a perpetual arms race.  There will be those few, the 
minority, that will find some way to get around that and then you know, the, the minority 
that is violating the standards will then cause some reaction to make sure that doesn’t 
happen and that just ratchets up and ratchets up.  That's why we are where we are now 
with authorship issues [CL:  Right].  The reason that Nature and Science and these 
biomedical journals are you know, demanding that authorship effort be stated explicitly is 
because people were just putting their names on there.  Maybe the person loaned a piece 
of equipment and said, "Well this is why you have to put my name on there."   
CL:  Right.  A gift authorship. 
I4:  Yeah.  Yeah. 
CL:  Okay.  Well wonderful.  That's about all I had.  I appreciate your time.   
I4:  All right.   
CL:  And for your insight and the fact that you're teaching ethics to your students. 
I4:  Yeah, it's actually a fun, a fun class and it can be difficult because some of the issues 
we choose to look at are ones that are not always clear cut [CL: Right].  Not always 
straight forward. 
CL:  They rarely are.   
I4:  Yeah.  You're right, they rarely are.   
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CL: So the purpose of this is to help me get a scientist's point of view on research about 
communication ethics.  I'm not going to ask you to confess or turn in anybody or 
anything.  It's more just a discussion [I5: OK].  So share whatever you are comfortable 
sharing and if you think I'm not asking the right questions and you want to veer me in a 
different direction, that's totally fine.  This is open ended, okay?  Do you have any 
questions before I start? 
I5: No. 
CL: Okay, great.  So first I'm just going to start with some basic just demographics about 
who you are.  So just state your name please.   
I5: My name is [name removed]. 
CL: And what's your title at Clemson? 
I5: I'm an Assistant Professor.  As of August 15th I will be an Associate Professor. 
CL: Congratulations. 
I5: Thank you.  
CL: Okay, and what is your field of research? 
I5: I'm a plant ecologist.  So I am both, I look at plants both on the population level, 
which is many individuals in the same location [CL: Right] and in the community level, 
which is many different species occurring in the same time and place. 
CL: So technically what department are you listed in? 
I5: I am in biological sciences.   
CL: I've learned that encapsulates quite a lot of fields. 
I5: Yeah. 
CL: And how long have you been publishing your research? 
I5: Since 1999.  So 22 years.  Sorry that's - no… 
CL: That's 12…[laughter] 
I5: That's 12 years.  It's like 22?  What am I talking about? 
CL: That makes me feel old.  Right.  12.  And I can check your C.V. online, but can you 
name a couple journals where you've published research?  
I5: Sure.  Ecology um, Oecologia, which is O-E-C-O-L-O-G-I-A [CL: Right].  Um, 
American Journal of Botany, Plant Ecology, Forest Ecology and Management. 
CL: Okay.  And were any of those articles coauthored with other scientists? 
I5: Yes.  All but one of my journal articles have been coauthored and I have a book 
chapter that was also single authored.  But everything else has been with coauthors. 
CL: Book chapter.  I haven't encountered  a lot of that in sciences.  Okay.  And have you 
ever received funding for your research from an organization other than Clemson? 
I5: Yes, I have. 
CL: Can you name a couple? 
I5: National Science Foundation and the UI5A. 
CL: Okay.  All right now, jumping in, how would you personally define research 
misconduct? 
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I5:  Research misconduct.  Um, I would personally define it as um, influencing the results 
of the data collection in a way that is not - that is subjective I suppose.  That is based on 
opinion. 
CL: Okay.  Do you know where you came up with this definition?  Or learned it? 
I5: I - um, it certainly, I've never taken a class.  I'm sure I sat through some kind of 
seminar or at least a component of a seminar in which they discussed research 
misconduct.  But I've never, yeah but actually maybe I haven't.  I'm sure there has been 
stuff that I have signed [CL: Right] especially for - more like for reviewing I guess.  
Which you know, which is different kind of ethical or misconduct… 
CL: Reviewing as in editor of a journal?   
I5: Editor for a journal or for grant proposals. 
CL: Oh okay. 
I5: Probably even more tricky would be the grant proposals.   
CL: Yeah.  So as a reviewer you felt like you encountered definitions and discussions 
about research misconduct more than as a scientist? 
I5: Yes. 
CL: Okay.  And when you think about your definition of ethical research, how you 
practice ethical research, does any aspect of communication or how you communicate, 
come to mind? 
I5: Well certainly - well - I guess there's sometimes in my mind, there's maybe a tricky 
line between presenting a story, which is what we all try to do to make our, make the 
results easier to understand [CL: Right].  So in trying to tell a story one might be tempted 
to leave certain aspects of a study out [CL: Right] because it might detract from the story.  
And so - but there's the - especially when it comes to statistics.  So you know there's that 
[inaudible 0:06:05.6] famous quote, which I'm probably not even going to correctly 
quote.  But it's like "lies, damn lies and then statistics" [CL: Yeah].  And it really is true 
that you can - there's many people and probably including myself, who know just enough 
statistics to be dangerous.  Because, I mean I know what kind of assumptions I need to 
make sure that the data or the models that I'm going to meet [CL: Right].  But, but there's 
still a variety of different ways to analyze data.  And so the - while I feel pretty confident 
about when I go out and set up an experiment and you know, with the design and the data 
collection, it's, it's in the statistics that I get most uncomfortable [CL: Right] and that's 
why the mis, and misconduct I think could come in at many different stages [CL: Right] 
of, of a research project.  But it may um, come into play a little bit more when analyzing 
data and analyzing it in a, a way that gives the outcome that you sort of desire.  And then 
how that is communicated, I mean which analyses you choose to put in, how you choose 
to interpret them [CL: Right] could be, could definitely be  
CL: Yeah, right.  So would you have a definition of ethical communication in science?  I 
mean it's to your point it's, you were saying before it's including the data and trying to not 
have a biased interpretation. 
I5: Right. 
CL: If I heard you right.  But… 
I5: Yes.  So try not to have a biased interpretation but then there's um, to a certain, well it, 
well realizing that we're all going to be biased in some way based on you know, we have 
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this observation, we create, we come up with a hypothesis.  Obviously you wouldn't 
come up with that hypothesis if you didn't think there was something to support it [CL: 
Right].  And so most times the trickiest results to communicate are when they don't 
support the hypothesis that you had.  Because, not so much because, it's just because oh 
people don't want to, or journals, don't want to publish negative results. But when you 
don't find a significant effect, there's always the question of well was your table size big 
enough?  Did you do everything to be able to detect it?  So we don't want to fail to 
support, or we don't want to reject a hypothesis so easily.  Um… 
CL: Someone said to me you can never get a publication out of a null hypothesis.  Even 
though that might have been informative [I5: Right] you're wrong but you're not going to 
get a publication out of nothing. 
I5: Right.  And, and it's because of this.  Okay well so if there was a hypothesis in the 
first place, it must have been somewhat substantiated [CL: Right].  And so by not finding 
support for it, what does that mean.  You can always, somebody could always come back 
and say well you didn't, you didn't control for this, that or the other [CL: Right] or and so 
it is a lot more difficult to, to publish that "no" result [CL: Right] or that negative result I 
guess.   
CL: Okay, interesting.  Um, were you ever taught or how do you think you learned how 
to be an ethical communicator in science? 
I5: I don't think it was ever really discussed.   
CL: Okay.  Are you… 
I5: Although, just as an aside, my husband was in a business, an MBA program in which 
they had to take at least one class in ethics.  And he said his professor was probably the 
most unethical person he encountered in the business school [CL: Wow] so that always 
makes me a little bit weary of people who teach ethics [CL: Yeah] [laughter]. 
CL: Interesting.  Um, are you aware that there are governing bodies like the Office of 
Research Integrity, ORI or the Office of Science and Technology Policy, the OSTP?  Do 
you know that they have a published, formal definition of research misconduct? 
I5: No, I - well I would assume that somebody would have but I'm not aware of it.   
CL: Okay.  So would you say that there are, that any official rules that say what is and is 
not misconduct guide the choices you make as a scientist? 
I5: Say it again.  Ask the question again. 
CL: So, do the rules that regard ethics, that tell you, that are these published rules. 
I5: Given that I didn't know about them, I would say no [laughing] [CL: Right].  If I 
knew that there were rules out there that I could read and apply to my research, would I 
do anything differently?  [CL: Right]  No.   
CL: Okay.  That answers the question, thank you.  Would you say that you are concerned 
about ethical communication in science? 
I5: Absolutely [CL: Okay].  Because we all somewhat assume that everyone is, is 
following ethical guidelines and that's, we think science is supposed to be this completely 
objective line of study or way of studying.  And if we're not being objective, then it sort 
of all crumbles. 
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CL: Right.  It's like the foundation [I5: Yeah.  Yeah].  Okay.  Now slightly shifting gears 
here, you specifically talk about authorship [I5: Mhm].  Would you say that authorship 
specifically is an issue or concern as you do your research and publications?   
I5: It is.  I, I am, I guess I am not as concerned about it as I guess some people are.  But it 
is definitely a concern.   
CL: What - well let me just ask a side question to make sure I have the background [I5: 
Mhm].  In your field, how are authorship order, for example, is often, is a discussion?  
How is authorship order listed in your journals or conferences? 
I5: Um, the way that most of them, most of them are ordered, is by percent effort.  So 
overall, in terms of idea generation, implementation, analysis and writing, the people who 
contributed the most or in decreasing order of amount of time, effort, whatever is how 
they're listed.  Now I have one publication with 22 or 23 coauthors and after the first 
three they're alphabetical [CL: Oh okay].  So um… 
CL: So there's no - in your field, the last author isn't of [inaudible 0:13:44.5]? 
I5: It - we have discussed that in ecology whether that is the case or not.  And I think it's 
on somewhat of a lab by lab basis, which means it's kind of difficult to determine what 
exactly is the practice [CL: Right].  But it, that seems not to be the case most of the time.  
However, so I would say that is not the case if you have three or fewer authors [CL: 
Okay].  When it gets to be four and five, then sometimes the head of the lab might be put 
on at the end.  But it, yeah. 
CL: It kind of varies. 
I5: It's kind of variable and that does create some strife.   
CL: Right.  I have to ask, you rattled off very eloquently, idea generation, 
implementation, analysis and writing [I5: Mhm] as the factors that affect publication.  
Are those terms from somewhere or is that just off the top of your head? 
I5: Those terms probably are somewhere, but there have been various publications that 
I've talked with my lab and other labs or other, in other settings about it in terms of 
determining authorship.  So there are, there have been published in, I think usually, I can't 
remember where it was published but maybe in the, one of the bulletin of the Ecological 
Society of America guidelines about if say for example, in one model, if someone 
contributes to two of these four areas, they should be an author [CL: Okay].  So there 
have been discussion [CL: Yeah] in our field about what merits authorship [CL: Right].  
I, but I also add into my list, if you couldn't have published this paper without the person, 
even if they only contributed statistical help [CL: Right], then I would list them as a 
coauthor. 
CL: Okay.  Also, I think you answered my question.  I was going to ask what should be 
considered when making authorship positions, but you just said that beautifully.  Have 
you ever researched formal authorship guidelines?  You mentioned you probably read the 
bulletin from your society, main society [I5: Right].  Would that be the extent that you've 
ever researched authorship guidelines?  
I5: Again, there are a couple of different papers that have been published that I've looked 
at [CL: Okay] or yeah.  So it has definitely been something that I have looked into. 
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CL: Right.  It's interesting, American Scientists had a big publication on this like two 
weeks ago, so right in the middle of my interviews some of the people [I5: Oh wow, 
yeah] keep bringing up that.  
I5: Oh no.  I haven't seen that.   
CL: Okay.  [Inaudible 0:16:32.0].  Have you ever, this is now making this a little more 
personal, have you ever felt unfairly represented as an author in these discussions you  
mentioned? 
I5: Unfairly represented meaning…? 
CL: Maybe whatever you would feel by the time a paper reached publication that you felt 
like either the order of your name or the inclusion of your name or what they did with 
your data or something that you, once it got published that you felt something was kind 
of unfair or somewhere along the publication process.   
I5: I, no, I don't. 
CL: No.  Great.  Do you know, can you walk me through a time maybe a recent 
publication where you felt fairly represented?  Maybe share a little bit of the process of 
how it was decided that you would be on that paper or what order you would be in and 
why you felt that was fairly handled. 
I5: Mhm.  Um, let's see.  So the most recent publications have been first authored.  So 
um, I'm trying to think about the most recent one where I was a coauthor and I guess the 
most recent one of those, I contributed help with the implementation of the project and 
some with the writing.  But I wasn't, but I was one of twelve, fifteen authors and we were 
alphabetical [CL: Oh].  Actually I think I was out of order, but that was a mistake [CL: 
Oh].  I mean I was bumped up [CL: Right].  So in the last let's see, ones where I was on 
with a graduate student, I feel like I was in the right place.   
CL: The ones even if you've been first author, is there a discussion that's ever had on 
authors?  Does everyone kind of know it or…? 
I5: No there definitely are discussions and the only time that I've ever felt some sort of 
strife with the author or author, order of authors, was one on which I was the lead author 
and then there was my PhD advisor and the person who helped me a lot in the field and 
with day-to-day kinds of things and with ideas.  But I wanted to put my PhD advisor last, 
thinking that she was the head of the lab and [CL: Right] even though she had contributed 
a lot, I thought that rather than her being in the middle, she would be third.  But she felt 
like she should go second because she thought she had put in more effort than the other 
person. 
CL: That seems like what you were saying earlier about because your field hasn't decided 
last is [I5: Right] important or not. 
I5: Yep, yep.  So at that point, I thought oh, based on other models that I had seen, 
especially from cell molecular, that it would be that she would belong or be happy as to 
[CL: Right] it was a shock to me when she said, when she kind of got bent out of shape 
that that is the way the manuscript came to her, when the draft came to her [CL: Right] 
with her being third author.   
CL: She wanted to be second. 
I5: Yeah. 
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CL: Okay.  Then I guess you answered my final question, which is, did you know of any 
circumstances that you've heard through the rumor mill about a colleague who felt 
particularly unfairly treated as an author?  That's about you had a personal experience but 
you, you've heard any stories? 
I5: I can't um, there are definitely ones out there, but I guess I haven't heard of any really 
egregious ones that people [CL: Yeah] talk about or have um, l mean every once in a 
while and on some papers by colleagues, I've thought, you know, would, I could have 
been an author on that [CL: Right] if they had, I mean they could have brought me in and 
- especially on a like a review paper [CL: Right] of some sort.  You know I could have 
helped with that.  And but, okay they decided that they didn't want that or perhaps, 
especially when it goes from being two authors to three authors, there's sort of a big 
change [CL: Yeah] and yeah, just being a part it all [CL: Right, right].  You know, it's not 
as nice as being in the two.  So I mean I guess I haven't heard any really, yeah, issues. 
CL: That's the end of my formal questions.  And just to let you know, what I'm looking at 
is that these major oversight bodies define research misconduct as falsification, 
fabrication and plagiarism; FFP, the standard definition. 
I5: Simon can you wait a couple minutes? 
S: Sure.  Do you want - I'll come back. 
I5: Okay.   
CL: And so the only thing that dealt with authorship or communication at all is 
plagiarism.  But I'm speculating, hypothesizing the communication ethics are actually a 
big deal and really affect the way a scientist work, does his or her work [I5: Mhm].  So 
I'm trying to look at maybe should there be a recommendation that an oversight body 
start regulating communication ethics?  Should that be brought up earlier or taught 
earlier?  And where does it fit into, is it even important?  Like I, I was going to go off on 
this tangent about communication ethics being so important, but I needed to stop and talk 
to scientists and see if it actually was [I5: Yeah].  So that's what I'm looking at and it's 
what I'm interviewing about ten of y'all and try to, try to understand.  But [I5: Uh huh] 
and then it became, as I started pilot research authorship was just the issue that kept 
coming up as something that really takes up time and concern and relationships and the 
drive to publish affecting how research is done [I5: Mhm].  So… 
I5: Actually now that you sort of - I don't know, I just remembered one where I was a 
coauthor of a fairly small number of people and then - and I did a lot - for it and then for 
the publication - and then at the end, there were five other people added on as coauthors 
and I [CL: which diminishes] yeah, diminishes my impact as it goes [CL: Right] um now 
it wasn't a very important paper or one that I really cared that much about, so it's not, it, I 
didn't lose any sleep over it [CL: Right].  I didn't contact the person that was responsible 
for it.  I let it go without ever making any kind of comment.  But… 
CL: Do you know why they were added? 
I5: I don't [CL: Okay] and that might have shed some light on why.  But I have a feeling 
that it was not for, it was not ethical [CL: Right] the reasons why they [CL: Inaudible 
0:23:51.7].  Yes, yeah.  Yeah.  Yes.  And yeah.   
CL: Do your journals, if I can ask real quick, do your journals require any statement of 
what was contributed?  Any…? 
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I5: No I've only seen that for the PNAS.   I mean there are, yeah.  Hmm, at least that I can 
remember that… 
CL: From what I, from my research it kind of started, the biomedical journals require it 
and science and nature now [I5: Okay] require it.  It seems to be trickling down [I5: 
Yeah] but the journal editors are a whole different group of people making these kind of 
decisions so [I5: Yeah] and they vary by, not only by field but I'm sure you've found by 
journal how they want authors listed or… 
I5: Right.  And I don't think there are any guidelines - actually okay, so the, here's 
another example that I just remembered [CL: Sure].  The paper that I had that was first 
authored by a former masters' student of mine and then me and somebody else, it went 
out for review, it got rejected from the journal that we sent it to but the editor actually 
called me up to tell me that to that in the reviews there was one reviewer who kind of 
went above and beyond but sort of in a bad way [CL: Yeah] in searching on the internet 
and had found a student report from, from this other university where the student had 
been working with my masters' student and had published this like little tiny [CL: Ah], 
tiny project.  But this reviewer thought that this person should have been a coauthor on 
the, on the article.  Even though, yeah, I, I know the reviewer and he signed his review so 
it wasn't revealed to me by the editor [CL: Right, right].  He disclosed it but it was just a 
strange thing that he thought - I, I thought it was pretty clear to anybody who would read 
that student's report, that they came, like she came for two weeks and did this little tiny 
project and that was made possible by this longer project by my masters' student was 
working on.  
CL: So it wasn't a plagiarism accusation. 
I5: No.  It was a like, you should have included, like why isn't this person included 
because I think there was a statement in the report that said she analyzed his data.  So the 
person thought that she did the data analysis and actually what she did was take part of 
the masters' student's data to put in her report [CL: Oh] and she analyzed it for her report 
[CL: Right, right].  She didn't have anything to do with his masters' project.  And in fact, 
so it was many layers of why would you think this [CL: Right].  But what the editor told 
me was, "Look, we, we, first of all, we don't think that your student did anything wrong.  
But second of all, even if he or she had, we do not determine who's an author on paper.  
You determine that.  So if, even if this person had done a fair amount of work, if you the 
authors decided that it didn't merit coauthorship, we are not going to say we think this 
person should be a coauthor [CL: Right].  So I think even if somebody wrote to this 
journal and said, "Hey, I should have been a coauthor on that article" they're not going to 
do anything [CL: Right, right] yeah. 
CL: Interesting.  Okay.  Well I appreciate your time.  Thank you so  much.  This has been 
great.  And I, as I said, I know you're busy, so thank you for working us in. 
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 Interview 6 
May 17, 2011 
 
I6: …Research papers, so I'm kind of used to it.   
CL: Oh.  Okay, perfect.  Um, okay, the purpose of this is I'm trying to get a scientist's 
point of view.  I've been doing my own research on scientific communication or on 
communication ethics in science [I6: Okay].  But I realized I wanted to actually hear what 
the scientists thought of it and their value.  So I'm asking a couple of y'all from different 
fields, for your opinions.  The interview is totally what you think [I6: Okay] share as 
much or as little as you want.  If you feel I'm not asking the right questions, feel free to 
divert me [I6: Sure].  However you want to approach it [I6: Okay].  Do you have any 
questions for me?   
I6: Not particularly.  So [CL: Okay] are there any particular results or conclusions you're 
looking for in this?  Or [CL: Um] is it kind of a comparison between what scientist in 
different fields think about these issues or… 
CL: Part of it's me learning how the different fields approach [I6: Okay] and after we get 
through the questions, I'll kind of debrief you in what I think I'm looking at and you can 
let me know [I6: Okay sure] if that makes sense [I6: Okay].  I don't want to lead you [I6: 
That's probably good] in one direction too much in the beginning [I6: Okay].  So we'll 
start with just the basic demographics [I6: Okay].  Please state your name. 
I6: Okay, my name is [name removed]. 
CL: And what is your title at Clemson?  
I6: Currently Assistant Professor.  I just found out last week I'm going to be appointed to 
Associate Professor as of this summer. 
CL: Congratulations. 
I6: Thanks.  
CL: Professor of…? 
I6: Computer Science I guess. 
CL: Yes.   
I6: Now we call it the School of Computing.  So [CL: Oh] whatever that makes my title.  
I like to say computer science because people know what that is.  
CL: Right.  What is your field of research? 
I6: I mostly study algorithms and optimization. So how to efficiently solve large scale 
computation problems kind of very broadly.   
CL: Okay.  And how long would you say you've been publishing your research? 
I6: Um, probably, counting my graduate years as well? 
CL: Yeah, if you were publishing in journals. 
I6: Probably nine, ten years, something like that.   
CL: And, I mean I can check your C.V. online, but can you name a couple journals where 
you've published your research? 
I6: Sure. 
CL: Journals or what's big in your field. 
 127 
I6: So I computer science, actually conferences have a lot of weight in addition to 
journals.  But a couple of, of journals that I've published in recently, let's see, 
Algorithmica is one that I've published a few papers in, let's see, there was a big paper we 
published in Mathematics of Operations Research.  Let's see, what else.  Discreet 
Applied Math, um… 
CL: What about some of the conferences? 
I6: Conferences.  So, what are some of the recent ones?  Um, actually let me pull up my 
list so I can get in the most recent.  So, some of the recent ones.  Automated Software 
Engineering, there's one called the Algorithms and Data Structures Symposium. 
CL: And I can pull - this is from the Clemson site? 
I6: That's just from my Clemson site.   
CL: Okay, perfect.   
I6: Grab the list from there real easily.   
CL: Great!  Thanks.  Okay.  And of those conferences and journal articles, are any of 
them coauthored with other people? 
I6: Quite a few, yeah. 
CL: Quite a few.  Is it most or… 
I6: Probably all of them actually.  Almost every single paper, it's at least authored with a 
student or with other, other professors here in the department. 
CL: Okay.  And have you ever received funding for your research from an organization 
other than Clemson? 
I6: Yes, from NSF. 
CL: Okay.  Super.  All right.  Now delving in, how would you personally define research 
misconduct? 
I6: Wow, easy questions. 
CL: I know, I jumped in. 
I6: Research misconduct.  There are many kinds of research misconduct.  So I'm not sure 
there's one catchall definition that, that gets all of them.  Because there's all sorts of bad 
things one can do in research.  Is there one particular kind of type of misconduct you're 
focusing on or…? 
CL: Well just general.  You say there are several different kinds of misconduct.  What 
kinds do you think of? 
I6: So there's misconduct in kind of being dishonest about your research results.   You  
know, misrepresenting results kind of claiming that certain things weren't true, your 
results that aren't true or kind of bending the truth a little bit more than you should be.  
There are some difficult issues misconduct involving projects in which you have multiple 
investigators you know, not assigning appropriate credit or authorship issues, things like 
that.  There's probably misconduct in funding.  You know spending funding on things 
that it's not supposed to be spent on.  So there's all sorts of issues with, with kind of 
academic misconduct you could probably get into. 
CL: Okay.  These different definitions or the look into it, do you say, how would you, 
how did you come to that?  Did you learn that somewhere?  Is it…? 
I6: Um, actually they don't, or at least for me, they didn't teach me much about kind of 
ethics and academic you know, how to properly conduct academic work.  They didn't 
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teach me much about that as a graduate student.  So it's kind of you learn by kind of 
keeping your eyes open and listening to what you know, other people have told you about 
their experiences and you kind of learn by example.  Not necessarily by engaging in this 
conduct yourself [laughter].  You hear enough things as, as an academic that you kind of 
quickly learn about you know, what to do and what not to do and everything.  And there 
are ethics type you know, all nine tutorials and such [CL: Yeah] that Clemson makes you 
go through to make sure that you're certified as a responsible researcher and whatnot.  It 
seems like they have a new one of those every year that they make you go through. 
CL: Like the PI certification, that sort of thing? 
I6: Things like that, yeah.   
CL: Okay.  When you think about how to research ethically in your different ways that 
could go, does any aspect of communication come to mind? 
I6: Um, so what exactly do you mean by communication?  [CL: Um] That's a word that 
I've never quite… 
CL: That you - right.  How you interact with other researchers, with your how you 
publish in general, um, the process of publication, of correspondence… 
I6: Okay.  So there's [CL: I mean it's…] I guess there's… 
CL: I'm leaving the door very open to see [I6: Okay] if you think of any way how you 
communicate with somebody else or through publication. 
I6: So I mean publication to me is kind of a - the act of publication itself is a 
communication [CL: Yes] and then there's [CL: Exactly] the communication that goes on 
during the research effort with your investigators.  You know, building the publication in 
the first place [CL: Right].  So both of those [CL: Yes] would interest you [CL: Yes]?  
So, okay. 
CL: And the fact that you identified that is an interest.  So yeah.  So when you think of 
those two aspects of communication, do you think of those as being ethical?  Are there 
ethical issues involved in either of those? 
I6: There are several ethical issues involved with both of those I guess [CL: Okay].  You 
know, just the publication in general, it's more of you know, representing your research 
properly.  You know, not stretching the truth or kind of any claim that needs, that you 
know, didn't happen in your results and then being as honest as possible [CL: Right] and 
then being within your own collaboration, it's important to make sure that everybody is 
on the same page as far as you don't want to kind of get to right before publication and 
then say, "Oh by the way, I'm putting you as last author on the paper" and you know, 
having someone be surprised by that.  You know, there should be kind of a understanding 
all the way through of how much credit everybody's getting and if there's funding, you 
know how the funding's being allocated.  So um, everybody should be on the same page 
with, with those sorts of issues.  So it's important [CL: Right] to communicate as clearly 
as possible about those things I guess.   
CL: Right.  You mentioned last author.  How does authorship rank work in, in your field?   
I6: Uh, it's actually, it's easy actually in computer science.  I know in most other scientific 
disciplines, like first author means something very specific.  Last author actually means 
something very specific [CL: Right].  In most computer science publications, it's strictly 
just alphabetical order.  So that makes life easy.  Especially for those of us who have 
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early alphabetical names [laughter]  because we always end up at the front of the list [CL: 
Yeah].  So to some extent, that removes a lot of the uncertainty or the, the squabbling that 
happens for authorship orders.  It just doesn't exist so much in my discipline.   
CL: Yeah, I'm finding a lot of different… 
I6: It's kind of interesting… 
CL: The fields are very different regarding that. 
I6: It's interesting, if I collaborate with people from other disciplines and for me, I've kind 
of gotten used to the fact that authorship order just doesn't matter at all [CL: Yeah].  It's 
strange for me to kind of work with other people because they're, they care a lot about 
what order the names appear in and so that's kind of been a challenge for me to kind of 
figure out what's the most appropriate thing for me to you know, to do as far as my name, 
the name order matters [CL: Right].  Usually it doesn't bother me too much [CL: Right].  
To me it's just you know, it's either on the paper or not on the paper.   
CL: Is that a conversation when you have to work, when order matters, is that a 
conversation that happens early in the research?   
I6: That should probably happen early, right [CL: Yeah].  Unless you get to the end of the 
project and realize so-and-so really didn't put much effort in at all and you'd like to you 
know, not list him as the first author as a result of that or something [CL: Right].  That's 
kind of the exception of the rule. 
CL: Right, okay.  I think you kind of mentioned this when you used the term allocation 
and getting on the same page, but would you have a definition of ethical communication 
in science? 
I6: Definition of ethical communication in science.  Um, I would say that when you're, 
when you're publishing results, what you write in your publications should be an accurate 
and truthful representation of, of your actual results.  And it shouldn't,  not only kind of 
factually accurate, that it shouldn't imply or kind of twist things in ways that are kind of 
you know, too far away from the truth [CL: Right].  And in terms of communicating with 
your peers, it's important to be as open and honest as possible about everything that, I 
mean so sometimes there are reasons in academia to withhold information.  You don't 
have to divulge all of your research to every single person [CL: Right] at any point in 
time.  But you have to be open and honest about things that matter like publication order 
or funding issues or things like that. 
CL: Okay.  Do, where did you learn that definition?   
I6: Where did I learn that definition?  Um, nowhere I don't think [CL: Okay].  I think it's 
just kind of collective experience over years as a faculty member probably.   
CL: Okay.  Um, are you aware that there's a governing body like the Office of Research 
Integrity, ORI and the Office of Science and Technology Policy or USTP?  Do you know 
that they have published definitions of research misconduct?   
I6: I would not be surprised.  But I did not know that specifically. 
CL: Okay.  Um, would the rules, I mean if you did know them, if you did go and read a, a 
formal rule on research ethics [I6: Mhm], would that affect how  you choose to 
communicate as a scientist? 
I6: Probably not.  Not much.  I would expect their definition would line up with my 
definition pretty closely probably. 
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CL: Yeah.  Okay.  Um, would you say, as a practicing scientist, that you are concerned 
with ethical communication practices?   
I6: Definitely, yeah. 
CL: Okay.  Okay.  Going from kind of big to more specific, you brought up authorship 
[I6: Mhm].  Is authorship an issue or a concern as you do your research and publication?  
I6: Uh, for, for me personally [CL: Mhm]?  Um, it is.  I mean in computer science, like I 
mentioned, it's less of an issue because most things are done alphabetically [CL: Right], 
so it's not as much of a stressful issue as it could be in other disciplines.  And I think I 
kind of care less about where my name appears on a paper.  I, I'm kind of happy if, if a 
student wants to have their name more prominent, I'm happy to let the student you know, 
put their name in the prominent spot because you know, they kind of need their moment 
in the spotlight you know [CL: Right], to get their careers started.  I think um, so it's kind 
of authorship, you kind of do whatever makes sense strategically for the participants 
involved.  You know, who needs the most credit you know, based on where their moving 
in their careers and things like that.  Or if you're applying for funding, maybe you want to 
make sure that the principal investigator is the one that's got their name more 
prominently, you know, displayed [CL: Yeah] since the funding agency will view that 
well or something.  But for me, it, authorship is not that much of a source of stress or 
concern.  It's mostly just how many papers is my name on.  That's what's the thing I care 
about the most.  
CL: So there is a concern to have a certain number though?   
I6: Right [CL: Yeah].  Quantities, quantity matters a lot for evaluation for you research 
productivity.  When you move up the food chain to the dean and the provost, it's mostly 
just you  know, how many papers did Person X publish [CL: Right].  So… 
CL: So for job concerns. 
I6: For job concerns, yeah. 
CL: Okay.  What do you think researchers should consider when they make authorship 
positions?  To your point of order or who's the PI or who gets more of the funding and 
that sort of thing, when you're working on the affect of authorship, what concerns? 
I6: I think one of the biggest and more complicated issues in authorship is figuring out 
when somebody should be an author on the paper or not.  Because a lot of times, people 
make small contributions or they'll be in the research group that puts out a publication 
and so it's not possible to talk to them at all about the you know, the content of the paper 
that the question is, at what level should they have contributed before you know, their 
name gets added on to the list.  Uh, and… 
CL: Do you have an idea of like, do you have a way that you define the contribution 
worthy of authorship? 
I6: I think for me, generally you have to be kind of official, you know, officially kind of 
on the team of people working on the problem and you have to, in some sense, be kind of 
an active participant in the discussions.  So a graduate student for example, the, the, as 
long as they are kind of, you know, they come to all of the meetings and all of the 
discussions for the paper, they help write the paper, it doesn't matter if the main idea from 
the paper doesn't like, originally come straight from them you know.  As long as they are 
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a participant in the process, I think that's usually fine [CL: Okay].  But they have to kind 
of participate and contribute as much as they possibly can. 
CL: Does everybody write something? 
I6: Uh, that depends.  I mean if you have like five or so authors, you may not have every 
single person writing the paper [CL: Right].  But usually I ask the, at least for students, 
that they try and write.  Mostly just for training purposes [CL: Yeah].  In many cases, I 
have to rewrite a lot of papers myself, but um, writing versus not writing, I don't think is 
as important for authorship.  I think it's more did they participate during the research 
process as opposed to the, putting the paper together process. 
CL: Okay.  The research and discussion [I6: Yeah].  Okay.  Um, have you ever 
researched any authorship guidelines?  
I6: Um, it's something you talk to a lot of people about, but I'm not sure I've officially 
researched any, any guidelines on, I mean I know I've, I've probably read articles about it 
here and there.  But I can't say that I've actively gone out and sought advice on that 
subject. 
CL: Right.  But even like when you're applying for your NSF grant, you do check on it. 
I6: Not particularly.  
CL: Okay.  Um, I guess it's, this is a little trickier for computer science regarding order, 
but at least I would say regarding whether or not you got on a paper or not, have you ever 
felt unfairly represented as an author? 
I6: Um, not too often.  Maybe early in my academic career there were some issues where 
I felt like I should have been further up on the author list.  But now that I have enough 
papers published, those issues don't bother me so much kind of any more.   
CL: I'm confused, so you're talking about - so there must be some interest in being early 
in the list. 
I6: Well, so when I was a graduate student, there were some papers that I was on where 
the order mattered I guess [CL: Oh, okay].  And so in, in that case I think I was a little bit 
probably too stressed out about you know, making sure my name was first [CL: Right] 
because those were my first papers and it kind of mattered a lot that I you know, had a lot 
of recognition.  Recognition at that point in my career.  Nowadays, even if the order 
matters, it doesn’t really concern me too much where I am in the ordering [CL: Yeah] 
so… 
CL: Can you tell me maybe about a recent journal or conference you did about the 
process about how you felt fairly represented as an author?  If that's the norm, like… 
I6: How I felt fairly represented as an author.  So for example, I'm collaborating with 
neuroscientists at MUSC and a group of five or six other neuroscientists and also a 
graduate student of mine.  So it was a paper we sent out that had eight or nine authors that 
really you know, longer author list than I'm used to.  And so the question is, how do you 
acknowledge all of these people contributing?  And I think we ended up using my name 
as the last author um, because it made sense for my collaborator to be listed as the first 
author so that - because we were publishing a grant and he needed that sort of credibility 
[CL: Right] and last author kind of is special because it indicates, the person who's lab 
the research takes part in [CL: Yeah] so that kind of made sense as well.  So I think that 
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was overall a fair thing to do.  I would have been fine being second author as well but 
[CL: Right] or whatnot. 
CL: Did y'all have a conversation, as you said, before?   
I6: We did. 
CL: You started? 
I6: We did.  Yeah, I think it's key when during the planning process is putting the paper 
together before it really gets substantially underway.  Everyone kind of has an idea of 
where the authors are going to stand in the authorship list, if the order matters.   
CL: Right.  Do you know of any stories or circumstances of colleagues of yours who had 
a particularly unfair treatment as an author?  
I6: Um… 
CL: You don't have to give names or anything. 
I6: Yeah.  I've certainly seen issues where people have contributed a lot more than is kind 
of demonstrated by their ordering and author list.  It can easily happen to people without 
much power or say, like junior faculty or graduate students.  Because a lot of times you 
want to put some you know, some big prominent person's name on the paper to kind of 
make sure that it has a better chance of being reviewed positively.  The trouble is, the big 
prominent people often are not the ones that are doing most of the work behind the 
scenes, so [CL: Yep].  That's usually where things are kind of slightly unfair [CL: Right] 
is that the junior people kind of do most of the work but don't get as much of the credit as 
they should.   
CL: Right.  Now I had no idea this is a allowable, but Delphine had mentioned an 
interesting story about your masters' [I6: Oh yes].  And I don't, if you're not comfortable 
sharing it, she was very vague in her terms but um, if you are comfortable sharing it, can 
you explain that to me from your point of view?  It sounded like it was an authorship. 
I6: It was authorship and also generally just kind of how he treated his graduate students 
from an intellectual standpoint.  Kind of his graduates generated a lot of good ideas.  Lots 
of his research is based on ideas that his graduate students came up with and I don't think 
he acknowledged the graduate students as much as he could have.  There were many 
papers that I saw him publishing further down the road that were basically ideas that old 
graduate students had come up with and the papers had basically just his name 
prominently on them, not much mention of the graduate student.  And issues like that.  So 
generally not giving his students enough credit [CL: Right] for the work.   
CL: Power dynamics seem to play into a lot of this. 
I6: Yeah, it does.  You have, it's interesting, you have a different perspective on it as a 
professor you kind of look back and you think, well okay, as a student it seems like I 
came up with the idea, I should be the first author on everything and, and you know, why 
should my advisor even be on that paper because you know, he didn't really contribute.  
He seemed to just you know, I wrote the thing, I came up with the idea.  But it is fairly 
accepted practice that you know, the person who's funding you and the person who's kind 
of you know, generally advising you and whatnot, should at least be on your publication 
[CL: Right].  So, so kind of your view on that kind of changes I guess I guess as you 
grow older and see it from the other side.  But yeah, the masters' advisor, he ultimately he 
did not get tenure and he left because I think a  large part of that was word got around 
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that he wasn't treating his students fairly [CL: Right] kind of from an intellectual 
standpoint and assigning credit where credit was due [CL: Right].  And there were some 
specific examples here and there of you know, I had written a paper with him where the 
draft of the paper had my name, then his name and then right before sending it out he 
swapped it over and sent it.  So it kind of you know, surprise you know [CL: Yeah, yeah].  
So it kind of - that would have been less annoying if we had just talked about it early in 
the process.  Even if the order, the fact that the order was switched didn't bother me too 
much, it's just that he kind of just did that at the last minute and then sent the paper out 
kind of… 
CL: Without discussion. 
I6: Yeah.  [CL: Yeah].  That's the kind of thing and then you know, finding later on, 
papers that he writes that you know, based on my research that either have my name or 
don't have my name on it, but that I just never knew about, things like that kind of, those 
are a little bit kind of outside what you would expect kind of standard ethical researchers 
to be doing [CL: Yeah].  So… 
CL: The um, senior publish, the senior faculty tending to give themselves more credit [I6: 
Mhm], do you feel that's  a drive for job concerns or for prestige or for funding?  Or all? 
I6: It's probably more for funding. 
CL: Funding.  Okay.   
I6: You sometimes feel like a paper has a better shot if it has a big name on it as the first 
author or for funding, if you've got a really impressive you know, investigator who has 
won all these different grants, you figure make them, you just kind of put them on your 
grant as a, you know as the big name behind the grant that everyone kind of will believe 
that you know - because a lot of getting funding is believing that the person on the grant 
you know, has the ability of pulling off what they're proposing.  So if you put someone 
on there that has an established track record, that gives the grant some more believability. 
CL: Right.  Does the, when the person in power requests being on…? 
I6: That's, that's tricky.  I guess if they request, if the person however requests being first 
author or last author, then that's the usual  thing of you know, do you try and put your 
foot down or do you disagree with your boss or [CL: Right] and that, I haven't actually 
dealt with that issue much myself. 
CL: Okay, so it tends to be more gift authorship than someone… 
I6: I would say so, yes.  [CL: Yeah, okay].  It's more kind of uh, in a lot of cases I'd say 
it's probably initiated by the junior person just to kind of - you want the, the, the, the 
people that are uh, in power, you want them on your side because they're the ones that are 
on the committees that are evaluating your performance and everything [CL: Right] so 
you figure you know, if you are nice to them and offer them authorship on papers that 
probably you know, puts you on their good side, things like that [CL: Right, right].  So… 
CL: Okay.  That's about all I have of formal questions [I6: Mhm] and little sidetrack, 
what - just so you know, the formal definition of um, research misconduct that comes 
down from above, the governing bodies, is um, fabrication, falsification and plagiarism. 
I6: Ah, interesting.  Okay. 
CL: Which you actually touched on almost exactly.  Um, and it's been the same definition 
forever or since the '80's.   
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I6: I think plagiarism of all, that is one issue that I see… 
CL: You did - right - you did say that you need to allocate the proper credit, which is 
related, but not the same. 
I6: But, yeah that does bring up a, kind of a slew of - I mean, yeah blatant plagiarism is 
obviously wrong [CL: Right], but there are many times when you have kind of issues of 
self plagiarism that there's kind of an interesting gray area where [CL: Yeah] you're 
submitting to a conference, kind of a report on results that you've published some of them 
elsewhere and you know, so there are some complicated issues with - or sometimes you 
submit to a journal a paper that you've already submitted to a conference that's been 
expanded so [CL: Right] self plagiarism is more of a complicated issue than just outright 
plagiarism.   
CL: Right.  Oh and it's under great discussion from different fields and things.  And even 
our ethics institute on campus has been discussing self plagiarism for sure.  Um, what's 
interesting is that, that FFP definition has not changed um, and yet there seems to be a lot 
of discussion about authorship and about communication ethics.  So it's [I6: Interesting] 
kind of looking at whether or not communication ethics should be rolled into the overall 
definition of research misconduct. 
I6: Is it falsification, [CL: fabrication] fabrication okay, [CL: And plagiarism].  So 
fabrication is just making stuff up out of thin air [CL: Right].  Falsification is twisting it a 
little more than it should be to - okay. 
CL: And then plagiarism, as you said, that even has lots of different definitions.  But, 
plagiarism is the only communication related misconduct and yet I am sensing that there 
is actually a lot of other communication issues that, that can lead to misconduct [I6: 
Sure].  So I'm wondering if communication issues are so important to scientists, 
especially authorship, should authorship be included into a grander definition of research 
misconduct?  Um, do you even care what the definitions are?  That's sort of where I'm 
[I6: I see] hanging out in my research. 
I6: I'm still kind of hung up on communi, so communication to me sounds like you can 
make that term so broad that it covers whatever you need it to cover.  So everything's 
kind of a communication issue [CL: Yes] in research and science you know [CL: Yes].  
Because everything is - involves communication to some extent [CL: Yes].  Um so, [CL: 
But]to make things complicated without a specific kind of notion of, of… 
CL: Well that's why I've - it does make things complicated.  Um, and authorship kept 
turning out over and over again and that's sort of what I'm focusing on within the [I6: 
Okay] communication is everything.  However, you are - your ability to say 
communication is everything sets you apart from some of your peers you say, "I'm a 
scientist, I don't really communicate" [I6: Oh, okay] or I you know, that's not of 
importance to me.  I just do my science and write a paper and - so there's, there is a 
disconnect between the role of scientist as an author, as a communicator [I6: Interesting, 
okay] and that's part of what my field is trying to do is make scientists better aware that 
they are communicators. 
I6: I thought that's what scientists were supposed to be. 
CL: That's fascinating that you've acknowledged that.  That, that yeah.  That's not 
prevalent. 
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I6: I guess you've got scientists that kind of, they like to live in their own world and kind 
of do their thing and then meet and send out papers and whatnot.  Um, but I think of 
science more of something that has to be - you know, you have to interact with the world 
outside you, with your peers and I think the most exciting things I come across in science 
when I talk to people that are not in my little world, you know, that are different worlds 
of communication, you know over on the other side of campus where they do you  know, 
really fun stuff.  So um… 
CL: Exactly.  The fact that our campus, it goes back to Plato.  Do you really want to 
know this division between rhetoric [I6: Yes] is artsy and it takes you away from the 
truth, versus there is a truth that scientists can discover [I6: Right], so there's, there's a 
history of separation I think we're now getting a little bit more savvy to realize the 
scientist is a communicator, but I really don't think everyone's there yet [I6: Yeah].  So 
with the understanding there's communication, means that there's communication ethics.  
And so, that's what I'm trying to figure out, is how important communication ethics are 
and whether or not they should be part of the scientist's research misconduct definition 
like that not always involves  plagiarism, but should there be more formal rules about 
authorship and about [inaudible 0:30:50.0]. 
I6: I see.  It's tricky because every situation is different [CL: Yeah].  And so there are 
some general guidelines but it's really kind of, you use a one size fits all definition for 
kind of ethics in general.  I mean, ethics is tricky because everyone kind of knows what, 
what it is and what's ethical.  You know, there's probably a few gray areas but, it's really 
hard to kind of write a one sentence thing because of, it's that [CL: Right], so, it's, it's a 
challenge.   
CL: But um, the authorship's interesting because some journals have definite definitions 
of what makes an author [I6: Yes].  Some of them require a statement at the beginning 
that says what every author contributed, so they… 
I6: That's becoming more prevalent I think, yeah. 
CL: Yes.  That's what I'm finding as well.  It started in biomedicine and it's kind of 
filtering to other ones.   
I6: Because they've had some, some bad cases of ghost writings and such that [CL: 
Right] have spurred that I guess.   
CL: Exactly.  So I think I've ended up focusing on authorship because it's one really 
prevalent, or I needed to see if it was prevalent and my pilot research shows that this 
um… 
I6: Yeah, people care about authorship. 
CL: Yeah.  It seems not be affecting your field as much, which is part of the reason I 
wanted to talk to a computer scientist, because I had one in my pilot research and I had 
never heard about the alphabetical and that seems to alleviate you from some of the 
stress.  But then again, you still talked about power issues and grants out there and it does 
still come up. 
I6: There are still issues of trust [CL: Right] yeah.  It's funny, there's I mean I teach 
mostly mathematic type stuff in my classes and so I usually don't get a chance to teach 
much about ethics and computing.  I guess there are some ethical issues in computing, 
but they don't come up a lot in my classes versus like what Delphine teaches, where 
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ethics is a big part of it [CL: Right].  Um, and so on course evaluations, there's a 
question, that's a standard question, that says, does your instructor cover the relevant 
ethical and societal implications in, in the coursework that you're being taught?  And I 
always got a really low score on that because there just isn't much ethics in like the 
mathematics area that I'm teaching [CL: Right].  So for fun, the last lecture that I give my 
students in my class is the ethics lecture [CL: Oh yeah], which is, it's kind of silly.  It's 
one slide that just says only use algorithms for good, not evil.  [Laughter].  My ethics 
score shot up quite a bit after that.  So I kind of take light of it I guess, but I think there 
are definitely some important issues to um… 
CL: Yeah, maybe you can talk to them about if they go and publish, how can they be 
ethical [inaudible 0:33:15.6]. 
I6: I try, any time I come across an interesting example, I like bring it up.  You know, I 
take my students out to lunch every week, so we always have discussions about these 
issues.  I figure it's my goal as an advisor is to not just teach them the science, but also 
kind of the how to conduct the science [CL: Yeah].  That's something that a lot of 
advisors don't actually get into at all.  So that's… 
CL: You mentioned that you didn't cover… 
I6: Yeah, I kind of, you get here and you find out you have to be kind of all these things 
you were never trained to be, like a manager and then whatnot.  So you kind of have to 
learn it all as you go [CL: Right].  So that's important to let your students know about all 
these other issues that you have to think about as a faculty member [CL: Right].  But 
uh… 
CL: Do you have grad students? 
I6: I've got quite a few, yeah.  I've got four PhD students right now.  
CL: [Inaudible 0:34:02.1] the PhD? 
I6: No, they, they're pursuing PhD.   
CL: What's the program at Clemson that's the PhD? 
I6: Uh, they'd be pursuing a PhD in computer science. 
CL: Okay.  I didn't realize we had a computer science PhD. 
I6: Okay. 
CL: I gotcha.  Yeah. 
I6: So.  
CL: I thought - okay.   
I6: So you're graduating, you're graduating by the end of December you said? 
CL: That's the plan. 
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CL:  Thank you.  Okay, um as I said, I’m looking into communication ethics, so I have 
some questions if you want to answer them or not answer them you’re welcome to.  If 
you think I’m going in the wrong direction, feel free to turn me around.  And the purpose 
of this is I’ve been looking into communication ethics and um some other issues that I’ll 
get into.  But I realized I needed a scientist’s point of view.  I was speculating on the 
importance that scientists gave to this and so I decided to interview um, scientists from 
several different fields.  I’m trying to be broad and see what your point of view is on 
some of the stuff that I’m looking into.  [I7: Sure].  Okay, so do you have any questions 
before we get started?  [I7: No].  Great, I’m going to start out with basic demographics.  
If you could um, give me your name please. 
I7:  [name removed].  
CL: And um, what is your title at Clemson? 
I7: I’m an assistant professor.   
CL: Of…? 
I7: Chemistry.  [Throat clearing] Excuse me. 
CL: And I’m writing just in case this crashes. 
I7: That’s perfect.  You’re fine.   
CL: It’s my back up.  And your field of research? 
I7: Chemical education.   
CL: Okay.  Um, and about how long have you been publishing your research? 
I7: I think the first thing came out about eight years ago now.   
CL: Okay. 
I7: Yeah, yeah, I think. 
CL: Um, and I can check your C.V. online, but could you name a couple of journals 
where your work has been published?   
I7: Uh, where I send a lot of stuff is Chemistry Education Research and Practice, which 
is published by the Royal Society of Chemistry.  Uh and I’ve published one thing on, in 
the Journal of Chemical Education which is published by the American Chemical 
Society.   
CL: Okay and um, have you coauthored any of your articles with any other researchers? 
I7: Yes.  I mean so are you – I’ve coauthored with my PhD mentor and my students 
whom I consider researchers.   
CL: Right.  Have you coauthored with any colleagues? 
I7: No. 
CL: Or co-researched? 
GL: No, I’m trying to think.  No.  I mean yeah.  Well we have a submitted paper with a 
couple of folks from one of the engineering departments. 
CL: Okay.  Um, and have you ever received funding for your research from an 
organization other than Clemson?  
I7: No.  Well yeah, the University of Oregon. 
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CL: Is that why you were at Oregon or… 
I7: Yeah, that was my first job was there. 
CL: Okay so you’ve been funded from your institutions. 
I7: Yeah. 
CL: Okay um, perfect.  Jumping more into what I’m looking at, how would you 
personally define research misconduct? 
I7: Oh God. 
CL: Yeah I know, it’s a biggie.   
I7: Uh, I’ll give you two, two answers.   
CL: Okay. 
I7: Um had we not ever – so as I was telling you when we were coming down here, uh, 
we’ve done some publishing in this area of um, ethical development [CL: Right], 
scientific ethics.  And so that forced or gave me an opportunity to look at some things 
that I probably wouldn’t have. 
CL: That’s right, yeah. 
I7: So had I not looked at that I think my definition would have been something to the 
effect of taking work that is not taking, taking work that is not yours that you have not 
primarily produced and, and selling it as your own.  Not giving uh, people 
acknowledgement for ideas that – so for example, I had a paper published last year where 
somebody from the Center of Ethics, we were just in a conversation and I was telling him 
about something and he said, “Oh you know, this kind of sounds like you know, they are 
applying this idea, like this other idea.”  Now I didn’t think that merited authorship from 
him, but I do think it merited an acknowledgment [CL: Yeah] because I would never 
have thought about making that connection had it not been for his comment [CL: Okay].  
So I think that’s really important [CL: Yeah].  Citing people for, from where you get the 
main, the major ideas that show up in your, in your um, in a publication.   Now um, after 
having done the research [CL: Yeah], one of the things I would add is to look at your 
professional society’s code of conduct.   
CL: So your research, your definition of research misconduct is what your professional 
society said, says it is? 
I7: I would say that is an addition to everything else that I said [CL: Okay].  I would have 
not thought much about the professional society’s code of conduct because frankly, I 
didn’t know to what extent even my professional society had [CL: Right] a detailed code 
of conduct 
CL: Right, okay.  Your professional society being…? 
I7: The American  Chemical Society [CL: Right]; the main professional society.  I mean 
I’m part of [CL: Right] a couple others, but those are… 
CL: Right.  Okay um, so my next question was going to be how did you come to this 
definition?  Um, we’ll continue to do it in two steps.  So your general understanding 
before you began your research was…? 
I7: I think general understanding was mostly shaped generally by some of my personal 
ethics and a lot of looking, observing others who were in mentoring positions or 
colleagues and both negative and positive modeling [CL: Yeah].  Like this thing about 
not giving people credit for ideas.  I’ve seen actually that it’s given very little importance 
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to.  I was once actually told by a research mentor of mine that you know, “Well why did 
you say that these were you know, in your group presentation you said you know, all of 
these are, this idea was somebody else’s and that idea.” And I said, “Well they were.”  
Because I was relatively new at that time [CL: Right], I wasn’t going to come up with 
[CL: Right] many of my own ideas.  And he saw this as something inherently negative.  
Uh but [CL: Hm] yeah, so be it. 
CL: Right.  Um I mean it sounds like your other understanding of professional societies 
has come through your research [I7: Yeah] and education, right? 
I7: Yeah, yeah, yeah.   
CL: Okay. 
I7: And the other and I’ll should add, the other couple of things that it’s come into is that 
I’ve done a lot of work especially with Clemson’s Office of um, the IRB Office.  So I’ve 
given some talks on, on um, God, ethics and mentoring and things like that.  So between 
that and thinking about what are, what are the ideas that I would want my students to 
leave with as far as what’s acceptable and what’s unacceptable. 
CL: Okay, so research you’ve done on how to teach ethics, right? 
I7: Well it’s just, just mostly a reflection on what you would want you know, want your 
research students to get out of.  Because [CL: Right] by my modeling, they’re going to 
take things away [CL: Right] by how explicit I am about letting them know, okay this 
behavior that you see is very purposeful  versus you know, that some other behaviors that 
are just kind of incidental. 
CL: Right.  Okay um, when you think about how to ethically do research, does any aspect 
of communication come to mind? 
I7: Yeah every aspect, especially written communication.  That’s one of the biggest 
things to me because that’s where you can either purposefully or inadvertently do things 
that are unethical.  The inadvertent thing is that sometimes you, you, you end up uh 
plagiarizing an idea and not realizing that this has been published before.  
CL: Accidental plagiarism. 
I7: Yeah.  And then of course you can purposely do that too.  But I, but I think it goes  
back to even in verbal communications, if you’re talking with just an informal 
communication let’s say with a, with a peer at a conference.  I think it’s important to be 
as careful in again, citing people’s ideas that you’re using rather than leave them with the 
impression that this was your idea or your insight [CL: Right].  I think it’s really 
important to give people credit for their insights that you’re using. 
CL: Right.  Okay.  I think you just did this, but in terms of the ethical, a definition of 
ethical communication in science.  It sounds like sharing ideas and giving credit for 
them? 
I7: Yeah.  I think. 
CL: I don’t want to put words in your mouth.   
I7:  Well I think it’s mostly making sure you give appropriate credit for the ideas.  I think 
the extent to which you share your research results sometimes, unfortunately, becomes a  
lot more complicated [CL: Right].  Just because there are – my field is much easier, not 
just my field, also the nature of what I do is unique in the sense that no one does research 
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on graduate students and their development.  So I’m not worried about you know, 
research competition because nobody’s, nobody does the type of research that we do. 
CL: So your – to make sure I understand your research, graduate student development 
within the study of chemistry or…? 
I7: Yeah, yeah [CL: Okay].  So, so basically what we study, we mostly study graduate 
students for a lot of methodological reasons, but what we’re interested in understanding 
is, how does scientific expertise develop [CL: Ah].  So based on that you know, I worry 
about some things that if I weren’t a more conventional area of science that you worry 
about, which is that you know, you’re racing against somebody else so to speak.   
CL: [Inaudible 0:11:58.0]. 
I7: Yeah.  [CL: Yeah].  So we don’t really have that issue [CL: Okay] for the most part.  
So I don’t, for the most part, have to think about what to withhold and what not to.  What 
I am learning more of having to sometimes withhold things or when it comes to writing 
grant proposals [CL: Yeah].  It turns out that you sometimes want to show that you’ve 
actually done more work you, so the proposal, you want to have a certain amount of work 
to show that you know, as in proof of concept [CL: Right].  So if you were publishing 
something, you would withhold that.  Excuse me, or you would just withhold the 
manuscript period.  Which, I think fundamentally, a lot of these things are you know, just 
games that you are playing and they’re unethical, but it’s also unfortunately something 
I’m having to learn because just trying to understand the whole funding game.   
CL: Yeah.  Um did you learn how to communicate ethically in the same way that you 
learned of the definition of research misconduct?  Was it from observation of others? 
I7: Yeah mostly.  Yeah.   
CL: Or were you formally taught? 
I7: No.  
CL: Okay.  Are you aware that there are governing bodies like the Office of Research 
Integrity of the Office of Science and Technology Policy?  That they have published 
definitions of research misconduct? 
I7: Yeah.   
CL: Do you know what they are? 
I7: No.  I couldn’t offhand tell you. 
CL: Okay. 
I7: And for that matter, I could not tell you offhand what my professional society’s 
definition is either. 
CL: So I guess that answers the question, are the rules that regard research ethics that 
come down from above, do they affect how you communicate as a scientist? 
I7: Probably from the societies, not that much. 
CL: Okay.  As a scientist, are you concerned about ethical communication practices? 
I7: Yes. 
CL: Okay.  And in going a little more specific, I’m going to go back to authorship, which 
you brought up.  Is authorship an important issue or concern as you do research and 
publications? 
I7: It is mostly to make sure that my students who work with me are appropriately 
represented.  And fortunately I have not had any sort of real sticky situation to you know 
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where two people have done almost the same amount of work and how to divide that up 
or whatever.  So I’ve been fortunate that until now that things have been very clear cut.   
CL: Yeah.  For [inaudible 0:15:18.9]. 
I7: Yeah, for, for… 
CL: What do you think researchers should consider when they make authorship 
decisions? 
I7: I think original, intellectual contribution to the work because there’s a difference 
between a lot of times people may do – so there’s original and intellectual contribution 
and what is considered, by your field at the time to be part of the cutting edge.  So I’ll 
give you a couple of examples.  So what I don’t always necessarily think should decide 
authorship is how much work you did [CL: Okay].  And the reason is because there are 
people for example who are technicians who often do a lot of work, but they don’t take 
any intellectual responsibility for any of the results or thinking about okay, what am I 
going to do next depending upon what, you know, what the outcome of this experiment is 
or whatever. 
CL: So they’re just basically lab workers [I7: Right], people figuring out the data. 
I7: Right.  Now they deserve authorship, but not primary authorship [CL: Okay] because 
they don’t – now um they um – oh and the other thing is that who provides the resources.  
So both resources of, not just financial resources, but literally access to being able to do 
research. 
CL: Both.  [Inaudible 0:17:10.7] in the lab or... 
I7: Right.  So for example when I was a graduate student, if I did not have my PhD’s 
mentor’s group to work off of, I could not dependently do any research.  So he deserves, 
he’s providing all of this infrastructure [CL: Right] to be able to do the research.  So you 
know, he deserves a certain amount of credit for that. 
CL: In your field, is there a difference, is there, there’s a primary author you mentioned.  
Is there anybody else in the rank of importance?   
I7: So yeah.  It really depends on how – and this becomes, especially when you’re – 
actually I was talking about this with somebody today, when you’re trying to hire people, 
this can become a huge issue of trying to interpret what authorship the – what to people 
authorship actually means.  Because there’s a corresponding author and that’s primarily 
the person who is essentially, at the end of the day, responsible, takes responsibility for 
the work.   
CL: The corresponding author. 
I7: Yep.   
CL: Where are they placed? 
I7:  Well see it depends [CL: Oh okay]; sometimes at the beginning, sometimes at the 
end.  I place mine at the end when I’m the corresponding author.   
CL: So it’s not standard that’s to your point to why it’s different for hiring [I7: Right].  
You don’t know… 
I7: Right, because if somebody, there are some people, let’s say if you have four students 
working on a project, there are some people who will just list them alphabetically, except 
that there are others who will interpret this, oh you’re the first author, so you have the 
greatest contribution to this.  So that’s the problem that there aren’t standard [CL: Right] 
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practices.  Even though there are dictates for standard practices there are – and if you 
read the, you know, each journal has definitions of how authorship should be.   
CL: I was going to ask.  One of my questions is have you looked into the journal? 
I7: Yeah and they’re very vague.  They’re almost, I would say, purposefully vague [CL: 
Oh].  Because what happens is that they will basically say that they’re you know, they’ll 
use a term like you know who, based on contribution, well that assumes you can agree on 
the contributions [CL: Contributions].  That’s, that’s uh… 
CL: So even within the field, even within something specific like chemistry education 
[I7: Absolutely], you’re still not sure? 
I7: Yeah absolutely in every – so this becomes a real problem.  Now for me, going back 
to this issue of how to what the state of the art is in the field.  So I’m part of, before I 
came to chemical education, I was synthetic organic chemist for a while and then I lived 
as a biologist for a few years [CL: Wow].  And there was a time in biology that if you 
could isolate a protein – well there was a time, if you could isolate a protein purely, you 
got a Nobel Prize.  So the person who isolated insulin got a Nobel Prize [CL: Yeah].  But 
even – and you know, and that was 56 years ago now – but even 20, 25 years ago, if you 
isolated a protein that was a PhD dissertation; just literally isolating it, no other.  But 
nowadays, it’s become so routine that it does not even merit mention in a publication 
[CL: Wow].  Even though it’s a lot of work [CL: Right].  So, that’s what I meant by what 
your field considers state-of-the-art; I think that.  So you may have isolated a protein and 
done all of the work to get to that point, but if you don’t do anything that’s original to 
your field at the time, it’s not worthy of primary authorship. 
CL: Okay that makes – I’ve talked to a couple of people who have talked about reagents 
and using someone’s reagent [I7: Right] or someone’s really well-developed mouse [I7: 
Mhm] the more important that reagent or mouse is, the more likely they are to get 
authorship [I7: Right].  But they’re not that important, possibly. 
I7: Yeah, so I mean like you know nowadays like a lot of people look at citations and 
things like that.  So Albert Einstein is one of the least cited authors [laughing] and part of 
it is part of his work is in the common domain of knowledge.  You don’t need to cite it. 
CL: That’s interesting because we still cite Plato in our papers [laughing]. 
I7: Right, yeah.  So… 
CL: It’s common domain, but he also gets a book.  Okay, so you have researched 
authorship guidelines.  Mainly, did you go to these journals’ Web sites? 
I7: Yeah.  Yeah. 
CL: Okay.  And you’ve kind of touched on this, but do you have a story in which you 
felt, you personally felt, unfairly represented as an author? 
I7: Uh, kind of.  And the reason I say kind of is because I, I agreed to it for – so when I – 
the first research group that I – I, I took a very circuitous route to my PhD because I 
thought I wanted to be a synthetic organic chemist first and in that research group, my – 
so it was a huge research group of 45 individuals and so what my advisor did at the time 
is he had every new student attached to a post doc [sp?] or senior graduate student.  The 
post doc that I was attached to – sort of typically what happened was that, that meant you 
got attached on an advanced project which was going to be at the completion you’d get 
your name on a paper pretty early on [CL: Oh okay].  It wouldn’t be primary authorship 
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more than likely; it would be secondary.  But nonetheless you would still have the 
publication very quickly [CL: Right].  What happened was that the post doc guy that I 
worked with, he – it was in a weird situation where he had, because of stroke of luck or 
whatever, had very few publications; I think one publication prior to this.  And he asked 
me if I would stay out, off of the paper and I agreed to.  At the time I agreed because if 
figured oh you know, I’m at the beginning of my PhD and I’m sure I’ll publish a bunch 
of things with this guy [CL: Right].  But I left his research group without ever publishing 
anything with him [CL: Ah].  So it’s not something I necessarily – I don’t regret it 
because I can say that everything I published is my own work [CL: Yeah].  So, so you 
know, it’s not that I did essentially technician work for somebody. 
CL: But that’s interesting.  He was negotiating based on what he needed [I7: Yeah].  Is 
that, so the negotiations are often about – is it job concerns?  Is it power plays? 
I7: In his case, it was job concern.  I don’t know, a lot of times I mean, there isn’t much 
negotiation amongst students per say [CL: Right].  It’s the advisor who often will 
dictatorially decide what happens.  The only other thing and I don’t think this is 
necessarily unfair, but it just happens that I was part of some work that was done that just 
never got published.  And it’s novel, it’s publishable or at least it was at some point.  But 
again, it, that doesn’t bother me because I was a sophomore or I just finished my 
sophomore year, I didn’t have a lot of intellectual contribution to that, so even though I 
may have done the first experiments, I didn’t have any intellectual contribution.  So it 
doesn’t really, like in any of these cases, it really doesn’t bother me per say.  Even though 
that technically I would have been considered, I should have gotten a publication [CL: 
Right].  But like I said, at the end of the day, it doesn’t. 
CL: And do you think part of the reason it didn’t is because you changed fields so it 
didn’t affect your job or your colleagues as well or do you think they just weren’t – you 
were publishing enough that you didn’t need those early ones?  Or…? 
I7: No not publish – I wouldn’t say not because of being prolific [CL: Okay].  Part of it 
may be because of changing fields, although it would have helped to have these other 
publications.  But I think partly just because of arrogance maybe [CL: Okay], of being 
able to say you know, what I have out there is mine [CL: Is enough] and not that it’s 
somebody else’s stuff that has my name slapped on it. 
CL: Right, right.  On the flipside, can you walk me through a time, maybe recently, 
where you felt you were fairly represented as an author?  Kind of the process that… 
I7: Yes.  So the, the um, I did some assessments/evaluations for a, one of the engineering 
departments and so I was working with a couple of their faculty members and so when 
we put a manuscript together – I mean it was really weird in that we never had an explicit 
conversation, but when I got a, one of the versions back from them, I had my, I was a 
corresponding author.  Which, given the fact that basically I collected all of the data, I 
taught them how to analyze the date, you know, all of that [CL: Right], I think I deserved 
that, but I didn’t have to fight for it or anything. 
CL: Right.  In engineering, are those journals also recognize a corresponding author, a 
final author, as the…? 
I7: The corresponding author is the person to whom – any time you have the 
corresponding author, it’s assumed that you are, this is your… 
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CL: Right is it labeled corresponding author?  Is it just known that that’s the last guy?   
I7: No so the corresponding author is not necessarily the last person [CL: Okay].  You’ll, 
it’ll be specifically labeled. 
CL: Labeled.  Okay.  Because it’s my understanding that some of the journals are starting 
to really require you to spell out the contribution that every author made [I7: Right].  It’s 
kind of where they’re going.  Okay, do you have any stories; of course you don’t have to 
mention names of colleagues who may have had a very unfair or bad experience with, of 
authorship? 
I7: Yeah, too many [laughing] to actually… 
CL: So it’s prolific? 
I7: Yeah.  It is.  And I think because things are not very well defined and most of us are 
not aware of the things that are defined.  Like you know, you ask me the questions about 
you know, whether I could say anything about the guidelines of you know, certain 
Offices of Research Integrity [CL: Right] or even my professional society.  So I would 
say I’m in the minority of people who are even aware that they exist [CL: Yeah] and but I 
wouldn’t be able to even tell you word one [CL: Right].  And then I think when you add 
on the fact that when, I think what a lot of people do is they go to – well they either go to 
the journal or they model basically what their PhD or post-doctoral mentor did [CL: 
Right].  And like I said, the journal to me, I don’t – I’m not a conspiracy theorist, but I 
think it’s almost purposely, purposefully vague so this way they don’t really have to 
adjudicate anything and they leave it up to whoever is submitting the article to fight it out 
between them. 
CL: Figure out themselves, yeah.  I had one question for clarity.  Right now you’re 
studying chemistry education.  Are you actually doing, is any of it like quantitative lab 
work or are you more… 
I7: No, I simply I, the only research I do is education research. 
CL: Do you – this is kind of off topic – but do you still get, you still get [inaudible 
0:30:34.1] scientist, yes?  
I7: Yeah, I do.  That’s been, so one of the things I study is professional identity [CL: 
Yeah].  And so that has been, that’s been an interesting thing in my development of that 
because there are times I did consider myself a scientist and times that I haven’t [CL: 
Right] you know and times that I am again.   
CL: Is your PhD in chemistry or is it in ed? 
I7: It was in the chemistry department, but my dissertation was in, it was an education 
topic.   
CL: Interesting.  Okay um, well those are my formal questions.  Just to kind of debrief 
you, what I started looking at is what the governing bodies define as research misconduct, 
which FYI is falsification, fabrication and plagiarism, FFP and has been since they first 
defined it in the ‘80’s.  But I was beginning to come under an understanding that 
authorship and communication ethics were actually of great import and I wanted to talk 
to scientists to see if they actually were important and then try to, wonder should we be 
teaching authorship guidelines, should we be discussing communication ethics more and 
then should these government bodies include authorship or communication among this 
definition; falsification, fabrication and plagiarism?  Plagiarism hints at a communication 
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and publication issue.  But it seems to me maybe that a lot of ethics are tied into the drive 
to publish, the drive to get credit so maybe those are so important that the governing 
bodies should – or that – they’re so important that maybe they should become taught just 
like fabrication is bad. 
I7: Yeah so where, where the difficulties are, are some of it rests on – so for example now 
National Institutes of Health, National Science Foundation both require explicit training 
[CL: Yes].  Except that, what does that explicit training mean, you know?  So… 
CL: Is it an online training tutorial like the PI thing where like you just click through?   
I7: Yeah, where it’s like a, the thing is it’s like um, for students, when they’re early in 
their career, for a lot of places that even do give some lip service to that, they’ll have 
students take a course in their first year of graduate school; which is inadequate at that 
time.  It’s the equivalent because where you actually have to think about things, about 
what would you do when you’re invested three months into your PhD degree, it’s real 
easy to say that you’d walk away [CL: Right].  When you ask an 18-year-old who’s 
dating somebody for three months, you know, what would you do if your partner cheated 
on you?  “Well you know, I’d throw his or her ass to the curb.”  [CL: Right].  You ask 
somebody that’s been married 20 years and has three kids and get a very different 
response.  So it’s the same type of thing that [CL: Yeah], you know, four years into your 
PhD that you’re going to think twice about just walking away and throwing that time 
away [CL: Right].  So my wife is a psychologist and that’s what her PhD is in and they 
do training, what I think is definitely more effective.  So what they do in their first year is 
they basically do the, the, their professional society’s guidelines.  So basically what 
they’re teaching you is so called rules in your first year.  And that’s you know, I mean 
you’re ready to, you know you’re smart enough at that point [CL: Right], where you can 
– and then you’re in your third year, then the, in, so part of your, she’s a counseling 
psychologist, so what they do is every term they have practicums where they actually 
counsel, they’re in a clinical setting.  And as part of their third year of their practicum is 
they revisit their ethics and ethical situations.  And now you have some experience, it’s 
[CL: Right] not abstract anymore.  You’ve been with it; you’ve been in the wild so to 
speak.  And now you can actually start thinking about well, what would I really do.  And 
I think that’s much more, much more effective. 
CL: Right.  I was – especially with the role that authorship and the drive to publish play 
that I’m finding play in your ethical decisions.  Maybe working with people once they’re 
actually working on publications or once they’re negotiating how this works or once their 
data doesn’t show what they wanted it to show and [I7: Right] they’re deciding how to 
write up the paper.  Maybe that should be another discussion. 
I7: Exactly and the other thing which comes with this is that, which often gets ignored is 
that so if you’re going to talk about let’s say scientific ethics in this issue of fabrication, 
falsification right?  So when you do any research, you collect probably conservatively 
you know, anywhere from 500 to a 1000 times material than you’re actually going to use 
finally in whatever you disseminate [CL: Right].  And it’s perfectly ethical to exclude 
things, but how do you exclude it [CL: Yeah]?  That process and understanding that 
process, presumes understanding of certain, not just the ethics of your field, but how 
knowledge in your field is created and how it’s – and which is essentially that type of 
 146 
training is nonexistent [CL: Right] in the sciences.  It is kind of assumed that by doing 
science, you automatically know this.  And we’ve seen, both from research that we’ve 
done with graduate students and research now that we’re doing with faculty, how little 
they know and how much they’re modeling basically what they get from their advisors. 
CL: That’s interesting.  Our fields kind of overlap there, because a lot of research I’ve 
been doing for this and then goes into scientific communication is you know, how is a 
fact relayed – how does it become fact.  So what are the rhetorical powers that a scientist 
uses to establish something as this is fact.  We don’t technically just discover something.  
You witness it and then you frame it in such a way that everyone agrees with you that it’s 
true.  And so we study a lot of the rhetorical [I7: Right] techniques that establish that 
credibility and like the credibility of the scientist itself and how that makes us more 
likely, if the person’s already published a lot, we’re more likely to believe them and 
persuasive [I7: Right] a lot of that stuff is what I’ve been looking – is my background 
research going into this.  But in a sense, you made a, just because you’ve known this, is 
the distinction between scientific or research ethics versus communication ethics.  And 
that’s you know, what I’ve been looking at.  But I guess I’m starting to see that they 
really shouldn’t be separate camps. 
I7: It can’t be [CL: Yeah].  Because one inherently involves the other.  Because again as 
you start trying to define those things, you have to be able to look at what you know, how 
you’ve actually processed the data. 
CL: Right.  So that sets you apart from some of your peers is that understanding. 
I7: So it’s just dumb luck mostly.   
[laughing] 
CL: Well I really appreciate your time today. 
I7: Absolutely. 
CL: And I didn’t even realize I’d come across somebody who is doing this and it’s really 
helpful.   
I7: I have a favor to ask you then. 
CL: Yes. 
I7: Would you mind touching base with a student of mine who’s doing the project on the 
faculty perceptions on contributions?  So we’re doing a research project on science and 
engineering faculties’ perceptions of contributions and um God, in the context and how 
credit is assigned in the context [CL: Oh] in the context of a scientific collaboration.   
CL: Wow, okay yeah.   
I7: So I think there might be some good overlap. 
CL: Yeah. 
I7: So her name is Andrea Verdan [sp?].  And… 
CL: V? 
I7: E-R-D-A-N. 
CL: Okay. 
I7: So if you don’t mind, what I’ll do is I’ll drop you an email and introduce you through 
email.  Out of sheer narcissism, I’ll send you the paper that we published I think last year.   
CL: Yes.  No I… 
I7: Where we looked at ethical development of graduate students.   
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CL: That’d be fascinating.  Thank you.  What journal did you publish that in? 
I7: That was in Chemistry Education Research [inaudible 0:40:00.2]. 
CL: Okay.  That’s another problem I’m having with this is that it seems all the different 
journals have had articles talking about authorship.  American Scientist, I don’t know if 
you saw [I7: Mhm], that happened in the middle of my interviews so it keeps coming up.  
So most of the journals take, give some lip service, give an article periodically about 
authorship and there have been more recently [I7: Right], but again they don’t agree with 
each other, the editors, there’s a council of publication ethics where the editors are trying 
to agree on stuff.  But to your point, it’s pretty vague [I7: Yeah].  But from what I’m 
finding most scientists don’t even bother to look at the journal understanding.  So it’s – 
what I’m wondering now too is does it even matter what oversight boards say or is it 
more just a discussion among people? 
I7: No on the oversight because most people aren’t even aware [CL: Right] of the fact 
that there is even an oversight board [CL: Right] let alone what they say.  Yeah, one of 
the other things about this issue of what happens when – you know, in the training itself, 
I mean one of the reasons we did this study was that when I – so in Oregon, they actually 
tried to do some training in ethics and but it was for the first year grad students [CL: 
Okay].  I taught it the two years that I was there.  It was an awful experience.  Not 
because of the students, but because number one they were at a point where you know, 
most of the, most of the responses were you know, I would leave [CL: Yeah] the program 
if you know.  Because all of the, and the scenarios are all abstract [CL: Right] so for 
example, talking asking a graduate student to decide how you dole out authorship is kind 
of ridiculous because they don’t they’re more often than not, they’re, they don’t have the 
power to make that decision. 
CL: Just the understanding of how a department works [I7: Right], the power plays and 
who’s on your committee, personnel committee, who’s determining your jobs.  It all gets 
a lot trickier when you’re… 
I7: Oh yeah.  And then I had one of my senior colleagues who, you know he was very 
well meaning , but you know, he came in one day and he talked about you know, what 
you would do when you’re you know, applying for a faculty position.  These folks are in 
their second quarter of graduate school.  They’re purely trying to make it through their 
first year [CL: Yeah].  They’re not thinking about they’re going to be a professor and 
what they have to do to put their dossier together [CL: Right].  So and so you know, the 
National Academy publishes a lot of stuff [CL: Yeah], but all of these case studies are not 
applicable to more often than not, students.  So what we wanted to find out is what are 
the ethical challenges students believe that they face, and see if we can eventually build 
something off of that rather than what their professors think could be potentially 
important - which is usually irrelevant. 
CL: Right.  Do you do anything with identity development?   
I7: Yeah.  Yeah, we’ve done some work on that; very interesting. 
CL: Because that’s what my husband does, student perspectives based on whether or not 
they perceive political bias in the classroom [I7: Mhm].  So he studies their [inaudible 
0:43:40.8] development and if they think that professors are biased.  Not that professors 
are actually biased [I7: Right], but if students think it. 
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I7: We’ve studied only professional identity development [CL: Okay], not all of identity 
[CL: Right] before we’ve left that.  So… 
CL: Interesting, stuff all overlaps but we’re in such different fields. 
I7:  Yes.  Well I’ve talked to Steve quite a bit [CL: Okay] in some other things that we do 
and on representation.  So he’s been really helpful [CL: Yeah].  So… 
CL: Um, let’s see I had one more, oh in biology all the biology students have to take 316 
I think it is, which is writing in the sciences [I7: Mhm] that Dr. Katz [sp?] and Dr. 
Tosinardi [sp?] kind of oversee and then – it’s English professors who teach it.   
I7: So 314.   
CL: 314? 
I7: Yeah.   
CL: English lecturers teach and it’s how to write biology and there are some ethical 
discussions about publication and credit and then how your responsibility to speak to 
different publics, you know, the everyday person versus your colleagues, and there’s 
some discussion.  Do chemistry or any of the other programs have a writing course? 
I7: Chemistry is required to take 314. 
CL: Okay so it’s the same.   
I7: Uh but there are several things about the English department because of budget cuts 
and their personal limitations, want to take that off the books.  The [CL: Oh] other thing 
is that, and this is nothing about – no reflection on the instruction – I don’t think the 
students get a lot out of it because they go in there disengaged.   
CL: It doesn’t apply to them, quote unquote. 
I7: Well either it doesn’t apply or just that there are other priorities [CL: Yeah].  When I 
was in graduate school, my penultimate year I took some statistics, and as I’ve said, the 
only thing that I got out of that was a wife [laughter] because what happened was it’s not 
that I – so of the two semesters, the second semester, the instruction was quite good.  But 
it had nothing to do with him.  It, I, it didn’t matter how good the instructor was going to 
be, I was, I had so many things going on and I knew that if I don’t really use it, I’m not 
going to really learn it anyway.  I knew I wasn’t going to use it any time soon and I knew 
I have enough of a technical background that just knowing how to do well in math, I 
could do well in the class [CL: Yeah].  The interesting thing is that fast forward whatever 
many years, um I, who did exceptionally well both semesters, asked my wife who barely 
scraped by with a B, questions about statistics because I don’t remember anything [CL: 
Okay/laughter].  But then again, it has nothing to do with the instruction, it was that I 
chose to be disengaged [CL: Right].  And so what happens is that our students, they take 
it at a time when they’ve got so many other things going on that they just don’t 
understand how this is going to fit in because they can’t fathom writing a research article 
for themselves or whatever at that point. 
CL: Right.  So it’s similar to the ethics training [I7: Yeah] timing.  
I7: Right.  Yeah, that it’s just, it just doesn’t you know… 
CL: Is your proposal that they take a class like every year or that it gets worked in a little 
bit throughout?  Have you reached that point in your research?   
I7: I think it has to be worked in at different times.  Theoretically you know, I don’t think 
every year.  What it would do is just saturate people [CL: Yeah] and you get to the point 
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where it’s just, again, you’re just going through the paces again.  Um but I think the 
problem with the sciences is we’re in a culture of telling rather than asking and these are 
types of things that getting students to reflect is a hell of a lot more powerful than tell – 
because we all, I mean, it doesn’t take a genius to know that if I copy something off of 
your paper on an exam that I’m probably breaking the rules [CL: Right/laughing] you 
know?  But the question is that what are the things that I actually face?  And you know, 
think about just this process of just doing this interview.  How many times did I go back 
and say, “Oh well there’s this other thing I do” or you know [CL: Yeah].  So you know, 
it’s by provoking somebody to think about it then there’s construct thinking about what 
are the things that they actually face and have these you know, holy shit moments of “Oh 
I’ve never thought about it” [CL: Right] “and I don’t know how to think about it” [CL: 
Right] and whatnot.   
CL: So that’s what y’all’s work is with the engineering faculty is? 
I7: No the… 
CL: [Inaudible 0:48:31.6]. 
I7: Engineering faculty was, yeah that was just… 
CL: Oh that was the same paper you already accomplished. 
I7:  Yeah.  Yeah. 
CL: Yeah, okay.  Great, I will look that up.  Are you the main author on that one? 
I7: Yeah, but I’ll send it to you. 
CL: You can send it to me.  Perfect. 
I7: Drea [sp?] is actually the first author, but I’m the corresponding author. 
CL: [Laughing] Fair enough.  By the way, that’s different from every field, but nice. 
I7: Really, yeah. 
CL: In computer science, it’s always alphabetical. 
I7: Yeah, so that’s, that’s the thing you know.  
CL: And as such… 
I7: And in chemistry it just depends on what your advisor likes to do.   
CL: Which is – how do you move on when you switch jobs or…? 
I7: Well that’s the problem because you’re going to interpret the way you feel like 
interpreting because this is how I do it [CL: Right], so obviously that’s what this article 
means.  Yeah. 
CL: Well thank you for your time [I7: Sure] and I again [I7: Sure]… 
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 Interview 8 
May 20, 2011 
 
CL: …Recorder.  Um so what I’m doing is, I’m looking at communication ethics in 
science and I’m getting my Masters’ Degree in communication.  So we study a lot about 
how scientists write or should write or don’t write.  And I was doing my research on this 
and realized I needed a scientist’s point of view.  So that’s what I’m here to look for.  I’m 
interviewing a handful of scientists to get your perspective.  So this is totally what you 
personally think or have encountered.  Share as much or as little or if you think I’m 
asking the wrong questions, feel free to divert me [I8: Okay].  And if you don’t mind, I’m 
going to take notes just in case this you know [I8: Oh, I don’t mind] freaks out on me.  
All right, my first questions are just some basic demographics, which is to state your 
name please. 
I8: [name removed].   
CL: And what’s your title at Clemson? 
I8: I’m associate professor in department of genetics and biochemistry.   
CL: Okay and what’s your field of research? 
I8: I am a molecular parasitologist.  [Laughing] 
CL: Is that the same thing [name of another scientist, a personal friend] does? 
I8: Oh, same idea. 
CL: Same idea, yeah. 
I8: Yeah. 
CL: And how long could you say you’ve been publishing your research? 
I8: Uh okay so, I’ve worked on parasites for my PhD as well.  So do I go back… 
CL: Yeah. 
I8: Back to then also? 
CL: Yeah if you were published. 
I8: Um oh yeah, so since 1992.  So that was a long time ago.  Is that 20 years? 
CL: Just about.   
I8: Oh man.  Okay. 
CL: [Laughing] And while I can check your C.V. online, can you name me a couple of 
the journals where your work has been published? 
I8: Sure, I’ve published in the ENBO Journal, which is a pretty good one.   
CL: ENBO? 
I8: E-N-B-O J. 
CL: Okay. 
I8: And the Journal of Biological Chemistry for example. 
CL: Okay, perfect. 
I8: And those are both pretty good.  
CL: Yeah.  And were any of these articles co-authored or co-researched with other 
people? 
I8: All of them [laughing].  
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CL: And have you ever received funding for your research from an organization outside 
of Clemson? 
I8: Yes. 
CL: Which ones, if you can name a few? 
I8: The NIH, American Heart Association, Rockefeller Brother Foundation, um, that’s 
about it. 
CL: American Heart for parasitology? 
I8: Mhm. 
CL: That’s cool. 
I8: One of the parasites we work on causes heart disease. 
CL: Really? 
I8: Yeah, in Central and South America and in Southern Texas and in Florida.   
CL: That’s fascinating! 
I8: Yeah [laughing].   
CL: Do people know they have a parasite? 
I8: No.   
CL: Wow! 
I8:  Yeah [laughing]. 
CL: Wow.  I’m from Texas and the joke is always like, if there’s anything that’s going to 
hurt you, like any creature that’s going to hurt you, it’s in Texas. 
I8: Yeah, pretty much.  It’s true. 
CL: They migrate elsewhere, but they start in Texas.  Okay, jumping in, how would you 
personally define research misconduct? 
I8: Oh I don’t know, boil it down, lying, cheating, stealing.   
CL: Yep. 
I8: I mean it’s pretty straight forward.   
CL: Okay.  And how did you learn this definition?   
I8: Well learn.  Um… 
CL: Or come up with or come to? 
I8: Yeah.  I mean I think as a 2-year-old I was taught what was right and wrong.   
CL: Yeah. 
I8: And I had good parents.  I just don’t see how it’s any different than the way someone 
in a normal civilization, you know, civilized society behaves [CL: Yeah].  You tell the 
truth you know.  It’s, to me, it’s, there really is not a distinction between everyday life 
and research in a way. 
CL: That makes sense.  Okay.  So when you think about ethical research practices, 
working as an ethical scientist, does any aspect of how you communicate come to mind? 
I8: Sure, sure.  I mean I think you have to have, you have to be completely transparent in 
everything you do and that means you know, that goes from having no books that are 
thoroughly documented as far as you know, documentations about what you have done 
exactly all the way to in public presentations, not overstating what you’ve discovered.  
And I think you can look at the Wakefield case, right? 
CL: Yeah. 
I8: Autism, and really learn about – I mean there are some gray areas of ethics.   
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CL: Yeah, oh yeah. 
I8: And I’m not going to defend that guy [CL: Right]. But some, in some cases, I can see 
people not understanding what’s ethical.  But you certainly, at that point, if it’s at all 
questionable, you need to seek advice, right?  And that’s what mom and dad didn’t teach 
me… 
[Chuckling] 
But certainly, the IRB we’re talking about here you know, that document may have 
surprised you that you needed to have, right [CL: Yes]?  Given that you’re not touching 
me [CL: Right].  But you can learn about it right [CL: Right]?  And do the right thing.  
Go find out about it [CL: Right] before you do it. 
CL: I actually am probably one of the few people who is really fascinated by the IRB 
process.  Like the things you have to do online [I8: Yeah.  Yeah, yeah], the course you 
have to learn.  So if I said how did you learn to be an ethical communicator in science, 
you’d say the communication came more from training? 
I8: Uh, I think it includes, and this sounds really ridiculous, but includes my upbringing, 
right [CL: Yeah]?  But I do think having mentors who are clearly straight shooters you 
know, that don’t participate or even tolerate any sort of misleading behavior.  You know 
it’s, that helps.   
CL: That’s not [inaudible 0:06:02.4].  Um, do you have a definition of ethical 
communication?  Is it be transparent?  You said be transparent and don’t overstate.  
Would that be…? 
I8: Yeah I mean I think that’s fair.  That sums it up.   
CL: Okay.  Are you aware that there are governing bodies like the ORI, the Office of 
Research Integrity or the OSTP, the Office of Science and Technology Policy?  Do you 
know that they publish a formal definition of research misconduct?    
I8: Uh so am I aware?  Yes, I’m aware.  I don’t know what they are so I’m on the IBC, 
which is the Institutional [inaudible 0:06:40.1] Safety Committee [CL: Ah].  And so we 
deal with a lot of NIAG’s, which I think the groups you mention also are entirely 
attached to those groups, right? 
CL: I believe ORI and OSTP are the like most senior oversight [I8: Right].  They’re part 
of the Department of Health and Human Services 
I8: And I’m familiar with them because of things like in Nature Magazine [CL: Yeah] 
they talk about people losing the ability to apply for grant funding because they cheated 
or lied or stole something [CL: Right] or you know, they misbehaved [CL: Right].  So 
that’s where I really know them.  I’m not surprised  
CL: Institute of Biosafety or International Biosafety?   
I8: No, it’s the Institutional Biosafety Committee. 
CL: I haven’t come across them. 
I8: And we deal mostly with recumbent DNA and then dangerous chemicals and things 
like that.  People have to get approval from us at Clemson, to do experiments.  And that’s 
where transparency is really important you know?  You’ve got to go to us first.  
CL: So you partner with the IRB?  Like they have to get both levels of approval? 
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I8: Uh the IRB is going to be a different channel [CL: Okay] but parallel, yes [CL: 
Okay].  So if you were going to give me a drug, that part would come through both IRB 
and us [CL: Okay] or a recombinant thing.   
CL: So do most – do all universities have some kind of biosafety committee? 
I8: Absolutely. 
CL: Okay.  So you apply on the university level?  
I8: Yes. 
CL: Okay. 
I8: Gotcha. 
CL: Do the rules – these rules that you learn – you said you weren’t aware of ORI’s, but 
from IBC that sort of thing, do the rules that regarding research ethics affect how you 
choose to communicate? 
I8: Yes [CL: Yeah], they do.  I tend to think, and this might get me in trouble and that’s 
okay, what you publish, what you write, has got to be precisely correct and honest.  I tend 
to tolerate in public presentations like posters and talks, a little more this is preliminary 
data kind of talk [CL: Right].  Even from my own group.  I don’t object to that because if 
you say it’s preliminary, that means it’s not published, therefore it’s not gospel, right? 
CL: It has been peer reviewed?   
I8: Right.  And as long as you say that I think you can get away with an experiment that 
doesn’t have enough replicates or things like that, just to provide the audience you know, 
some juicy tidbit that may or may not be play out right.  It could be exciting.   
CL: The conversation should come before the paper, right? 
I8: Absolutely, yeah. 
CL: As a scientist, would you say you’re concerned with ethical communication 
practices? 
I8: Am I concerned?  I am concerned because I am selfish, right?  I’m concerned because 
I think my group plays by rules and I think there are people who don’t and that in the end, 
can influence the number and quality of publications you have and therefore the amount 
of grant funding and  you know, if we’re not all playing on the same level field, it’s not 
exactly fair [CL: Exactly].  So I guess I would be concerned. 
CL: Okay.  Kind of taking us in a little bit more, specifically to authorship, would you 
say that authorship is a… 
I8: Could we back up just for a second?  I think the tenure promotion thing also is, is tied 
into that and I think it can be bad.  The pressure to get tenure and to have a job and you 
know, I have a friend who is at a big university who has a very sick child and who needs 
to be at a big university because of the medical system.  If he doesn’t get tenure you 
know, it’s bad news for his child too [CL: Wow].  So the pressure on him is immense.  So 
the field has got to be absolutely level or he is going to be cheated.   
CL: Right.  Or he is going to be tempted to cheat. 
I8: Or conversely right?  He, he right.  He may say everybody else is doing it you know 
[CL: Right]?  And so I’m telling you, that tenure promotion system, in my opinion, is 
really broken frankly [CL: Um].  Anyways… 
CL: Is it… 
I8: And I’m tenured [laughing]. 
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CL: Is it, in your field, is it based on, is it quantity or quality?  I know some departments 
are like how many publications, others are how the top, the tier of the journal, the more 
rank you are as author. 
I8: I think, in our department, it’s an ‘and’ [CL: Okay].  So there has to be some amount 
right, demonstrating breadth of effort or something.  But I do think you, publishing in the 
Bi-Lo [sp?] shopper doesn’t count [CL: Yeah, right].  So…so, so yes, a combination of 
those things [CL: Okay].  And our department’s small enough where we know the weight 
of various journals [CL: Right] and we appreciate that.   
CL: Right.  So it sounds like, that you backed up you kind of answered my question on 
the importance of authorship.  To research a publication you would say yes it’s important 
because it’s about your job. 
I8: Right.  That’s how I’m evaluated [CL: Right].  But it’s funny, placement and 
authorship in our field is important too. 
CL: Can you tell me how your field does order?  Because I’m learning it’s different in 
different fields. 
I8: Yeah, it is.  So the first author and the last author are the two, sort of, main 
contributors.  The last author tends to be the senior person who perhaps directed the first 
author, right and provided the funding and probably mentorship.   
CL: And the first is…? 
I8: The person who did the lion’s share of the work [laughing] and the writing, typically.  
And everybody in between, in theory, is supposed to have contributed something that is 
essential to the publication of the paper.   
CL: That’s one of my questions, contributing something essential [I8: Yes], what kind of 
considerations do people do you think people personally should make when considering 
authorship? 
I8: Uh okay, so is data from somebody in the middle, in a figure?  Does it make up a 
figure?  And could the paper stand up without them?  So those are some important 
questions, right?  But I’ve noticed again, this, I’m starting to straddle a couple of different 
fields, which is new to me [CL: Yeah].  So I’m sort of this kinetics guy who now is 
playing with medicinal chemist types.  And there, I ran into occasion where a guy made a 
compound, years ago, that we needed [CL: Yeah].  He wanted to be an author on our 
paper.  You know, you’ve made that compound; you’ve published it in 30 different 
journals you know?  But yet our paper wouldn’t be as strong without it [CL: Right].  So I 
mean I could see it in both ways.  He’s getting these throwaway publications and has you 
know, on his C.V. 200 thumbs [sp?], but it’s all junk you know [CL: Right]?  But 
everybody in that field does that.  They make an important compound and then they 
claim – you know, stick a stake in it and say [CL: Yeah] “we don’t do that.”  [CL: Oh 
okay].  I, I, I was hired at Clemson primarily because of reagent [CL: Yeah].  They didn’t 
know that at the time but that’s why I was hired and… 
 
CL: Because your reagent was getting used. 
I8: Yeah.  And it’s still used and we don’t get complications from it.  That’s the way it is.  
It was published once and then some people had – they got advice from me on how to use 
it, maybe I got a few authorships out of that but then you know, the reagent.  So… 
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CL: Is that trend, with the exception of this guy, does that tend to happen when you do a 
reagent or a mouse or something that’s really important, it gets published for a few times 
while people use it, but after that it kind of becomes common knowledge? 
I8: Yeah, well I think formally, it’s, if the NIH pays for it, it becomes a reagent after it’s 
published one time [CL: Oh okay].  I think there’s some courtesy where for example, the 
reagent that I made, some people needed a fair amount of help with it.  They sent people 
up here to use it [CL: Oh okay].  So then I have contributed to their effort [CL: Right].  
But everybody else, people in Germany who are using it, I just sent it to them and they 
just [CL: Okay]…  They acknowledge you sometimes.  In the acknowledgments they say 
‘Thanks to Jim [CL: Right] for this’, but I don’t get authorship. 
CL: Okay.  So you have, if your data's used in a paper or if the paper can't stand without 
you.  So you don't have to write to be an author. 
I8: No but I think you need to read and edit and - so here's where I'm torn and I don't 
know the answer to this.  I'm sure that it's available, but I don't know it.  You look at 
these giant labs that have 20 post docs and 20 graduate students and then this guy who 
runs it and he's on the end of, the last author on every paper [CL: Right].  What does he  
know about that paper, right?  And that's where we have, I mean we can look at well the 
guy who runs NIH, Francis Collins had a kid, made up a lot of data in his lab you know, 
they had to retract all kinds of papers [CL: Ah] and, and, and you know, Collins is not the 
one who's cheating, it's this student. 
CL: But technically your last author doesn't have any ownership of the… 
I8: You have looked at this paper and you agree with what it says.  But, but his case is 
that, I think, and you know, I don’t know but I think it is, is that I have to trust the data 
that the kid was showing me [CL: Right].  And if the data was falsified, nobody would 
know that.  Well so at some level, the middle authors are going to have to be - I mean, I 
know in the Wakefield paper there are a couple of those authors who said, "No thank 
you" anymore [CL: Yeah].  They realized all this stuff happened.  And, and how can you 
know from afar, what's really going on [CL: Right]?  But it's sort of your job to keep an 
eye on it you know.  And, and… 
CL: When you've been author in the middle as you said, do you get a chance to read the 
paper before it's submitted? 
I8: Absolutely.   
CL: Are you expected…? 
I8: You better [CL: Okay].  I mean - yeah. 
CL: Okay, um… 
I8: But you know, at some level you read the paper and you're in the  middle and you 
don’t know day-to-day what happened to get the data [CL: Right], you just see the data 
and you're like any other reader in a way.   
CL: Right.  You just have to assume. 
I8: So it can be dangerous.  You have to have you know, some working relationship with 
the people that are involved.   
CL: Right.  Um have you ever researched authorship guidelines?   
I8: Sure.  Journals right?  Journals have these.  And maybe I'm not answering the 
question.  
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CL: No that's… 
I8: But the journals provide  guidelines about who they think should be an author and 
who shouldn't.  And some of them now are asking for explicit you know, what did you 
contribute to write this out [CL: Right].  And, and you know, it's just as much or as little 
as design and development of the paper.  You know, what does that mean [CL: Right]?  
With the talk in the hallway about some key idea you know.  But still they want you to at 
least look it. 
CL: Is that online that you go look at the…? 
I8: Yeah.  And I think it's in part to fight this idea that people add senior folks to help in 
their cause right?  If I have a paper that some very senior on it, views are going to be very 
different [CL: Right] than if it's just me.   
CL: Paper.  Does that apply to grants too?   
I8: Uh, it can, yeah.  Yeah. 
CL: So in theory, if you gifted authorship to this senior person [I8: Right] on the journals 
that require you to state what they contributed, do people just kind of say [I8: Well, well] 
oversight or ideas or do they not do that because it gets…? 
I8: Well I don't know, but if I were to do that I would definitely make sure that they 
contributed intellectually [CL: Yeah] whatever that means.   
CL: Right.  Okay personally, have you ever felt unfairly represented as an author?  Either 
in the order or whether you were included or not or how it's published or where the 
money went, I mean there's a whole bunch of… 
I8: No, not personally.  No.  I, I have seen, as an observer, and this is hearsay, you know 
I've seen where in a lab that I was in, in my past life, where two folks were invited to be 
on a paper; a student and a mentor.  The mentor said, "No" and he said the student should 
stay on it because she contributed something significant.  He said no because he didn't 
agree with the conclusions of the paper [CL: Oh].  And it didn't hurt the student because 
she was providing you know, a key figure that was not misinterpreted according to him 
[CL: Okay].  That's how he justifies it [CL: Okay].  But I haven't had that problem.  I 
mean it's, I have good colleagues [laughing]. 
CL: Yeah.  Fair enough.  Um so can you walk me through on the flipside of time when 
you felt fairly represented as an author?  Like how that process goes? 
I8: Okay so the stuff from my lab, I feel for sure, right I mean, that, that's… 
CL: If it's from your lab, you're always last author. 
I8: Yeah.  Uh I'm always…well, so far.  I mean I would say that in fairly, I have provided 
the funding and a lot of the sort of theoretical drive behind experiments right?  I mean, 
it's sort of my ideas also.  So that's fine. 
CL: So does everyone know that when the experiment starts, when the paper gets done? 
I8: Do my students know that?  Yes.  And they're the people I'm published on.   
CL: That you know that and okay.   
I8: Yeah. 
CL: Okay. 
I8: So recently we published a big collaborative effort along medicinal chemists and the 
funding line came directly out of my lab.  So I was the last author.  But the first author 
was not someone from my lab [CL: Oh], which was kind of interesting [CL: Yeah].  And 
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uh, but again, these people are working at the University of Pittsburgh and I've been to 
visit them.  We had a very close working relationship with them and we still do their EPA 
[sp?] and it's, it's the kind of dream collaboration that you can imagine [CL: Yeah].  
We're always on the phone with each other and we know what's going on so it's almost 
like an extension of my group or I'm an extension of theirs.  That's the way it should be 
and it's been great. 
CL: And it's, it… 
I8: Is this blinding you, by the way? 
CL: No, no you're fine [I8: Okay].  And it's been really amicable authorship order and 
[I8: Yes, yes] - okay. 
I8: And I think the near future presents a new challenge 'cuz now there's a new group, 
there's a third group involved [CL: Ah].  So we did this one thing with the group in 
Pittsburgh and that was fun.  The third group comes on board to provide all these, some 
more expertise or something else and now so there're really three parties and I don't know 
how it's going to play out because there's not three places to put people [CL: Right].  And 
one of my students was heavily involved in this project and I'd like her to go first, but you 
know, I don’t know how it's going to play out.  It may be that we take a bigger story and 
break it into littler pieces, which at some level you have to have ethics.  That too, but 
um… 
CL: Are these discussions that are happening?  Do y'all sit down and talk about 
authorship order or is it assumed and then contested later or…? 
I8: Mm, I don’t know how it's going to work out.  We again, have conference calls and 
all the parties involved, I really like [CL: Yeah].  It really helps that we get along [CL: 
Yeah for sure].  We see, I mean, everybody's aware of this [CL: Right] so we sort of 
danced around it and it's not, it's not going to be bad.  I think what will happen is the 
medicinal chemist will have a paper that is stand alone that could have been rolled into a 
giant paper, and they'll take the lead authorship on those and then we'll take sort of the 
biology side [CL: Yeah]; us and Pittsburgh [inaudible 0:21:54.9] [CL: Right] you know.  
And it'll work out.  I mean, at the end of the day, we're working on a neglected tropical 
disease that nobody cares about [laughter].  So what we care about is trying to help some 
folks out in Africa right [CL: Right]?  So… 
CL: So the authorship of that.  Um… 
I8: Uh, for me, I'm tenured now, so it doesn't - I mean I hate to say that 'cuz for [CL: No, 
that's] grants it does, right?  [CL: Right].  It needs to be clear that it came out of my 
group, but if I don't know, I'm not going to suppress some beautiful publication just 
because I'm annoyed about my position. 
CL: Okay.  And you touched on this with the story of the mentor student in your lab, but 
do you have any circumstances that stand out where you've heard about a colleague or a 
peer that got really unfairly treated as an author?   
I8: Mhm. 
CL: Are you willing to share any of those? 
I8: Mm, I mean I, so sure.  There, there, I think it comes down to interpretation of data, 
right?  And I had heard where there were two local colleagues and a third party that was 
off campus you know, in a different place.  And one of the local colleagues said, "I don't 
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agree with the way you guys are interpreting this."  And so the solution was not to 
address it experimentally, but rather just to dump it [CL: Oh].  And because it was in part 
a philosophical, but not entirely, in my opinion [laughing], but you know I can see it 
from, I tend to try to look at things from both sides [CL: Right] and I can see the issue.  If 
you don't agree with this complaint, this person is going to complain until you're 
paralyzed you know [CL: Right].  And what do you do?  And if what they're suggesting 
you do takes another two years well, and it may not answer the question.  I, we're in such 
that, the thing's so fluid that you've got to act [CL: Right] right?  So, but [CL: That's 
interesting].  That really, to me, is a really gray area [CL: Yeah].  We deal with 
committees too.  I don't know if you, if you're graduate committee [CL: Yes].  You know 
this, right [CL: Yes].  You got a committee member you don’t agree with or he's being a 
pill about your thesis, you know what you should do?  Kick them off and replace them.  
CL: It's easier said than done, right.   
I8: Well, but you can do that [CL: Right].  And - your boss can do it.   
CL: Well my husband's [inaudible 0:24:18.6] committee had a few bumps along the road.   
I8: Yeah.  So what was his…? 
CL: There was a committee member who was too busy to show up to anything except for 
the defense and then at the defense raised concerns that should have been raised back at 
the proposal level and so, but his chair was the least senior member [I8: Yep].  So she 
didn't feel like she [I8: See, tenure] - yeah, very tenure related and so it became, he got 
caught up basically in politics and had to do a revision that should have been something 
that was cited a year before. 
I8: Hey, not to get too nosey, but what program since we're being open? 
CL: He's in [department removed] [I8: Okay] is what his PhD is in.  He's actually um, 
works at Clemson now. 
I8: Oh cool.   
CL: So yeah.  Actually everyone… 
I8: Do I know him?   
CL: Do you know [husband’s name]?   
I8: No.  Okay.  'Cuz I know some new people who are over at the office that get mad at 
you when you break rules.  And they're all education leadership people too, I think.   
CL: The office gets mad at you when you break the rules.   
I8: So it's the integrity office [CL: Yes].  Yeah, yeah, yeah. 
CL: One of the, Dr. Fishman's on my committee [I8: Okay].  She's head of the Rutland 
Institute [I8: Okay, cool].  Yeah.   
I8: All right, anyways, I'm sorry. 
CL:  But yeah, no that's okay.  And actually most of the people on his committee have 
now left Clemson, but it was just, it was very educational for to watch him go through the 
process and learn about the effects of tenure and power and… 
I8: Well okay, so… 
CL: And committee ethics.   
I8: I'm a science nerd [CL: Yeah] in high school, college, always a science nerd.  Guess 
what?  I have tenure now.   
[laughter] 
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I can be a bully. 
[laughter] 
Bully.  What's going to happen when you grant somebody, who forever has been 
squashed, now some sort of authority.  Well they're going to be complete jerks just 
because they never had it, socially or you know? 
[laughter] 
I mean I just, the system is so broken [CL: Yep].  So anyways. 
CL: Well now you've answered my questions and basically to let you know what I'm 
looking at is um, so the Office of Research Integrity and the OSTP, those two big 
government oversight, their definition of research misconduct is fabrication, falsification 
and plagiarism - FFP and have been since the '80's when they first defined it.  But, based 
on publications that have come out and conversations I'm having with scientists, seems 
like authorship mainly is a really big issue or an issue of import that causes a lot of these 
gray areas.  And I'm hypothesizing maybe even that the drive for authorship is what 
causes the falsification, fabrication and plagiarism.   
I8: Certainly I think maybe not authorship in the middle, but you know, authorship to 
tenure [CL: Yeah] that process to grant… 
CL: The drive to publish.   
I8: Is, is I think drives most of it.  But, but you know, and again, I think this is sort of off 
the record but you can include it, I don't care.  We have found that it's a societal thing too 
[CL: Yeah].  Um you know, back when I went to school it snowed all the time and I 
walked up hill both ways right [CL: Right]?  And that kind of thing.  But now there is a 
monster out there, this database of information that a lot of us don't know how to handle 
and, and a lot of us being even the new generation and as graduate coordinator in our 
program, I saw a lot of plagiarism that was inadvertent [CL: Yeah].  Right?  We have the 
machine, turn it in in other programs that will hunt the stuff down.  You know, it's 
unbelievable like what those programs can do.  And there's a new one even related to 
science papers that I know you - this guy made this algorithm where they look at all these 
science papers and they can see who's copied their own stuff in intros over and over and 
over. 
CL: It's self plagiarism.    
I8: Yeah.  Yeah, yeah, yeah. 
CL: That's a real interesting side issue. 
I8: But I, I, I, what we have found is that in, in to be fair, we most identify the people 
who are nonnative English speakers first.  And that's not fair, but so obvious [CL: Yeah] 
that they'll do some exercise and the grammar's perfect in some area [CL: Right] and 
you'll say this is - but then turn it in and boom, they've copied it off the internet without a 
reference.  Well there's a lot of that that goes on in society that's tolerated.  Just not here 
in the U.S. so explain that issue [CL: Ah] is a bit tricky you know [CL: Right].  It's, it's 
breaking a habit that is longstanding.  It's their entire lives right [CL: Right]?  Because 
they're young and they've been doing this forever.  The idea being, why rewrite 
something when it's perfectly written anyways, right?  I mean, I can kind of understand 
where it comes from, but, but it… 
CL: Well we'll tolerate it as long as you cite it. 
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I8: It's insidious.  I mean it's - is that the word I want?  Recipient.  Yeah so anyways, you 
know the word I'm looking for [CL: Yeah] right?  To the point where you know 
Wikipedia, you can almost - so these large classes that I teach, these Intro to Genetics 
classes, you'll have them do extra credit and you can almost look at Wikipedia and find 
those answers in the stack [CL: Wow].  And you know, it's, it's not cheating it's just the 
way we do it.  We communicate by copy and pasting and, but in my opinion it's… 
CL: It is. 
I8: It's plagiarism. 
CL: Plagiarism, yeah. 
I8: And, and holistic people gets run off the, you know they get mad [CL: Right]!  Run 
them up and say this is plagiarism and I'm going to get, you know I've warned you about 
it.  You can't copy from the internet.  But, but I do think both at the societal level where 
different societies tolerate this differently and then the age group you know?  I, I'm an old 
fogey.  And I, I have to somehow be sensitive to that right?   
CL: Our, our ways of learning how to collect information were different than our current 
generation. 
I8: Right.  I mean I learned in a library in fifth grade that you had note cards [CL: Note 
cards] and you write down something and you know, you'd write where you got it [CL: 
Yeah].  Then you'd glue the note cards together on - you know, that old thing [CL: Yes] 
and that's just not the way it's, that's not the way it's done now.  It's so easy to and that 
doesn't make it right.  I'm just saying it's an interesting [CL: Right] problem.   
CL: It's making an [inaudible 0:30:06.4] plagiarism.  I mean that's why Turn It In exists. 
I8: Okay, but to see some of these papers that have come out.  In Science and Nature they 
talk about them, these things that were um, cobbled together science papers that are all 
other people's data.  And you can never, because of the volume of it, discover them [CL: 
Right], right?  Until now there are these, these programs these guys have written that 
really were not - they were looking for um, I don't know they were sort of database 
mining base programs that were converted into looking for cheaters [CL: Wow].  And 
there have been some articles about them and you know, some of these papers are 
completely fabricated and, and I understand again coming back to this tenure thing, it's, 
it's all tenure and it's all grantsmanship [sp?].  Those things are what really creates 
corruption because without those things, you can't be powerful right?  And without power 
you're going to be the science geek you were in high school, you know? 
[laughter] 
You know I mean, I understand the motivation is, and it's longstanding and it's just 
human nature [CL: Right] to be in charge. 
CL: In our field, often if you just write the review paper, that's where you're going to get 
all your citations, so every few years you write a review paper to up your citations and 
everything.   
I8:  Yep.  I don't know, it's true in our field too so it's not, it's a little bit different, but we 
have you know, impact factor [CL: Yeah].  Well how does a journal crank on its impact 
factor?  Well you get people to submit reviews [CL: Reviews], the reference and then 
their impact factor goes way up [CL: Right].  It's a complete bogus you know. 
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CL: But I, one of the scientists that I know is in a field where you know, on Google now 
you can search for an article and it'll tell you how many citations it has and they actually, 
it goes in their tenure file, their number of citations.  So the quantity [I8: Yeah] does… 
I8: Well I, my, my, one of my resumes, one version of my C.V. has, it's a um, so there's a 
group of a thousand scientists who had this journal called whatever, Thousand Scientists 
Journal, I can't remember [CL: Right] the name of it right now.  It's off the top of my 
head, but anyways, they read papers that they think are of note and give them some sort 
of score [CL: Oh].  You know this is a meritorious paper um, and so I include that about 
the papers that are being considered and you know, that [CL: Right] what does it mean?  
Well nothing.  It means who have I talked to in that group or who do I know on that 
panel.  You know?  I, but yet again, it's all about power, prestige, blah, blah, blah [CL: 
Right], tenure.  There's no way around it.  I don't know how unless you give everyone 
pie, you know a piece of the pie [CL: Right].  Here's your grant money every year and 
[CL: Right].  And some people aren't cut out to be scientists [CL: Right, true].  But that 
should have been figured out a long time ago I think. 
CL: And so your peers filter you out. 
I8: Yep.  So. 
CL: Well thank you for your time.  This has been great. 
I8: Good. 
CL: And that's what, like I said, I'm trying to get ten of y'all and I think I have eight now.  
And it's been really fascinating how the fields are all different or authorship order of 
fields is different.   
I8: Well you'd get a different answer from somebody in my field perhaps.  I mean I… 
CL: No and it's, it's, part of it's the personal angle of it.  I mean, I'm, if I wanted to know 
what all scientists thought, I'd do a giant survey but I'm trying to get just some ideas 
through interviews.  For example, computer science, they list authors alphabetical.  No 
question. 
I8: Oh wow.  So how do you figure out who did what?  Or you just know?   
CL: You don't really care. 
I8: Oh. 
CL: You've all worked on it, you put it alphabetical.  They did say, every once in a while 
you'll put an asterisk next to somebody if they really were first author. 
I8: Wow. 
CL: But in, when they work with other fields, they enter into this conversation and then 
people start to care and not care and it gets tricky.  And then I spoke with another field 
where no one has agreed on whether or not there's a last author.  So you don't know if, for 
example, someone's applying for a job and they were last author on similar articles, you 
don't know if that meant that they were the corresponding most important or if they were 
applying to journals that just did alphabetical or if they just didn't care because there's no 
regulation in that field.  So while some people might be arguing over it, other people 
don't care but then how do you know?  How do you compare? [I8: Yep, yep, yep].  So it's 
[I8: Wow] something as little as order.  See I guess I'm wondering is if these government 
oversight bodies should start putting author regulations as part of like the very most 
senior things that they look at.  Or if at least they should elevate the importance of 
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communication among, besides just plagiarism, but like how you present your data.  How 
you share your information [I8: Ah].  Should that be regulated?  Just… 
I8: I mean so the meetings we go to are really interesting 'cuz there's been a, an evolution 
in this.  I won't keep you, but it's, so for example, if you identify every protein in an 
organ, a couple of years ago, what would happen is the person would say, "We've 
identified every protein in this organ using this new technology and here they are.  Here's 
the list" and it would be numbers, would not be informative [CL: Yeah].  Number one, 
number two, number three.  And you'd say, "What is number one?" And they'd say, "We 
can't tell you.  Sorry.  Come see me afterwards and we'll talk about it."   
CL: Because they couldn't share?   
I8: Because they weren't willing to share [CL: Okay] because somebody would scoop 
them [CL: Right].  They put all this effort into identifying them and then somebody 
sitting out in the audience would, would and their fear was having stuff you know, stolen 
[CL: Right].  Which that must have happened because they did it.  And then some of the 
organizers in these big meetings we'd go to every year, got up and said, "You can't do 
this.  This is a waste of our time."  And it is a waste of our time.  Except I understand you 
know [CL: Right, right].  So then how do you handle that?  Well you encourage people 
not to scoop, but you know, it's, again, it's about greed and you know pride and all this 
stuff because by golly I identified every single one of them.  But you know, I can't study 
all those. 
CL: Right.  But that's part of the balance too because the, scientific paper from my 
understanding is supposed to present your data in such a way that someone else can 
replicate it.  
I8: This is a talk. 
CL: This is a talk, right. 
I8: This is not, so many people have taken this preliminary data thing to an extreme 
where they don't show any data.   
CL: Just so it's a progress report? 
I8: Yeah.   
CL: My father-in-law is a meteorologist and he always says when he was on review 
committees, "I hate when people tried to publish progress reports and not final." 
I8: Yeah, yeah.   
CL: But interesting. 
I8: Yep.   
CL: Yeah it's a, it's, and back to the internet, when things want to get shared it can go all 
over. 
I8: Boom! 
CL: Yeah.  Yeah.   
I8: Gone. 
CL: You need to hold onto it tighter. 
I8: Yep.  You used to have to ask somebody for one of their manuscripts you know, if 
you didn't have a subscription to the journal which you didn't have them all right [CL: 
Right].  You could send them a letter and you'd say, "Can I have a copy of your reprint." 
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[CL: Right].  And some way you knew who was looking at your stuff.  In some way.  
Not, it wasn't entirely that way, but nobody asks now.  You know 'cuz you've got all… 
CL: That's only like 20, 15 years ago.   
I8: Yeah. 
CL: Yeah.   
I8: So. 
CL: Shocking. 
I8: Right.  Okay. 
CL: Thank you for your time. 
I8: Yes ma'am. 
CL: It's been fabulous.  I appreciate it. 
I8: And your timing is perfect.   
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 Interview 9 
May 18, 2011 
 
CL: Okay, I'm studying communication ethics in science and as part of my thesis in 
professional communication program and I was writing about how scientist work and 
write and think and realized I needed a scientist's point of view.  So I'm conducting 
interviews, trying to get various fields of science represented.  For just your personal take 
on communication ethics and some related stuff that we'll get to with the questions.  So 
before I get started, do you have any questions? 
I9: No, no.  Not at all. 
CL: We'll start with some basic demographics.  Your name? 
I9: [name removed]. 
CL: And your title at Clemson? 
I9: Assistant Professor. 
CL: Of…? 
I9: Biology I guess. 
CL: And your field of research? 
I9: Um, developmental biology.   
CL: I've never heard that term.   
I9: It, it refers to how embryos develop and the processes [CL: Ah] involved in taking an 
organism from a single cell to, to when it's born.   
CL: Okay.  And how long have you been publishing your research?   
I9: Eleven years.   
CL: Okay.  And though I could check your C.V. online, could you name me a couple 
journals where your research has been published? 
I9: Development [CL: Oh] yeah, Developmental Biology, [CL: Okay] I wish I could say 
Nature Science and so on, but… 
[laughing] 
CL: Not yet. 
I9: Not yet.  Yeah.  [laughing] 
CL: And of these articles that have been published, were any coauthored with other 
researchers? 
I9: All of them except one.  And I think there's sixteen of them.   
CL:  Okay.   
I9: Ish.  [laughing] 
CL: Right.  And then have you ever received funding for your research from an 
organization other than Clemson? 
I9: Yes. 
CL: Which ones? 
I9: NIH [CL: Okay].  The Wellcome Trust. 
CL: Welcome? 
I9: Yeah, W-E-L-L-C-O-M-E.  It's the biggest biomedical charity of the world.  It mostly 
operates in the United Kingdom. 
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CL: Oh, okay.  Yeah, okay.  Great.  Now jumping into the more involved questions, how 
would you personally define research misconduct?   
I9: Uh, it's a really hard topic [CL: Yes].  I find it very hard.  Um, in my opinion, it's any 
point where you misrepresent your data.  Data is always data.  How you interpret it is 
another thing entirely [CL: Right].  And that's why I publish in peer review journals, 
because hopefully if I am misthinking something or there's something I don't know, they 
can point it out to me and then I can update my interpretation.  But the data is the data.  
And how you collect that data and present that data has to be completely ethical.  You 
have to be able to repeat experiments.  That's a big problem is sometimes people publish 
stuff and no one else can repeat the experiment.   
CL: Because the [inaudible 0:03:52.1/cross talking]. 
I9: That doesn't necessarily… 
CL: I'm sorry.  Because they didn't share enough information or because it's not actually 
replicable? 
I9: Sometimes it's not replicable because the person who collected the data lied [CL: 
Yeah] um, and, and you know, usually it's not replicable because there's some sort of 
issue [CL: Right].  It's not that you know, the chemicals don't work in one lab but they do 
in another or so on.  Usually it's because something's wrong. 
CL: Right.  Perfect.  And how did you come to this definition or understanding? 
I9: There is nothing formally written down about the rules.  So most of this comes from 
my mentor.  Starting you know, as an undergraduate student and moving all the way 
through personal [inaudible 0:04:50.7] training.   
CL: Starting as undergrad? 
I9: Yeah.   
CL: Did you have the same mentor the whole time? 
I9: No.  I [CL: Oh okay] had different mentors, but every single one of them has you 
know, stated very much the same thing.  And, and that's a good thing [CL: Right] because 
you hear it again and again and again.  Then you know um, you know it really ingrains it 
into you.  And of course, as you start writing your own papers, you start questioning your 
mentors and saying, "What about this?" and "How does that work?"  But I would say that 
there is no set of written rules for communication ethics in research biology, at least. 
CL: Right, right.  Okay so when you think about ethical research practices, does any 
aspect of communication come to mind?   
I9: Um… 
CL: You mentioned interpretation.  How the data's interpreted.   
I9: Yeah.  You know, so there's many different types of data.  There's images [CL: 
Mhm], images are a huge problem.  Most of the journals in our field now employ 
software that determines how an image has been manipulated.   
CL: Wow.  Interesting. 
I9: Yes.  Statistics are another huge problem.  Mostly because biologists don't actually 
know much about statistics. 
[laughing] 
CL: It can be really misleading though.   
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I9: Oh absolutely.  You can use statistics to tell people what you want them to hear [CL: 
Right] so you  have to be you know, a bit careful.  Um, you know, many of my scientist 
friends say that science is self-correcting because when someone tries to repeat your 
experiment, they get a very different result.  Then you know, you have to figure out you 
know, who's right and who's wrong and, and what's going on.  And it creates doubt [CL: 
Right].  But this isn't always because there's something wrong.  It's just because of 
interpretation [CL: Right] and you know, when there's twelve hypotheses for something 
and you're trying to you know, shore up your own pet hypothesis, it can be um, it can 
take a while before we can reach a consensus.  So you know, but that's a good thing.  
That means you  know, we're trying to find out what the reality is.   
CL: Right.  It seems you put a lot of import in the role of your peers. 
I9: Absolutely.  Yeah.  I mean, you need it because no one scientist can know everything. 
[Chuckling] 
Well there's some that thing they can, but… 
[laughing] 
You know, knowing you know nothing is the beginning of wisdom so [CL: Yes] that's 
the path to wisdom.   
CL: Right.  So would you have a definition of ethical communication in science? 
I9: I would say that ethical communication has nothing to do with the truth.  Rather, it 
has to do with accuracy, repeatability, I was going to add another word but it's lost.  Um, 
and the, I guess that you recognize that your interpretation may be incorrect.  I think 
that's something that's very important for scientists to actually admit [CL: Mhm] is that 
maybe I've got this wrong.  If somebody comes up with new data, then you know, we'll 
have to change our outlook. 
CL: Right.  How did you come to this, to this definition of ethical communication?  So 
the same as mentors at school?  Or…? 
I9: Well um, I've you know, we're not really taught ethics as scientists, um, I have a 
friend called Scott Gilbert who has written a book on um, ethics and evolution.  That's a 
very good textbook.  Of course I've done Clemson's ethics course as well. 
CL: IRB or a different one? 
I9: It's the one run by the institute of… 
CL: Right.  The Rutland Institute. 
I9: Yeah.   
CL: Okay.   
I9: But I think that ethics are something that I teach my students all the time.  I talk about 
the ethics of research in lab meetings.  When we talk about how to present data for a 
paper, I talk about the ethics.  You can change your picture this way, but you can't change 
it that way [CL: Right].  But in awful lot is pretty much word of mouth. 
CL: Right.  Okay.  You mentioned no formal rules.  I was going to say, there are 
governing bodies like the Office of Research Integrity, ORI and the Office of Science and 
Technology Policy, OSTP.  Are you aware that they actually have published definitions 
of research misconduct? 
I9: I wouldn't say I was consciously aware of it, I'm aware that they must have, but they 
have no impact on my research or how I communicate my research whatsoever. 
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CL: Okay.  That answers two questions right there.   
[laughing] 
All right, my next one is do the rules affect how you communicate, so I'll say no.  As a 
scientist, are you concerned about ethical communication practices?   
I9: Of course.  Of course, you have to be because there's money in science and there's 
power in science.  At any point, people are trying to keep a job or get a job or get a grant 
or move to the next step in their career.  Ethics is always a problem.  There's, there's a lot 
of pressure, especially in younger scientists to succeed.  And it's very tempting to make 
the data up because you think that is what your supervisor wants [CL: Right].  And that's 
why you have to constantly communicate with your lab and classes you teach about the 
ethics. 
 CL: It's interesting because you said you don't feel like you formally learned it in school, 
and yet you make it a point of teaching your students in school.   
I9: Well I think because my mentors made it a point of teaching me. 
CL: Okay.   
I9: It's something that was talked about regularly, openly you know?  There was no 
secrets.  It was like, because the thing is, is that if you, if you lie, you're going to be found 
out.  Maybe not this year, maybe not next year, but eventually and retracting papers 
because they are false, there's false information in them, that'll kill your career [CL: 
Right].  And so it's very important that you instill this in young scientists from the 
beginning because one mistake is all it takes.   
CL: How does it kill your career? 
I9: Um, because people know that you've lied.  People know that you're prepared to 
manipulate the data to get where you want to be. 
CL: So they won't work with you?  Or they won't hire you? 
I9: Yeah, they won't work with you.  You go in a blacklist with the journals, they won't 
publish your work, um grant awarding agencies can sanction you with things like you 
can't apply for grants to them for three years, five years, ten years.  And if you can't get 
grant money, you're finished.  
CL: Right.  Okay.  Going specifically from general communication ethics to authorship, 
would you say authorship is an important issue or concern to you in your research and 
publication? 
I9: Um, in what aspect?  You mean which author is on the paper or…? 
CL: It's, mm, it's kind of up to you to define.  People have talked to me about authorship 
order [I9: Mhm] or generally the drive to publish, to be an author, to have your name on a 
paper at all. 
I9: Right.  Okay, well let's deal with those first two.  So in my field, there was a 
convention of authorship. 
CL: What is that convention? 
I9: The first author is generally the person who did the work.  Who physically sat there 
and did the experiments [CL: Wow].  And they would also, so for example they'd be a 
graduate student or post doctoral fellow [CL: Okay].  They would also be expected to 
have intellectual input.  In fact, all authors on paper should have intellectual input into the 
paper.  They, you know, they may have done experiment number two, experiment 
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number three, but they should know what the entire topic is about.  And then the senior 
author, in other words the last author on the paper, is usually the principal investigator, 
which is me. 
CL: Right.  So that's interesting.  That's a little different than other fields in that first 
author might be a low level student if you will, but if they were the ones in the lab every 
day, day in, day out doing it then they would get a first author. 
I9: Yeah.  I have published with a technician as a first author, but basically that person 
did the work. 
CL: Right.  If there's more than two authors, how is authorship determined within those? 
I9: Authorship is determined by the intellectual contribution and the amount of work 
contributed to the paper.  Usually when we're doing this research, we have discussions 
about who has, in you know, quote, unquote "ownership" of the paper.  Because you give 
a project out to a single person, but sometimes that person may supervise an 
undergraduate for example.  Now we don't put undergraduates on paper generally unless 
they've made a significant contribution.  Then for the more senior authors, usually there's 
only the PI so I'm always the senior author.  But if we've collaborated with another lab 
for example, it's a very important thing that right when you start collaborating, you have 
discussions and you write to each other to determine authorship.  So if my… 
CL: So even before the research is done? 
I9: Absolutely.  It's, it's critically important because people assume and that makes an ass 
out of you and me [CL: Mhm].  And often when it comes to actually publishing the 
paper, they find instead of being an author, they're suddenly in an acknowledgement.  
There's some huge feuds in science because of those kind of miscommunications.   
CL: Right.  Right.  So that's regarding order.  You said you might also touch on just the 
drive to be an author; the drive to publish.  Is that a concern? 
I9:  Um, I'm just a very driven sort of person anyway and I believe that if the science is 
good, it should be published.  And one of the reasons I believe that is the public is paying 
for this research.  And so the research needs to be made public.  Also, it depends on 
which country you, you get trained.  In the U.S., it's expected that you will publish as a 
first author prior to getting your PhD.  And so for students to be successful and move on 
to the next phase, which is a post doctoral fellowship, particularly in my field, there's 
really no hopping straight to a tenure track position or faculty position of any type.  
Unless you've published, you can't really prove to the people in your field and people 
you're applying to for jobs that you're actually worthy.  And given the intense 
competition to, to get that next job, even I, I get, I get several applications a month, 
emails, people asking me you know, do I have a job.  And one of the first things I'll do, if 
I think they're at all interesting is I'll have a look and see what they've published.  And if 
they've published nothing, I'm really not interested because only people who've published 
generally have the motivation and the determination to succeed in this field.  But of 
course, that does create problems because it opens up temptation to get the publication.  
And, and of course the thing about young scientists is, and young people in general, is 
they cannot see things from our perspective.  I've read everything.  If, if they copy 
something from another paper and put it into the paper, I can usually recognize it [CL: 
Right].  And our technology's given us the, the help in order to determine plagiarism [CL: 
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Right].  And in fact, I never submit a paper or a grant, even if I write it myself, without 
running it through Turn It In or ET or one of the other plagiarism detectors.  And it's not 
because I think I'm plagiarizing, it's just that sometimes you copy and paste something 
and you forget to paraphrase it or [CL: Right] or even reference sometimes.  And so you 
know, it's nice to be able to use technology to help me. 
CL: Right.  Right.  Have you ever researched authorship guidelines?   
I9: Hmm, I've done some of the um, research uh, what is it called?  The program we have 
here.  Um, responsible conduct of research [CL: Yes] and they've given a, a  number of 
um, um, if only I could talk English it would help so much wouldn't it. 
[laughter] 
A number of references online and so on.  And of course, the other thing is that if you're 
going to publish in a journal, it's always a good idea to read their [CL: Right] definitions 
so that you know what they expect. 
CL: You read it online? 
I9: Yeah. 
CL: Okay.   
I9: Yeah.  I certainly don't read you know, paper books about this.  It's all online.   
CL: Right.   
I9:  In our field… 
CL: Do you find they all have different definitions? 
I9: They do. 
CL: Okay.   
I9: For example, some journals will require a statement at the end of the paper detailing 
what the individual scientists or individual authors contributions were [CL: Right].  So 
you know, I may have conceived the study and written the manuscript and you know, 
first author number one um, did all of the experiments and number two author did 
experiment three.  And they actually require you to detail this is an attempt to stop senior 
authors from let's say for example, the department head, saying any paper you publish 
has to have my name on it [CL: Right].  And that has been pervasive and they're trying to 
get rid of it.  The other thing is sometimes what will  happen is that a lab with lower 
standing will try and get a well-known author onto their paper.  They will offer them a 
gift authorship as it were, in order to try and raise the profile of the paper.  And of course, 
that's completely unethical.   
CL: Do you think the listing of author's contributions has helped curve this?  Or do 
people…? 
I9: I think it has.  I, I think that the publishers themselves have done a lot to raise 
awareness of who should be on a publication.  It also depends on how you do your 
science.  I mean some labs are what we call factory labs.  So person number one will do 
all the sequencing and person number two will do all the mouse work and person number 
three will do all the histology.  And so every paper they publish has every worker in the 
lab on it.  I, I prefer to publish based on you know, individual contribution [CL: Right].  
But as I say you know, there's nothing wrong with running your lab in the factory way.  
It, it just depends on the type of research you're doing. 
CL: Right.  Have you ever felt unfairly represented as an author?   
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I9: No I don't think so.  Occasionally I haven't been on  paper that I thought I should be 
on [laughing]. 
CL: Yeah.  Like in the acknowledgements but not authorship? 
I9: Yeah and that, that tended to happen when I was a younger scientist.  I guess the you 
know, the PI I  was working for felt that my contribution wasn't sufficient.  I felt 
differently, but you know, that's okay.  I, I, I think you know, because when you're 
young, you're so desperate for that first paper [CL: Right].  But once you've published 
one, two, three papers, then, then that kind of goes away I think.  I think almost every 
paper I've ever published, I've either been first or last author [CL: Okay].  Um, there, 
there's a few where I'm kind of stuck in the middle somewhere, but yeah.  But I don't 
think it's a problem.   
CL: Okay.  In that case, can you walk me through a situation in which you were fairly 
represented as an author?  What was the process that made you feel that that was fair? 
I9: Well I think, as I said before, it starts very early on in the, in the process.  Which is to 
say, you know, to give ownership of a project to a member of the lab.  And to say you 
know, "Look, you're going to be the first author on this if you do X,Y and Z [CL: Right].  
So for example, currently in the lab, we're writing a paper where two graduate students 
have both done work on the paper.  But clearly, one of them has done much  more of the 
work than the other.  And so we had a discussion, we had a sit down and said, you know, 
do you feel that you know, you, you would feel that you're being ripped off or do you feel 
this is unfair if you're the middle author and this person's the first author?  And, and that's 
really the way to deal with it is to have a sit down and have an open communication.  
And that's pretty much what we've always done.  I, I think that sometimes as PIs, you 
have to hold back people.  I know my previous PIs have sort of had to you know, rein in a 
little bit because I, you know because I wanted to be a senior author and I kind of got 
[making noise], but as you move on you realize you know, that, that's one of the things 
that motivates you to go and seek your own position [CL: Right] is because you want to 
be the senior author, you want… 
 
[equipment failure; remainder of interview was not recorded] 
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